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PREFACE

As I look back over the last five years the convolutions that my program has
taken are absolutely amazing to me. After completing a residency in Equine Medicine
here at LSU, I began working full time in Dr. Horohov*s laboratory. I had completed
the majority o f my course work during my residency and so I expected that, working full
time in the laboratory, I would complete my Ph.D. in approximately two to three years. I
struggled initially to find a project that held my interest. Evie Vandergrifft had recently
cloned equine IL-2 and IL-4 in our laboratory and interferon-y was available from the
laboratory o f Dr. Doug Antczak, thanks to the efforts of his graduate student Gabriel
Grunig. With the unique availability o f these three reagents, my idea was to determine if
horses exhibit cytokine patterns consistent with the T-helper (TH)1/TH2 paradigm.
Because o f my background in equine medicine and familiarity with the work o f other
investigators in the School o f Veterinary Medicine, I proposed to explore the TH1/TH2
paradigm in three equine diseases that had immunologically well characterized mouse
and human corollaries, influenza virus infection, Strongylus vulgaris infestation, and
Summer Pasture Associated Obstructive Pulmonary Disease (SPAOPD). There was, and
remains to this day, no easy way to identify helper cell phenotypes. There is no magical
surface marker that warns the investigator of a TH1 or TH2 response and so I began, a
veterinarian whose greatest asset is her power of observation, on the road to quantify
messanger RNA in the realm o f the unseeable.
After reviewing the literature I hoped to utilize Northern blotting so as to avoid
the pitfalls of the polymerase chain reaction (PCR). PCR (dubbed ‘polymerase chain
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rubbish’ by some) with it's Iogrhythmic expansion whose efficiency is limited by mispriming, primer dimer, secondary structure, magnesium concentration, annealing and
extension times, pH, and entering the dreaded plateau phase, was something that as a
practicing veterinarian, I surely wanted to stay away from. Besides, people who knew
far more about molecular biology then I said they knew graduate students that spent
years just standardizing their PCR reactions. And so I forged into the land of Northerns,
dot blotting, end-labeling, and random priming, ribo-probing with fluorescent dyes and
radioactive poisons determined to avoid PCR. When dot blotting didn't provide a signal,
I tried solution hybridization northerns (RNase protection) to tap into their 'greater
sensitivity' and stability. But this too did not work. That assay required tremendous
amounts o f RNA (more than 10 pg of RNA per cytokine), had unlimited opportunities
for RNase contamination, and would never be adaptable to large sample numbers. So
after almost two years o f Northern blotting it was time to try a PCR based method.
Southern blotting using fluorescently-labeled random-primed probes was sure to give
results. But the blots again had too much background and were too insensitive. So there
I was, two years o f intense work and no hope o f any data. Frustrated and on the verge
of quitting, I decided to clone equine IL-10 and P-actin so that I would have something
to show for my time, maybe someone would give me my Masters degree if all else failed.
Luckily I did manage to clone these genes but expression and bioassay o f the cytokine
was a little less fruitful. And then it happened, the black box that was to revolutionize
quantification o f PCR products arrived - the Perkin-Elmer QPCR System 5000.
Still reticent about PCR I abdicated that I would have to perform a PCR based
quantification but by now some data was better than no data. And it didn't look as
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though I would ever have data. So into the land of quantitative PCR (QPCR) I forged.
The company literature and initial presentation made the QPCR System 5000 seem like
a Red Rider BB gun. Little did I know just how proficient I would come to be at
understanding the functioning and interpretation of luminosity values from the QPCR
System 5000. One year after the machine's arrival I finally understood how it really
worked (which is actually quite powerful but not exactly in line with my initial
understanding) and with the exception of three months for the birth o f my daughter, I
was ready to 'generate data'.
From my proposal four years earlier, many changes had occurred in the samples
I was to analyze. In fact, as I complete my final writing, samples that I collected to
answer many of the questions that I have formulated sit dormant at -80 °C as the
development of this assay came together too late for me to learn the answers. As for the
original questions of a TH1 response for protection against equine influenza virus, which
has been documented in other species, I initially proposed looking at changes in the
cytokine profile of peripheral blood mononuclear cells derived from horses both before
and after vaccination and stimulated in vitro with influenza virus. Though I initially
suggested to, I did not believe that we would be allowed to nebulize equine influenza
virus to horses in the facilities as they exist at LSU. I noted in my original proposal that
this killed virus vaccine, by virtue o f it's induction of the humoral immune response, was
actually more likely to induce a TH2 response and that our best hope for detecting a
TH1 response with equine influenza hinged on assaying the cytokine profile of
lymphocytes from the portal o f infection (draining the respiratory tract) and comparing
this profile to that of a distant lymph node following a live influenza virus challenge.
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Though I will not personally get to answer these questions, I have not only collected and
frozen RNA to address the vaccination question, but also collected peripheral and
respiratory associated lymphocyte samples from ponies challenged with equine influenza
virus, and been co-investigator on a funded research proposal to address this question o f
TH1 responses in live equine influenza challenge of ponies.
My second disease state of interest, Strongylus vulgaris infestation, became a
focus of this dissertation. My initial proposal sought to characterize the cytokine
response o f peripheral blood mononuclear cells (PBMC) from parasite free and
chronically S. vulgaris parasitized ponies in response to stimulation with a crude S.
vulgaris antigen. As I addressed my committee I noted that data from mice indicated that
a protective TH2 response to gastrointestinal nematodes was sometimes restricted to the
GI tract and not detectable in PBMC, indicating that lymphocytes draining the GI tract
might be more useful in our assays. Over the next few years I managed to collect
lymphocytes from blood, as well the peripheral and colonic lymph nodes of close to a
hundred ponies with a variety o f parasitic conditions. In a moment o f humor I suggested
that following the cytokine response of parasite free ponies to nematode parasite
infestation could be accomplished using serial surgeries. Little did I know this comment
would come to fruition as a funded USDA grant and a whole new set of freezer samples
that would become the focus o f my dissertation.
Being a clinician at heart, my greatest interest lay in the study of horses with
SPAOPD. Horses with this disease suffer immensely and factions studying the disease
stand divided as to how to determine its cause. My original proposal for these horses
was to examine cytokine production from PBMC's collected monthly from horses with
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SPAOPD. I further proposed that bronchoalveolar lavage (BAL) lymphocytes be
evaluated similarly. My first samples were tracheal aspirates (TTA) and had the copious
mucous characteristic o f tracheal aspirates from SPAOPD horses. Unfortunately, after
developing a method to separate the mononuclear cells from the TTA mucous, the
procedure was only repeated once on a limited number of horses. These samples were
collected and frozen. However, as o f this writing, I am aware that a proposal submitted
by Dr. Horohov and Dr. Beadle examining some of the above issues has been funded and
hopefully will provide some direction for therapy in this disease.
It is hard to finish when you feel you are finally ready to embark upon your goals
of six years prior. This preface is to those who secretly wondered what was taking so
long and those who will benefit from my work, ideas, and ‘my legacy’ o f frozen RNA
samples, so that you will know their origins.
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ABSTRACT

The effect o f oral vaccination with radiation-attenuated Strongylus vulgaris
larvae on the cytokine responses o f ponies to oral challenge with S. vulgaris was
examined. Message was quantified using RT-PCR by interpolation against a plasmidderived standard curve. PCR product was detected using the Perkin-Elmer QPCR
System 5000. Standard curves were analyzed with a two parameter exponential rise to
maximum fit o f the data. By altering the cycling parameters to maintain P-actin
amplification within it’s exponential phase, P-actin was used as a normalization factor.
The assay resolves 2 fold changes in message, has a linear dynamic range on the order o f
3 logs, and is precise with errors in the range of 10% for replicate amplifications from
the same sample. The error between replicate RNA samples from separate extractions of
the same cell population, following P-actin normalization, was 13-27%. Equine
Interleukin(IL)- , IL-10, and P-actin were cloned and sequenced for use in this assay.
6

1 0

ponies were reared parasite-free. Four received 500 attenuated S. vulgaris L,

9 and weeks prior to challenge with 1000 nonirradiated L,. Four nonvaccinated ponies
6

were also challenged. Control ponies were neither vaccinated nor challenged. Four days
prior to challenge, and on days 4, 9, and 14 post-challenge, peripheral blood
mononuclear cells (PBMC) and colonic lymph nodes (CLN) were collected. Prior to
necropsy on D14, CLN were obtained surgically. PBMC and CLN cells (CLNC) were
assayed for EL-2, IL-4, EL-5, IL-10, and EFN-y. Vaccinates and nonvaccinates
demonstrated TH2-like cytokine patterns with significant elevations in EL-4 and IL-5 in
response to S. vulgaris challenge. Vaccinates produced more IL-4 and IL-5 than

xvi
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nonvaccinates prior to challenge (not statistically significant), and significantly more EL-4
in response to challenge, first in CLNC at D4 and then PBMC at D9. IL-4 in CLNC o f
nonvaccinates increased significantly by D9. Thus, ponies appear to generate TH2-like
responses to gastrointestinal nematodes and anamnestic IL-4 production may be one
component o f the protective immune response generated by vaccination. Strongylus
vM/gora-specific antibody isotypes and lymphoproliferative responses were also
examined.

xvii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INTRODUCTION

Cytokine production by helper T-lymphocytes has been divided into two
categories based on the relative balance of the cytokines that are produced (Mosmann et
al., 1986). T-helper (TH)1 responses, characterized by a predominance of interferongamma (IFN-y), interleukin (EL)-2, and tumor necrosis factor-alpha (TNF-a)
production, have been shown to be integral to delayed-type hypersensitivity reactions
(DTH), graft rejections, and to the protective immune response to intracellular
organisms such as viruses (reviewed in Abbas e ta i, 1996). TH2 responses, which are
characterized by a predominance o f IL-4, IL-5, and IL-13 production (as well as EL

- 6

and EL-10 in the mouse), are integral to the protective immune response to some
extracellular organisms including gastrointestinal nematode parasites (reviewed in
Finkelman et al., 1997). Because these cytokine profiles have been identified in cell
populations that are not composed purely o f helper T-cells (Robinson et al., 1992), the
terms Type I and Type II responses, respectively, have been coined to describe TH1 and
TH2 cytokine profiles in non-T-cell populations or cell populations that are not purely
CD4+ T-cells.
The purpose of this dissertation was determine the contribution o f Type I and
Type II responses to vaccine induced resistance to Strongylus vulgaris infections. S.
vulgaris is a highly pathogenic gastrointestinal nematode o f horses whose life-cycle,
which takes 4 to

6

months to complete, causes severe inflammation in arteries that

perfuse the intestine (Ogboume and Duncan, 1985). These lesions can compromise
intestinal perfusion resulting in a syndrome, known as verminous arteritis, that is

1
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2
characterized by ischemic infarctions o f the bowel which result toxemia, abdominal pain,
and death in severe cases (White, 1985). However, clinical signs of infection including
pyrexia, anorexia, depression, and colic appear within the first week following ingestion
o f third-stage infective larvae (L3) and are near maximal by 14 days post infection (Klei
et al., 1982). Oral immunization with radiation-attenuated L produces a strong
3

protective resistance to challenge infection which prevents classical lesions of verminous
arteritis and eliminates clinical signs o f infection (Klei etal., 1982).
Natural and experimental infections with S. vulgaris result in eosinophilia and
eosinophilia is known to be an IL-5 (Type II) dependent phenomenon in murine models
(Coffman et al., 1989). Furthermore, when compared to parenteral vaccination with
adult or larval somatic antigen homogenates which did not confer resistance to challenge
infection, the protection observed in ponies vaccinated orally with radiation-attenuated
L correlated to both pre-challenge anti-5, vulgaris antibody titers specific for surface
3

antigens of late L stages, and to induction o f a post challenge anamnestic-like
3

eosinophilia (Monahan et al., 1994). Infections by S. vulgaris have also been shown to
activate eosinophils in vitro (Dennis etal., 1988), and eosinophils from S. vulgaris
primed but not unprimed ponies kill S. vulgaris L in vitro in an antibody-dependent
3

manner (Klei et al., 1992), indicating that an antibody-dependent phenomenon involving
eosinophils may contribute to the resistance seen in immune ponies. In addition, a
cytokine or combination o f cytokines which exhibits chemotactic activity for eosinophils
has been found in the supernatant o f S. vulgaris stimulated peripheral blood
mononuclear cells (PBMC) from immune but not nonimmune ponies (Dennis et al.,
1993). A synthesis o f these findings suggests that differential cytokine production,
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3
perhaps similar to that seen in classical Type n responses to helminth parasites may play
a role in immunity to S. vulgaris.
The underlying hypothesis o f this study was that in the equine, as in murine
species, Type II responses confer protective resistance to gastrointestinal nematode
infection. Identifying Type I and Type II cytokine responses requires cytokine
quantification and so two major portions of this study were devoted to cloning and
sequencing IL

- 6

and IL-10, which are Type II cytokines in the murine system, and

developing a method for quantifying equine cytokine messenger ribonucleic acid
(mRNA). This latter step also necessitated the cloning and sequencing o f equine P-actin
for use as an internal standard in the cytokine quantification assay. Using this assay, the
cytokine responses in both peripheral blood mononuclear cells and colonic lymph nodes
taken from a region o f parasite invasion were examined to elucidate the nature of the
cytokine responses in both vaccinated and nonvaccinated ponies
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LITERATURE REVIEW

The TH1 and TH2 Paradigm
The clinical response to infectious organisms, most notably Mycobacterium
leprae, provided early and convincing evidence of a dichotomy in the immune response.
Patients with the tuberculoid form o f the disease demonstrated reduced numbers of
organisms in association with strong delayed-type hypersensitivity reactions (DTH) and
low levels of antibody, while patients with the lepromatous form displayed large
organism burdens, high antibody titers, and a relative lack of DTH (Turk and Bryceson,
1971). Recognition that CD4+ helper T-cells were required for both antibody and DTH
responses raised questions as to how a helper T-cell subset that appeared phenotypically
homogenous based on surface staining characteristics could present such differing
functional capabilities as antibody production and DTH.
The recognition o f at least two distinct helper T-lymphocyte responses originated
in murine studies o f T-cell help for antibody production. Tada et. al. (1978) first used
the term "Th[" cell to describe a subset of carrier-specific mouse Lytl+,2-,3- helper Tcells which did not adhere to nylon wool, did not express the class II major histocompatability (MHC) antigen la, and provided help for anti-hapten antibody production by Bcells, only if the hapten was linked to a sensitizing carrier on the same molecule. Tada
termed this cognate interaction or 'linked' help. In contrast, Tada's "Th2" cells were nylon
wool adherent, Ia+, and did not depend upon the relevant carrier being coupled to the
hapten in order to provide help for B-cell anti-hapten antibody production (nonlinked
help). Studying cloned Lytl+,2- L3T4a+ helper T-Iymphocytes, Kim et al. (1985) also
4
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5
determined that helper T-cell subsets could be identified by characteristics o f the help
provided for antibody production. Based on their activity in bulk cultures with B-cells,
Kim defined 4 types o f helper T-cell clones. "Type 3" clones were unable to provide help
for antibody production and some actually suppressed the ability o f other clones to
provide help, while "Type 4" clones were specific for antibody directed at class II (la)
antigens. When compared to clones he defined as "Type 1" helper T-cells, Kim's "Type
2" clones resulted in 15 fold greater antibody production, which was predominately of a
single idiotype. Limiting dilution analysis determined that this idiotype specificity
resulted from both a higher precursor number and greater clonal expansion o f the
idiotype specific B-cell precursors. Such differences in precursor frequency for a single
idiotype could not be attributed to the B-cells which bear the same germ-line encoded
idiotype. This lead Kim to postulate that "Type 2", not "Type 1" helper T-cell clones
delivered a critical activation signal for the B-cell in the form o f either enhanced affinity
receptors or more likely via secreted molecules. He suggested that such a molecule from
"Type 2" helper T-cells, now known to be interleukin(IL)-4, could act by increasing
MHC class II expression on B-cells, thereby allowing B-cells with low MHC II
expression to become activated. Collectively these and other early studies indicated that
despite fairly uniform surface distribution of CD3 and CD4 antigens, when assessed by
functional criteria, at least two types of helper T-cells exist whose activities might be
linked to differing patterns o f secreted molecules (Waldman, 1977; Swiekosz et al.,
1979; Asano et al., 1982; Imperiale etal., 1982; Melchers eta l., 1982).
The description by Mosmann et al. (1986) of two classes o f antigen-specific
mouse helper T-cell clones that could be identified not only by differing modes o f B-cell

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

6
help, but more significantly by distinct patterns o f cytokine production was an
immunologic milestone. Mosmann's "TH2" clones, which secreted IL-3, EL-4, and EL-5,
bound nylon wool, were Ia+, enhanced the production of IgGl and IgE by LPS
stimulated B-cells, and stimulated the expression of la antigen on B-cells. In contrast, his
"Th1" clones which secreted EL-2, interferon-Y (EFN-y), granulocyte-macrophage
colony stimulating factor (GM-CSF), and EL-3, did not bind nylon wool, were la-, and
did not possess IgG l, IgE, or la enhancing activities. A second major finding o f this
paper was that the "Th" phenotype was dependent upon the antigen used for clonal
stimulation. Chicken RBC-specific T-cell clones (200 in all) from three different mouse
strains exhibited the "TH1" phenotype, while fowl y-globulin stimulated clones from the
same mice all exhibited the "TH2" phenotype. Interpreted together, these findings
suggest that antigens which induce substantial IgE responses may do so by preferentially
inducing the "TH2" phenotype; whereas antigens that induce high IgM and low IgE titers
may do so by preferentially activating the "TH1" phenotype, which aids in IgM
production and suppress IgE production.
Recognition of distinct cytokine phenotypes in mouse Thl and Th2 clones lead
to attempts to characterize cytokine production by helper T-cells in experimental animals
and humans in response to a variety o f antigenic stimuli, both in vitro and in vivo.
Cloned helper T-cell subsets with characteristic cytokine patterns have been described in
humans (Del Prete et al., 1991; reviewed in Del Prete et al., 1994; Romagnani, 1994),
rats (Druet and Pelletier, 1996), and cows (Brown et al., 1995). However, initial studies
o f existing mitogen induced and alloreactive human T-cell clones indicated that most
clones produced combinations o f the Thl and Th2 cytokines (Maggi et al., 1988;
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Paliard et al., 1988; Umetsu et al., 1988), leading to scepticism regarding the functional
significance o f Thl and Th2 clones in mice (Kelso, 1995). In sharp contrast to the early
human clones which were derived from unimmunized or mildly immunized individuals,
Mosmann's clones originated from strongly immunized mice which were stimulated for
prolonged periods in vitro. Further analysis of cytokine patterns from alloreactive mouse
T-cell clones, T-cell clones maintained for a short period in vitro, and T-cell clones from
unimmunized mice indicated that these clones also exhibited the unrestricted cytokine
patterns of early human T-cell clones (Kelso and Gough, 1988; Mosmann and Coffman,
1989a). Mosmann also observed that the generation of distinct Thl and Th2 phenotypes
was most rapid with cells from mice that had been immunized with antigens that
stimulated strong Thl and Th2 responses in vivo. In support of this observation, the first
human Thl and Th2 clones were generated from normal humans in response to purified
protein derivative (PPD) o f Mycobacterium tuberculosis and exceretory/secretory
antigen of Toxocara canis, respectively (Del Prete et al., 1991). These antigens, as will
be discussed, originate from classes o f infectious organisms, namely intracellular bacteria
and helminth parasites, that classically evoke Thl and Th2 responses, respectively, in
vivo. Together these findings indicate that polarization to a Thl or Th2 response is
dependent not only upon the nature o f the inciting antigen, but also the duration of
exposure to the antigen, with polarization toward the Thl or Th2 response increasing
with the chronicity o f exposure. Unrestricted cytokine patterns, termed ThO, therefore
reflect an earlier step in the maturation of the antigen-specific immune response, while
distinct Thl and Th2 responses become more pronounced in chronic disease states. The
occurrence of clear helper cell phenotypes in association with persistent infections, Thl
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(reviewed in Kaufmann, 1993) in association with leishmaniasis (Reiner and Locksley,
1995), listeriosis (Hsieh et al., 1993b), and mycobacterial infections (Yamamura et al.,
1991), and Th2 in association with helminth infections (Sher and Coffman, 1992),
substantiates this hypothesis.
The characterization o f distinct classes of CD4+ helper T-cells whose functions
are determined by their cytokine repertoire, termed the Thl/Th2 paradigm, provided an
explanation as to how a T-cell subset that appeared phenotypically identical based on
surface staining characteristics could present such differing functional capabilities as
immunoglobulin production and DTH. Several questions raised by Mosmann's
characterization of Thl and Th2 cytokine phenotypes have lead to an explosion of
research in order to elucidate the relationship between antigen stimulation, secretion o f
defined patterns of cytokines by helper T-cells, and generation of the protective antigenspecific immune response. These are: 1) What cytokines define the TH1 and TH2
phenotypes? 2) What is the ontogeny of the TH1 and TH2 phenotypes? 3) How are they
differentially regulated? 4) Is selection of the helper T-cell phenotype by antigen real
and what determines it? and 5) What is the role of each subset in normal in vivo
responses?
Cytokine Phenotypes of T hl and Th2 Responses
Continued investigation into the cytokine repertoires of Thl and Th2 cells has
confirmed that in both human and murine systems, production of EFN-y, IL-2, and tumor
necrosis factor-P (TNF-P) is unique to Thl cells, while only Th2 cells produce EL-4, EL5, and IL-13 (Mosmann et al., 1986; Cherwinski e ta i, 1987; Janeway et al., 1988;
Mosmann and Coffinan, 1989b; Romagani, 1991; Romagnani, 1994). However, IL
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(Romagnani, 1992) and IL-10 (Del Prete et al., 1993), which segregate exclusively with
Th2 cells in mice, are produced by both Thl and Th2 cells in humans.
The nature o f the pathogens which incite Thl and Th2 responses, as well as the
immunologic activities o f the cytokines produced by each helper cell subset, suggest that
Thl responses provide protection against intracellular pathogens through phagocyte
mediated mechanisms, while Th2 responses protect from extracellular pathogens
primarily via phagocyte independent mechanisms. EFN-y has been termed the signature
cytokine of the Thl response (Abbas et al., 1996) and its functions have been reviewed
(Trinchieri and Perussia, 1985). Produced by CD + T-cells, CD4+ Thl cells, and NK
8

cells, EFN-y was initially recognized by its ability to inhibit viral replication in fibroblasts
(Wheelock, 1965). IFN-y is now recognized as a potent activator o f macrophage
function, greatly augmenting oxidative and nitrogen dependent microbicidal activities
(Murray, et al., 1985; Belosevic et al., 1989; Nacy and Meltzer, 1991; Beaman et al.,
1992). IFN-y also modulates expression of class I and IIM HC antigens on a variety o f
cells, potently upregulating class II expression on classical APC and inducing de novo
synthesis on a variety o f other cells (reviewed in Trinchieri and Perussia, 1985). As will
be discussed in more detail, IFN-y is involved in the differential regulation of Thl and
Th2 responses, augmenting induction o f Thl cells while impeding the induction,
proliferation, and effector function o f Th2 cells (Mond et al., 1986; Belosevic et al.,
1989; Gajewskief al., 1989; Swain e ta l, 1991). In the murine system, IFN-y stimulates
the production of complement fixing IgG isotypes, IgG2a and IgG3 (Snapper and Paul,
1987; Coffman et al., 1993), which also bind to the high-affinity Fey receptors o f
phagocytes, making them integral to osponization and phagocytosis of pathogens. In
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addition, IFN-y augments cytotoxic immune mechanisms by directly activating natural
killer (NK) and cytotoxic T lymphocytes (CTL) (reviewed in Trinchieri and Perussia,
1985).
IL-2, whose functions have been extensively reviewed (Smith, 1988; Swain,
1991), is well recognized as an autocrine growth factor for T-ceils which is especially
significant in the development o f antigen-stimulated cytotoxic T-Iymphocyte precursors
into functional cytotoxic effectors, and augmentation of NK responses. However, IL-2
also activates most cells o f the immune system. EL-2 is produced primarily by activated
T-cells, though B-cells have been induced to secrete IL-2 in vitro. IL-2 activates
monocyte mediated cytotoxicity, and increases phagocytosis. In conjunction with other
cytokines, IL-2 induces B-cell differentiation and immunoglobulin secretion (Coffinan et
al’, 1988; Loughnan and Nossal, 1989).
The activates o f TNF-P have been reviewed (Paul and Ruddle, 1988) and mimic
those of TNF-a. Though the two proteins display only 30% amino acid homology, TNFP can activate both o f the TNF-P receptors (Aggarwal and Eessalu, 1987) (whose
expression is upregulated by EFN-y), making TNF-P a mediator of inflammation and
graft rejection, able to recruit and activate inflammatory leukocytes. In addition to
production by CD4+ T-cells, TNF-P is also produced by activated CD + T-cells
8

(Ruddle et al’, 1987), and B-cells (Aggarwal e ta l, 1994). TNF-P was first described as
a cytotoxic activity in culture supemates of activated lymphocytes and is one o f the
cytotoxic mediators involved in CTL, CD4+, NK, and LAK cell killing. TNF-P is
directly cytotoxic toward tumors, both in vitro and in vivo, and has been shown to kill
antigen presenting B-cells, while also functioning as a B-cell growth factor.
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The collective actions o f the TH1 cytokines which induce macrophage cytocidal
mechanisms, the generation o f opsonizing, complement fixing antibodies, and induce

lymphocyte mediated killing mechanisms support the notion that Thl responses are
designed to destroy host cells which have been altered either by infection or malignant
transformation. Cytokine induced mononuclear phagocyte recruitment and activation
lead histologically to inflammatory reactions that are characteristic of delayed type
hypersensitivity reactions. In contrast, the signature cytokines of the Th2 response, IL-4
and IL-5, support the destruction of extracellular invaders, primarily via phagocyte
independent mechanisms.
IL-4 and EL-13 share many, though not all, functions and will therefore be
discussed together. To date at least two mechanisms for this cross reactivity have been
documented. Both cytokines utilize the IL-4 receptor-a (IL-4 Ra) subunit in signal
transduction (Kotowicz et al., 1996; Andersson et al., 1997, Orchransky et al., 1997),
and EL-13 binding to its low affinity receptor induces the expression of a high affinity IL13 receptor capable o f binding IL-4 (Hilton eta l., 1996). However, the receptor system
for these two cytokines still requires study. Both IL-4 (Howard et al., 1982; Isakson et
al., 1982) and IL-13 (McKenzie et al., 1993) stimulate the proliferation of activated Bcells and provide help for immunoglobulin production. In addition to production by Th2
cells, IL-4 is also produced by CD4- CD - splenic T-cells (Zlotnick et al., 1992),
8

CD3+CD4+ CD - Thymocytes (Fischer et al., 1991; Bendelac and Schwartz, 1992),
8

some CD + clones (Yamamura et al., 1991; Seder et al., 1992a), as well as basophils
8

and mast cells (Plaut et al., 1989). IL-13, in addition to production by T-cells, is
produced by mast cells (Krishnaswamy et al., 1997), basophils (Dahinden et al.,, 1997),
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and certain B-cell lines. IL-4 (reviewed in Paul, 1992; Paul and Ohara, 1987) and IL-13
(Defrance et al'., 1994) have stimulatory effects on both resting and activated B-cells,
including increasing MHC H , and Fee receptor expression. Two prominant roles of IL-4
which have been substantiated in vivo are the augmentation o f IgE production via
induction of isotype switching (Kuhn et al., 1991; also reviewed in Finkelman et al.,
1990; Schultz and Coffinan, 1992), a function demonstrated in vitro by EL-13 in an EL-4
independent manner (Punnonen et al., 1993), and the ability to drive the Th2 response
(Zlotnick et al., 1987; Swain et al., 1990) while inhibiting the generation o f the Thl
response (LeGros et al., 1990; Swain et al., 1990). Inhibition o f Thl responses by EL-4
also applies to IL-2 stimulated B-cells whose proliferation is inhibited by IL-4 (reveiwed
in Paul, 1992). IL-4 also augments the production of non-complement fixing IgG
isotypes (Bruggemann et al., 1987; Dangl e ta l, 1988), IgGl in mice, and IgG4 in
humans. Augmentation of IgG4 production by human B-cells has also been
demonstrated by IL-13 (Punnonen et al., 1993). Both IL-4 and IL-13 have also been
shown to act as cofactors in the inhibition of B cell apoptosis (Lomo et al., 1997).
Though IL-4 and IL-13 do enhance MHC II expression on monocytes
(McKenzie et al., 1993), both cytokines also exhibit potent inhibitory effects on
monocytes (Figdor and te Velde, 1992; de Waal Malefyt et al., 1993; Doherty et al.,
1993; Bogdan et al., 1997; Mijatovic et al., 1997). IL-4 and IL-13 inhibit monocyte
cytotoxicity by decreasing production o f monocyte derived cytotoxic metabolites, such
as nitric oxide (Doherty et al., 1993), as well as inhibiting the production o f a wide range
of monokines, including IL -l, EL-6, IL- , IL-10, EL-12, GM-CSF, granulocyte colony
8
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stimulating factor (G-CSF), IFN-a, and TNF-a (de Waal Malefyt et al., 1993). Both
IL-4 and IL-13 also increase production o f the EL-1 receptor antagonist (IL-IRa).
Both IL-4 and IL-13 have unique attributes. IL-4 is a growth factor for mast
cells (reviewed in Figdor and te Velde, 1992) that also enhances CTL differentiation
(Widmer et al., 1987) and has demonstrated potent anti-tumor activity in vivo. EL-4
induces tumor infiltration by cytotoxic eosinophils, followed by a long lived immunity
that is mediated by CTLs (Tepper et al., 1989; Bosco et al., 1990; Golumbek et al.,
1991; Tepper et al., 1992). In contrast to EL-4, IL-13 does not inhibit production of
EFN-y, RANTES (regulated on activation, normal T expressed and secreted),
macrophage inhibitory proteins l- a and 1-p, or perforin by IL-2 stimulated T cells
(Minty et al., 1997). IL-13 functions as a cofactor for dendritic cell differentiation
(Piemonti et al., 1995) and like EL-4 induces the expression o f VCAM-1 (vascular cell
adhesion molecule-1) on endothelial cells (Ying et al., 1997). IL-13 also induces MCP-1
(monocyte chemoattractant protein- ) release from endothelial cells (Goebeler et al.,
1

1997), which in coordination with VCAM-1 upregulation results in recruitment of
inflammatory cells including eosinophils, monocytes, and T-cells.
Recent studies have indicated that IL-4 and IL-13 can exhibit paradoxical effects
on monocytes, inducing both activation and suppression o f monocyte functions
(Kanbayashi et al., 1996; Minty et al., 1997). To date the differences in action o f these
two cytokines have related to the timing of monocyte exposure to IL-4 and IL-13. When
monocyte exposure to IL-4 or EL-13 preceded LPS or SAC stimulation, monocyte
activation, characterized by increased monokine production, ensued whereas
cotreatment with IL-13 or IL-4 and LPS inhibited monocyte activation. This differential
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effect is an area o f ongoing interest which may have significant ramifications for the
modulation o f the inflammatory response in the face o f ongoing infection.
In vivo neutralization experiments indicate that IL-5 is the predominant regulator
of eosinophilia (Coffinan e t al., 1989; Sher et al., 1990b; Korenaga eta l., 1991; Urban et
a l, 1992) stimulating mature eosinophil progenitors to proliferate and differentiate into
mature effector cells (reviewed in Sanderson, 1992). IL-5 was originally described as a
B-cell stimulatory factor (reviewed in Takatsu, 1991) and has demonstrated growth and
differentiation activities in the murine system, including differentiation o f antigen
stimulated B cells to plasma cells, and expression of the IL-2 receptor. However, the
role of EL-5 in human B-cell growth and differentiation remains controversial (Azuma et
a l, 1986; Yokota et a l, 1986; Clutterbuck et al., 1987).
IL

- 6

is a Th2 cytokine in the murine system. However, this polarization is not

always clear in human CD4+ subsets (Romagnani, 1992). EL was initially described in
- 6

separate experiments as an antiviral, hybridoma/plasmacytoma growth (Nordan and
Potter, 1986; Van Snick et a l, 1986), hepatocyte stimulating, and B-cell stimulating
factor (Hirano et a l, 1985). The biology and functions of EL

- 6

have been extensively

reviewed (Akira e ta l., 1990; Van Snick, 1990; Hirano, 1992). IL

- 6

is produced by

macrophages, T-cells, B-cells, fibroblasts, and a variety of transformed cells (Hirano et
a l, 1985; Kawano et al., 1988; Tsato et a l, 1988). It is an inflammatory cytokine that
demonstrates a broad spectrum o f actions, overlapping those o f TNF-a and IL-1. Unlike
TNF-a and IL-l, which amplify their own production as well as the production of EL

- 6

(Shalaby et a l, 1989), IL

- 6

suppresses production of both TNF-a and EL-1 by

macrophages (Schindler et a l, 1990). EL functions in an endocrine manner, traveling
- 6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

15
via the blood stream to induce systemic events collectively termed the acute phase
response and characterized by fever, and the hepatic synthesis of proteins including C3,
haptoglobin, serum amyloid A, alpha^macroglobulin, and fibrinogen (Ramadori et al.,
1988). IL

- 6

induces monocytopoesis (Jansen et al., 1992) and synergizes with IL-3 in

the induction o f pleuripotent stem cell differentiation (Ikebuchi et al., 1987). IL

- 6

exhibits a late effect on both B-cell and CTL function, augmenting IgM secretion in
proliferating B-cells (Hilbert et al., 1989), and IL-2 expanded CTL function (Takai et al.,
1988; Uyttenhove et al., 1988), presumably via induction of serine esterase, and perforin
(Liu et al., 1990). IL

- 6

has exhibited characteristics of a costimulator for T-cells by

permitting a growth response to EL-2 ( Garman et al., 1987; Stein and Singer, 1992). IL6

appears to play an important role in the mucosal immune response, functioning as a

cofactor in IgA production (Rafferty and Montgomery, 1995; Okahashi et al., 1996; Van
Cott et al., 1996; Yamamoto et al., 1996), but does not appear to function as an IgA
heavy chain switch factor (Kawanishi and Joseph, 1991).
EL-10 was first characterized independently by two research groups as a factor
from murine Th clones that inhibited EFN-y production by Thl clones (Fiorentino et
2

al., 1989), as well as a factor in B-lymphoma supemates that enhanced the proliferation
o f murine thymocytes in response to IL-2 and IL-4 (Suda et al., 1990). These activities
were later confirmed to be EL-10 (MacNeil et al., 1990). The biologic activities of EL-10
have been reviewed (Moore et al., 1993). IL-10 inhibits cytokine synthesis by murine
and human Thl cells, human Th2 and ThO cells, NK cells, and macrophages. IL-10
inhibition o f cytokine production by Thl and NK cells is indirect, being macrophage
dependent. Similarly, IL-10 also inhibits macrophage dependent T-cell proliferation. The
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macrophage cytokine profile inhibited by IL-10 (de Waal Malefyt et al. 1991; Fiorentino
etal., 1991; D’Andrea etal., 1993) parallels the inhibitory actions previously described
for IL-4 and IL-13, inhibiting TNF-a, EL- , IL- , IL- , GM-CSF, and G-CSF
1

6

8

production, while also increasing EL-lRa production (Pajkrt et al., 1997), and decreasing
reactive nitrogen and oxygen intermediates (Bogdan et al., 1991; Cunha e ta l, 1992;
Gassinelli et al., 1992). The effects o f EL-10 on macrophages that lead to inhibition of
IFN-y synthesis by T cells are multiple. EL
-

1 0

inhibits production of the p40 component

of IL-12, which is produced by macrophages primarily in response to bacterial products
and has been shown to be required for optimal EFN-y production in vitro (Trinchieri et
al., 1992; D’Andrea et al., 1993). IL-10 also inhibits production of EL-1, which
functions as a co-stimulatory molecule for EFN-y production by T cells (D’Andrea et al.,
1993). EL-10 inhibits upregulation o f B7 expression, which is significant in macrophage
costimulation (Ding et al., 1993). EL-10's inhibition of TNF-a production by
macrophages also eliminates a necessary costimulatory factor for IFN-y induced
macrophage activation (Oswald et al., 1992). There is also evidence that EL-10 plays a
role in the paradoxical activation and suppression of monocytes induced by both IL-4
and EL-13, with EL-10 levels being elevated in association with antigen/cytokine timing
manipulations that result in monocyte suppression and decreased in association with
those manipulations that result in macrophage activation (Kambayashi et al., 1996). In
vivo experiments support the in vitro findings that IL-10 is a modulator o f the
inflammatory response. IL-10 protects mice from lethal endotoxic shock mediated by
inflammatory cytokines, including TNF-a and IL-1 (Howard etal., 1993a), and
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neutralization o f IL-10 in vivo results in elevated IFN-y, TNF-a, and IL

- 6

(reviewed in

Howard etal., 1993b).
One o f IL-10's earliest documented activities was the ability to augment the
growth and proliferation o f murine mast cells lines in response to EL-3 and IL-4. IL-10
also augments the proliferation, differentiation, and immunoglobulin secretion of
activated B-cells. In conjunction with EL- , IL-10 appears to play a significant role in the
6

generation o f IgA responses, though not via isotype switching (Jackson et al., 1996;
Okahashi et al., 1996; Van Cott et al., 1996; Yamamoto et a l, 1996). In addition, IL-10
depleted mice also have decreased serum IgM and IgA depletion o f peritoneal B-cells,
and fail to develop in vivo antibody responses to bacterial antigens, highlighting the role
of IL-10 in B-cell function.
Ontogeny of T h l and T h2 Responses
It is now clear that T hl and Th2 cells originate from antigen naive CD4+ T-cells,
termed pre(p)TH (Swain e t al., 1991). Upon receptor engagement and costimulation,
pTH produce IL-2 but little or no EL-4 or IFN-y. Upon priming, pTH cells can develop
into cells that make IL-4 or IFN-y, termed effector(e)THl and eTH2, respectively.
Generally, IFN-y producers retain IL-2 production while IL-4 producers loose it. pTH
cells may traverse through a ThO like state in which both EFN-y and EL-4 are produced
prior to differentiation into eTH phenotypes, but it is not clear if this state is obligatory.
Early support for this single cell progenitor came from 48 hour mitogen stimulated single
cell cultures which were split into culture pairs and cultured under conditions favoring
IFN-y or EL-4 production (Rocken et al., 1992). Upon restimulation, twin cultures from
the same parent cell produced EL-2 or IL-4, depending upon the culture method.
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Differentiation o f the naive CD4+ T cells into EFN-y producing TH1 or EL-4
producing TH2 phenotypes is driven primarily by cytokines which reflect the
environment and nature o f the inciting antigen. EL-12 drives differentiation into the IFNy secreting Thl phenotype (Hsieh et al., 1993), while EL-4 is the primary driving force
for the differentiation o f naive CD4+ T cells into IL-4 secreting Th2 phenotypes (LeGros
etal., 1990; Hseih etal., 1992; Seder etal., 1992b).
EL-12, which is produced primarily by activated macrophages and dendritic cells,
is potently induced by intracellular pathogens (reviewed in Scott, 1993). IL-12 activates
three transcriptional factors: signal transducer and activator o f transcription (STAT)l,
STAT3, and STAT4, of which STAT4 is exclusively activated by EL-12 (Jacobson et al.,
1995). EL-12 (Magram et al., 1996) and STAT4 knock out mice (Kaplan et al., 1996;
Thierfelder et al., 1996) display markedly reduced Thl responses. Prior to the
characterization o f EL-12 there was some evidence that EFN-y was the driving force for
Thl differentitation. IFN-y induced substantial EFN-y production in polyclonally
stimulated mouse CD + spleen cells, but unlike IL-4, which potently induced both IL-4
4

and IL-5 production, EFN-y only supported low to moderate IL-2 production (Swain et
al., 1991). However, more reductionist experiments using murine T-cells with antigenspecific transgenic T cell receptors (TcR) indicated that IFN-y was not sufficient for
IFN-y priming (Seder et al., 1992b), suggesting that while EFN-y augments Thl
expansion and possibly differentiation, it is not itself sufficient to bias the immune
response toward the Thl phenotype. EL-12 itself is a primary mediator of IFN-y
production from T-cells and NK cells (Chan et al., 1991; D ’Andrea et al., 1992) and
EFN-y promotes TH1 development by enhancing macrophage IL-12 transcription (Hayes
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et al., 1995; Ma et al., 1996) and by maintaining the expression o f IL-12 R P subunit on
2

CD4+ T-cells (Gollob et al., 1997; Szabo etal., 1997). IL-10 ( D'Andrea et al., 1993)
and IL-11 (Leng etal., 1997) inhibit IL-12 production by macrophages, and EL-12 can
induce IL-10 production by human T cell clones (Meyaard et al., 1996). Though the
significance o f this latter finding has not been substantiated, collectively this suggests a
Thl induction loop. Cytokines induced by intracellular pathogens facilitate pathogen
destruction by activating macrophages and then induce negative feedback in the form of
IL-10, which downregulates the reaction after the inciting agent is eliminated.
IL-18 is a newly characterized cytokine (Okamura etal., 1995), also termed
EFNy-inducing factor, which like IL-12 may be important in the development of the Thl
response. Studies are limited at this time and have been restricted to the murine system.
Like IL-12, EL-18 has been produced by activated macrophages in response to bacterial
products (Okamura et al., 1995) and shares IL-12's capacity to induce IFN-y production
by Thl cells, as well as to induce the production of IL-2 and GM-CSF, while inhibiting
IL-10 production (Ushio et al., 1996). IL-18 has been shown to serve as a costimulatory
factor for established Thl clones activated in a variety of manners, as well as antigen
stimulated T cell lines, augmenting their proliferation and production o f IFN-y, whereas
IL-18 failed to support EL-4 production or proliferation from similarly stimulated Th2
clones (Kohno et al., 1997). IL-18 is a more potent inducer o f IFN-y production than
IL-12 and appears to utilize a separate induction pathway (Kohno et al., 1997). Though
the role of IL-18 in driving pTh to Thl cells has not been fully elucidated, recent
evidence suggests that IL-18 is dependent upon IL-12 mediated upregulation of the EL-
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18 receptor for its activity, making it likely that IL-12 remains the pivotal Thl inducing
cytokine (Ahn et al., 1997).
The mechanisms involved in the generation o f Th2 cells are not as clear as those
that drive Thl differentiation. EL-4 is considered to be the primary driving force, though
its signaling pathway and origins remain enigmatic. Two transcriptional factors are
currently known to be activated by IL-4, STAT and insulin response substrate (IRS)-2
6

(Hou et al., 1994; Ryan et al., 1996). Though the mechanism by which STAT induces
6

IL-4 production is not clear, a multimeric STAT binding site does exist within the IL-4
6

promoter (Lederer et al., 1996), suggesting that IL-4 may participate in an
autoregulatory mechanism. Prolonged activation of STAT is characteristic of
6

populations undergoing Th2 differentiation, and STAT is activated in an autocrine
6

manner when differentiated Th2 populations are stimulated by antigen receptor ligation
(Lederer et al., 1996). Furthermore, IL-4 (Kuhn et al., 1991; Kopf et al., 1993) and
STAT knock out mice (Kaplan et al., 1996; Shimoda et al., 1996; Takeda et al., 1996)
6

exhibit deficient Th2 responses. Other transcription factors including NFAT, which is
activated in both eThl and eTh2 cells but only supports IL-4 production by eTh2 cells
(Rincon and Flavell et al., 1997), and NIP45, which has been shown to synergize with
NF-AT and proto-oncogene c-Maf to drive IL-4 production in B lymphoma cells
(Hodge et al., 1996), suggest that the control of IL-4 upregulation is complex. In light
of the potent suppressive effects of IL-4 and its associated Th2 cytokine congeners,
intricate regulation o f Th2 induction is not so surprising.
Because IL-4 appears to be the earliest signal for TH2 differentiation and it
appears to be autoregulated, many theories have been proposed to explain the original
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source o f IL-4 that drives Th2 differentiation. Naive T cells produce small amounts of
JQL-4 upon initial activation (Schmitz et al., 1994), and it is proposed that Th2 induction
may result from a threshold effect, with IL-4 levels necessary to drive the Th2 response
resulting from a collective increase in lymphocyte activation at the local site o f antigen
presentation. Along these lines, it has been suggested that antigens stimulating Th2
responses may act as superantigens (Paul and Seder, 1994) or be presented in
association with nonpolymorphic molecules (Yoshimoto and Paul, 1994) inducing the
production o f small amounts o f LL-4 from a large number of CD4+ T-cells with diverse
TcR specificities. Other cells have also been implicated, including mast cells and
basophils (Plaut et al., 1989), and NK 1.1T cells (reviewed in Bendelac et al., 1997).
Mast cells and basophils have been discounted by some because immunoglobulin
mediated triggering requires prior exposure to the antigen for B-cell priming. However,
there is ample evidence that mast cells and basophils can be triggered via
nonimmunologic mechanisms as well as via the induction of products o f the complement
cascade, C3a, and C5a (Rockoff et al., 1970; Findley et al., 1981; Sheflfer, 1983;
Eggleston et al., 1984).
Though cytokines appear to be the major driving force that determines which Th
response will be generated, a number o f other factors including co-stimulation by
accessory molecules, the dose o f the antigen, and the type of antigen presenting cell have
been shown to influence pTh differentiation. However, there is conflicting data regarding
the role that each of these factors plays in determining the Th phenotype. The best
defined co-stimulators are B7-1 and B7-2, whose kinetics have been characterized on B
cells and dendritic cells cultured in vitro (Hathcock et al., 1994), but not on traditional
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antigen presenting cells during in vivo immune responses. B7-2 expression, which tends
to exceed B7-1 by as much as 100 fold (Inaba et al., 1994), is induced early during
activation, followed later by B7-1 expression. However, alterations in the course of B7-2
and B7-1 expression have been characterized (Hathcock et al., 1994; Lenschow et al.,
1994; Constant et al., 1995). Both molecules bind to their T-cell receptors, CD28 and
CTLA4, with differing avidity (Kariv et al., 1996) and CD28, which is constitutively
expressed on all T cells, has a 20 fold lower binding avidity for B7 molecules than
CTLA4, which is expressed following activation (Linsley et al., 1991b).
CD28/B7 interactions are required for early IL-2 production during activation o f
naive T-cells, thereby complicating interpretation o f the effects o f B7 interactions on Th
differentiation (Seder et al., 1994). Blocking of CD28/B7 interactions in Thl clones,
which inhibited IL-2 production but did not affect cytokine secretion by Th2 clones,
provided the first evidence o f a possible B7 mediated costimulatory effect (Mcknight et
al., 1994). Since that time studies of B7 mediated signals have yielded conflicting results.
A number of studies using antibodies to B7-1 and B7-2 indicate that B7-1 mediated Tcell stimulation provides co-stimulatory signals for TH1 differentiation, while B7-2 helps
to drive TH2 differentiation (Freeman et al., 1995; Kuchroo et al., 1995, Lanier et al.,
1995 and reviewed in Constant and Bottomly, 1997). However, there are also conflicting
studies that report the reverse effect (Lenshow et al., 1995; Levine et al., 1995; Natesan
et al., 1996) or no effect (Lanier et al., 1995 and reviewed in Constant and Bottomly,
1997) on Th differentiation. In contrast to the aforementioned studies which examined
the immune responses to systemically administered protein antigens, B7-1 and B7-2
neutralization experiments in a mouse model of gastrointestinal nematode infection in
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which Th2 responses are protective showed that blocking both molecules was required
to decrease Th2 responses, but there was no elevation in Thl cytokines (Gause et al.,
1997).
The variable effects o f anti-B7 antibodies in different disease states have been
postulated to reflect the significance of different antigen presenting cells and
concentrations of antigen at different stages of an infection (reviewed in Constant and
Bottomly, 1997). Differing characteristics of the antigen, including low dosage and/or
other characteristics that result in weak TcR signaling, could increase the requirements
for costimulation which may be mediated primarily by B7-2 because it is more rapidly
upregulated. Whereas, in the case o f high antigen density or antigens that for other
reasons potently signal via the TcR, the need for co-stimulation may be limited or even
bypassed, such that exogenously added blocking antibodies would have little effect on
the response. Other authors have suggested that differences in neutralization studies with
B7-1 and B7-2 reflect differences in the nature of the immune response to intact
pathogens, as compared to protein antigens, withB7-l being able to provide both a co
stimulatory and a down-regulatory signal (Gause et al., 1997).
Equally confusing and interrelated are the effects o f differential B7 signaling
through the CD28 and CTLA4 receptors on T cells. However, unlike B7 mediated
signaling experiments, a variety o f in vitro and in vivo systems suggest that CTLA-4
mediated signaling is integral to the generation of Th2 responses in naive T-cells
(reviewed in Gause et al., 1997). Blocking CTL-4 mediated signaling at the beginning o f
the immune response inhibits the generation of Th2 responses but has no effect if
administered following the initiation of the immune response (Corry et al., 1994; Lu et
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al., 1995, 1995). Taken together with the dependence o f Thl clones and naive T-cells on
TcR and CD28 mediated signaling for activation and IL-2 production (Linsley et al.,
1991a; Reiser et al., 1992), and the ability o f some Th2 clones to utilize EL-4 as an
autocrine growth factor (McArthur and Raulet, 1993) or to utilize IL-1 as a cofactor
with TcR crosslinking without CD28 costimulation (Lichtman et al., 1988; Weaver and
Unanue, 1990; McArthur and Raulet, 1993), CD28/CTLA-4 signaling appears to be
required for IL-2 and IFN-y production in vitro and for the differentiation of naive Tcells into Th2 cells, but not for the activation o f differentiated Th2 cells, which appear to
be able to utilize other co-stimulatory molecules (reviewed in Gause et al., 1997).
Differential Regulation of T h l and Th2 Responses
Shortly after characterization of Thl and Th2 clones it was discovered that IFNy could inhibit proliferation and cytokine synthesis o f Th2 clones (Femandez-Botran et
al., 1988; Gajewski and Fitch, et al., 1988) and search for a Th2 derived cytokine that
inhibited cytokine synthesis o f Thl cells lead to the discovery o f IL-10 (Doherty et al.,
1993). Continued interest in the differential regulation o f these two populations has
indicated that cytokines from each Th population inhibit functions of the opposite
phenotype. The cross-regulatory mechanisms appear to be quite complex with co
stimulatory molecules and a variety of cytokines being capable of exerting inhibitory
roles. Significantly, IL-13 has been shown to inhibit IL-12 production by macrophages
(de Waal Malefyt et al., 1993). However, this discussion will be limited to crossregulatory mechanisms mediated by IL-4, EL-10, IFN-y and IL-12.
IL-4 has been shown to prevent the generation o f IFN-y producing Thl cells
from accessory cell stimulated TcR transgenic (Hseih et al., 1992; Seder et al., 1992b;
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Tanaka et al., 1993) and polyclonally stimulated naive CD4+ T cells (reviewed in Swain
et al., 1991). There is also ample evidence that IL-4 inhibits effector functions o f Type I
populations in vivo. IL-4 inhibited delayed type hypersensitivity reactions and IFN-y
production by lymphocytes draining the site o f antigen challenge as effectively as IL-10
(Powrie et al., 1993). In the murine model of Leishmania major infection in which
susceptibility is associated with a Th2 cytokine profile and resistant mice exhibit a Thl
cytokine profile, exogenous IL-4 blocks the generation of the IFN-y producing
protective Thl phenotype in resistant strains (Chatelain et al., 1992), while neutralizing
EL-4 at the time of/,, m ajor challenge converts susceptible mice to a resistant Thl
response (Heinzel eta l., 1989;; Saddick et al., 1990; Chatelain etal., 1992). Unlike IL4 neutralization, neutralizing IL-10 does not change the course o f L. major infection in
susceptible strains (Coffinan et al., 1991), suggesting that IL-4 may be more potent than
EL-10 in the differential regulation o f Th phenotype. However, unlike IL-10, IL-4 does
not inhibit proliferation or cytokine production by Thl clones .
Despite the intense interest in Thl and Th2 responses, the mechanisms by which
IL-4 inhibits Thl differentiation and EFN-y production are poorly characterized. IL-4 has
been shown to down regulate expression of the IL-12 R P subunit during Th2
2

differentiation, thereby inhibiting IL-12 signaling that drives Thl differentiation (Gollob
et al., 1997; Szabo et al., 1997). IL-4 is also a potent down regulator o f macrophage
function and has been shown to reduce CD40 mediated IL-12 secretion by dendritic cells
(Kelsall et al., 1996). EL-4 inhibition o f IL-2 production and associated priming for
IFN-y production may also play a factor (reviewed in Seder and Paul, 1994), though
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IFN-y does not appear to be essential for the generation of Thl responses in all systems
(Seder etal., 1993; McKnight et a l, 1994).
EL-10 was first recognized as a cytokine produced by mouse Th2 clones that
inhibited cytokine synthesis by, but not proliferative responses o f Thl clones
(Fiorentino eta l., 1989). However, human IL-10, which is clearly not exclusively a Th2
cytokine, has been shown to inhibit both proliferation and cytokine production by Thl as
well as Th2 cells (Del Prete e t al., 1993). In the face of conditions that usually propagate
a Th2 response, including in vitro cultures of TcR transgenic mouse T cells (Coffinan et
al., 1991), as well as in vivo models of murine gastrointestinal nematode infection
(reviewed in Urban et al., 1991b), neutralization of IL-10 changes the cytokine pattern
to Thl-like. However, as previously noted, IL-10 neutralization is not sufficient to alter
the course of L. major infections in susceptible hosts, while IL-4 neutralization will
(Coffinan et al., 1991).
Early on it was recognized that IL-10's inhibitory effect on cytokine production
by Thl clones required antigen presenting cells and had a delayed onset

( 8

hours)

(Fiorentino et al., 1989), suggesting that IL-10 acted via an indirect APC dependent
mechanism. Consistent with these early findings, EL-10 has been shown to inhibit
expression o f co-stimulators, such as B7-1 on antigen presenting cells (Ding et al., 1993)
that are required for up regulation of IFN-y production by some Thl clones, and to
inhibit the induction of Thl development from naive T-cells by inhibiting IL-12
production by antigen presenting cells (D*Andrea et al., 1993; Kennedy et al., 1994;
Murphy et a l, 1994; Minty et a l, 1997).
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IFN-y and IL-12 have both been shown to play a role in the down regulation of
Th2 responses. IFN-y inhibits the proliferative response o f Th2 cells (Femandez-Botran
et al., 1988; Gajewski and Fitch, 1988; Maggi et al., 1992), as well as their generation
from naive CD4+ cells (Femandez-Botran et al., 1988; Noble et al., 1993). However,
this latter effect is dependent upon the degree of IL-4 priming present (Seder et al.,
1992b). With optimal levels o f EL-4, EFN-y is not sufficient to inhibit the generation of
the Th2 phenotype. However, in the presence of suboptimal IL-4 concentrations, IFN-y
inhibits the generation o f IL-4 producing Th2 cells. In vivo findings in the mouse L.
major model using IFN-y supplementation (Scott, 1991) and neutralization (Reiner and
Locksley, 1995) substantiate the findings that IFN-y decreases IL-4 production in
susceptible strains, but unlike IL-4 neutralization, IFN-y administration is not sufficient
to induce the protective Thl phenotype (Sadick et al., 1990; Reviewed in Scott, 1991;
Reiner and Locksley, 1995).
The mechanisms by which IFN-y inhibits Th2 differentiation and effector
functions are not clear. CD28 mediated co-stimulation of Th2 cells has been
demonstrated to induce IL-4 responsiveness in an EL-1 dependent manner, and IL-1
receptors, which are expressed on T-cells only after primary stimulation (Luqman et al.,
1992), are upregulated on Th2 cells following EL-4 exposure (Koch et al., 1992).
Accordingly, a growing number o f experiments indicate IFN-y inhibits Th2 proliferation
by inhibiting EL-1 co-stimulation (Gajewski and Fitch, 1988; Oriss etal., 1997).
Differentiation to Thl is also associated with loss of the IFN-y RP chain which is
maintained on ThO and Th2 cells (Pemis et al., 1995), and Th2 cells have been shown to
transduce signals via this receptor that are lacking in Thl clones (Pemis et al., 1995;
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Groux et a l, 1997), suggesting that IFN-y may provide negative signals that inhibit Th2
differentiation. However, the significance o f the IFN-y receptor on Th2 cells remains
enigmatic. Studies o f rIL-12 mediated suppression of Th2 responses in murine
leishmaniasis (Heinzel et al., 1993) and murine graft vs host disease (Via e t al., 1994)
indicate that IFN-y is required for inhibition of IL-4 priming. Accordingly, IFN-y KO
mice on a resistant Thl background switch to the susceptible Th2 phenotype when
challenged with L. major (Wang e t al., 1994a). However, IFN-yR KO mice effectively
mount Thl responses to pseudorabies (Schijns et al., 1994) and L. major (Swihart et al.,
1995), even in the presence o f IFN-y neutralizing antibodies.
While it is well accepted that IL-12 inhibits Th2 responses (Manetti et al., 1993),
factions stand divided as to the IFN-y dependence of this inhibition. As previously
indicated, IL-12 mediated Th2 inhibition has been shown to be EFN-y dependent using
EFN-y neutralization experiments in a number of murine Th2 models, including graft vs
host disease (Via et al., 1994), the egg granuloma stage of S. mansoni (Finkelman et al.,
1994; Oswald et al., 1994; Wynn et al., 1994), anti-IgD stimulation (Morris et al.,
1994), and leishmaniasis (Heinzel e ta l., 1993). However, the leishmaniasis model
presents a paradox. IL-12 adminstration at the time of infection protects susceptible
strains in an IFN-y dependent manner (Heinzel et a l, 1993), but other experiments
support direct inhibition o f IL-4 production by IL-12. Exogenous EL-12 decreases EL-4
transcription and protein production, converting susceptible strains to resistant if
administered during the first week o f infection (Seder et al., 1993; Sypek et al., 1993), a
time when both resistant and susceptible strains produce equivalent amounts o f IFN-y
(Morris et al., 1992; Reiner et al., 1994). Furthermore, experiments with EFN-y

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

29
neutralization in Balb/c and IFN-y KO mice indicate that IL-12 can directly inhibit EL-4
transcription independent o f IFN-y (McKnight e ta l., 1994; Wang e ta l, 1994b). As
with all cytokine treatments, timing appears critical in that rIL-12 cannot suppress
established Th2 responses (Heinzel e ta l, 1993; Finkelman eta l., 1994; Via et a l, 1994;
Wang et al., 1994b), due to a lack of the IL-12R signaling chain on ThO and Th2 cells
(Szabo et al., 1995; Gollob et a l, 1997; Rogge et a l, 1997). However, the finding that
early exposure o f Th2 cells to EFN-y maintains the EL-12RP subunit (Szabo et al., 1997)
suggests a mechanism by which some CD4+ subpopulations can exhibit IFN-y
independent EL-12 mediated suppression of IL-4 production.
In Vivo Significance of the Thl/Th2 Paradigm
Studies o f L. m ajor in mice were especially significant because they
demonstrated for the first time that susceptibility or resistance to disease are attributable
to the specific Thl or Th2 phenotype that is generated during interaction with the
pathogen and that endogenous cytokines produced as a result o f interaction with the
pathogen not only determine the Th phenotype that is generated, but can be manipulated
to direct the development o f a protective or resistant Th phenotype (reviewed in Reiner
and Locksley, 1995). Thus, lymphocytes draining the lesions of disease resistant
C57BL/6 and C3H/HeN mice produced Thl cytokines, while lymphocytes draining the
lesions of Balb/c mice, which develop a chronic and eventually lethal systemic disease,
produced Th2 cytokines. Furthermore, treatment of resistant mice with anti-EFN-y or
anti-IL-12 ablated Thl development resulting in a susceptible Th2 expressing phenotype,
whereas treatment of susceptible mice with anti-IL-4 or IL-12 supplementation inhibited
Th2 differentiation and conferred a resistant Thl phenotype. Interestingly, IFN-y
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supplementation was not sufficient to drive conversion of susceptible mice to the
resistant phenotype, though it did substantially reduce IL-4 production. Further
investigation has substantiated a major role for IFN-y in protection from Leishmania in
that resistant C57BL/6 mice with disruption of the EFN-y gene converted to the
susceptible Th2 phenotype (Wang et al., 1994a). However, other non-IFN-y dependent
mechanisms for control of Leishmania appear to exist as IL-12 has been shown to
suppress IL-4 transcription even in the absence of IFN-y (McKnight et al., 1994; Wang
etal., 1994b).
Since the original characterization of Thl induced resistance to L. major, a
growing number o f studies have supported the notion that Thl responses, by virtue of
their EFN-y and TNF-a mediated potentiation of macrophage cytocidal activities, play a
crucial role in defense against a wide variety of intracellular pathogens, including
parasites, bacteria, and viruses (Sher and Coffinan, 1992; Kaufman, 1993). Thl
responses have been associated with protection in human leprosy (Yamamura et al.,
1991b), human lyme disease (Yssell et al., 1991), human leishmaniasis (Pirmez et al.,
1990; Pirmez et al., 1993), Toxoplasma gondii (Suauki et al., 1989), Plasmodium sp.
(Sedegah et al., 1994; Stevenson et al., 1995), Cryptosporidium parvum (Ungaar et al.,
1991; Urban et al., 1996), Listeria monocytogenes (Buchmeier and Schreiber, 1985;
Hsieh et al., 1993), and murine cytomegalovirus (Orange et al., 1996) infections (From
Finkelman et al., 1997). However, macrophages are certainly not the sole mediators of
resistance in Thl dominated responses in vivo, with NK cell, CTL, and cytotoxic
antibody responses all being induced or augmented by Thl cytokines.
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Thl responses by virtue o f their activation and recruitment o f macrophages to
the site o f infection result in delayed type hypersensitivity reactions. This is especially
true for slow growing, persistent organisms, such a sM leprae, for which resistance has
been associated not only with the development of Thl responses but also the presence o f
granulomatous inflammation (Yamamura etal., 1991). However, Thl responses, by
virtue of the toxic side effects o f TH1 cytokines and inflammatory mediators from
recruited cells, can result in pathological inflammatory reactions. In particular, Thl
cytokines have been linked to diseases characterized by organ-specific autoimmunity
(reviewed in Romagnani, 1994), including autoimmune thyroiditis, Crohn's disease,
experimental autoimmune uveoretinitis (Dubey et al., 1991), experimental allergic
encephalomyelitis (Beraud et al., 1991), insulin-dependent diabetes mellitus (Hahn et al.,
1987), and multiple sclerosis (Benvenuto, etal., 1991; Brod et al., 1991). It is certainly
tempting to attribute such disease to faulty Th2 cross-regulatory mechanisms, especially
in light of the association o f lethal exacerbations of pathogen induced inflammatory
reactions with disruption o f the IL-10 gene (Gazzinelli et al., 1996).
In contrast to intracellular pathogens, studies o f parasitic helminths in rodent
models indicate that Th2 responses provide protection from extracellular pathogens
primarily via phagocyte independent mechanisms. Though many parasites have been
studied to determine the Th phenotype induced in susceptible versus resistant hosts, four
models are primarily responsible for establishing that Th2 responses are important for
protective immunity to nematode parasites. These are Trichinella spiralis,
Heligmosomoides polygyrus, Nippostrongylus brasiliensis, and Trichuris muris
(reviewed in Urban et al., 1992; Finkelman et al., 1997).
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The lifecycles o f these four parasites have been briefly reviewed (Urban et al.,
1992; Finkelman et al., 1997). H. polygyrus and T. muris have strictly enteral lifecycles.
H. polygyrus third-stage larvae (L ) invade the wall of the small intestine, then enter the
3

gastrointestinal lumen approximately 7 days after infection, mature to adults, and remain
alive for a period o f several months in susceptible (Balb/c) strains. Challenge infections,
however, are eliminated more rapidly in immune hosts, especially in rats where the effect
is extremely rapid, occurring within 1 hour of challenge. T. muris, which infects as Lj in
a resistant egg, parasitizes the large intestine. Infections are chronic in some strains
(B10.BR) and more short lived in most inbred mouse strains (Balb/k), which expel the
parasite before it develops into egg laying adults.
In contrast to H. polygyrus and T. muris, the lifecycles o f T. spiralis and N.
brasiliensis have visceral migration phases. T. spiralis infects its hosts as Lt, matures
and mates within

2

days o f infection, and then resides within the wall o f the small

intestine, where females release larvae beginning 4-7 days after ingestion. Larvae migrate
through the body via intestinal lymphatics and venules, settling primarily in striated
muscle where they encapsulate. Adults are generally expelled from rodents less then 2
weeks following ingestion. N. brasiliensis penetrates the skin o f hosts as L and migrates
3

to the lungs by 36 hours, where the parasite causes eosinophilic granulomas before being
coughed up, swallowed, and maturing to egg laying adults in the small intestine. N.
brasiliensis have been mouse adapted. In the mouse the prepatent period is 5-6 days. N.
brasiliensis are expelled by

1 0

days after inoculation, and challenge infections are

characterized by a decrease in the number o f larvae that reach the intestine, and
markedly reduced or obliterated egg production.
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Protective immunity to each o f these parasites has been shown to be CD4
dependent (reviewed in Finkelman et al., 1997). Anti-CD4+ mAh treatment causes
increased fecundity in primary H. polygyrus infections, blocks immunity to H. polygyrus
challenge infections (Urban e t al., 1991a), prolongs primary infections in T. muris
resistant mice (Koyama et al., 1995), prevents expulsion of N. brasiliensis (Katona et
al., 1988), and prevents the rapid expulsion of T. spiralis in previously infected rats (Vos
eta l., 1983).
IFN-y and IL

- 1

2

have been shown to inhibit protective immunity to

gastrointestinal nematodes. These effects are most evident in T. muris and N.
brasiliensis infections (reviewed in Finkelman et al., 1997). Mouse strains that develop
chronic T. muris infections produce strong IFN-y responses as compared to resistant
strains which produce a strong EL-4 response (Else and Grencis, 1991; Else el al., 1992).
IFN-y neutralization at the time o f T. muris inoculation shortens the duration of
infection (Katona et al., 1988). IFN-y (Urban et al., 1993) or IL-12 (Finkelman et al.,
1994) supplementation during M. brasiliensis inoculation enhances egg production and
prolongs the duration o f infection. IL-12 administered in this manner will also retard, but
not inhibit the Th2 response leading to rapid clearance of challenge infection (Finkelman
eta l., 1997). IL-12 also increases the susceptibility of resistant hosts to T. muris
(reviewed in Finkelman e ta l., 1997). EL-12's effects in enhancing susceptibility have
been shown to be IFN-y dependent using IFN-y mAB and IFN-y KO mice (Finkelman
et al., 1994). Though IFN-y was once thought to contribute to T. spiralis resistance
because of the more rapid expulsion from mouse strains expressing higher IFN-y (Pond
et al., 1989), subsequent studies using IFN-y neutralizing antibodies (Finkelman et a l,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34
1997) and adoptive transfer o f immune T cells expressing Thl or Th2 phenotypes
(Ramaswamy et al., 1994) now indicate that Th2 phenotypes are significant in protection
immune responses directed against this parasite.
Studies o f the effect o f IFN-y supplementation on immunity to nematode
parasites were also enlightening because they suggested that strongly polarized Thl or
Th2 responses could interfere with the ability to generate the opposite response in vivo.
Heat killed Brucella abortis injected intravenously, a strong inducer of IFN-y
production, increased N. brasiliensis adult worm survival and fecundity in a manner
similar to that of exogenous IFN-y (Urban et al., 1993). These parasite sparing effects
were reversed by the administration o f anti-EFN-y and anti-EFNa/p, suggesting that
animals with systemic IFN responses may be more likely than healthy animals to develop
severe nematode infections. This finding was also consistent with observations from
Eimeria spp. infected mice, which have enhanced IFN-y production but demonstrate
depressed eosinophil and mast cell responses and increased fecundity in response to
infection with N. brasiliensis (Upton et al., 1987). Similarly, ongoing Th2 responses
induced by helminth parasite antigens have been shown to alter the Thl phenotype of
purified protein derivative (PPD)-specific Th cells to include EL-4 and EL-5 production
(Pearlman et al., 1993).
Several other key characteristics of helper T cell phenotypes originated in studies
of nematode infections. First, the nature of the helper T-cell response to a given
pathogen is, at least for some pathogens, a local phenomenon (Svetic et al., 1993).
Perhaps reflecting the totally enteral lifecycle, H. polygyrus infected mice displayed large
increases in Th2 gene expression in gut wall, Pyefs patch, and mesenteric lymph nodes,
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while only minor changes were seen in the splenic expression of these cytokines. A.
second finding was that the kinetics of Th cytokine expression are not always the same
with different pathogens (reviewed in Urban et a l, 1992). IL-3, EL-5, and IL-9 were
rapidly expressed within 24 hours of infection, followed by IL4, IL-10, and IL

- 6

at day 3

post-infection in H. polygyrus, whereas IL-3, IL-4, and IL-9 were expressed 3 days post
and IL-5 at

8

days post infection with N. brasiliensis. H. polygyrus infected mice

exhibited slight increases in EL-2 and IFN-y production followed by an IFN-y decrease
below baseline levels, while N. brasiliensis infected mice failed to show increases in IL10 or EL-2 and only exhibited a decrease in IFN-y production.
Though IL-4 production is a characteristic of nematode infections, its protective
effects are best demonstrated in H. polygyrus and T. muris infections. Neutralization o f
EL-4 or the IL-4R blocks immunity to challenge infections with H. polygyrus (Urban et
al., 1991b), and IL-4R neutralization converts T. muris resistant to susceptible hosts
(Else et al., 1994). However, immunity to H. polygyrus appears to be more EL-4
stringent than immunity to T. muris in that EL-4 KO mice fail to expel H. polygyrus but
efficiently expel T. muris (reviewed in Finkelman et al., 1997). Thus, IL-4 appears
necessary for immunity to H. polygyrus, but EL-4 alone has been shown to be insufficient
for complete immunity in H. polygyrus infected SCID mice (Urban et al., 1995).
EL-4 appears to play a less crucial role in protective immunity against N.
brasiliensis and T. spiralis. EL-4 and IL-4 R neutralization do not significantly alter the
course o f N. brasiliensis infection (Madden et al., 1991; Ungar et al., 1991) but
sustained EL-4 stimulation via IL-4C (IL-4 complexed 2:1 with it's Mab to increase its
half-life) cures CD4 depleted and SCID mice (Urban et a l, 1995). (This treatment also
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cures established T muris and H. polygyrus infections in immunocompetent mice (Else
et al., 1994; Urban, et al., 1995)). Studies in T. spiralis are limited by a lack o f IL-4
neutralizing reagents for rats, but IL-4 R neutralization in the mouse model modestly
exacerbated T. spiralis infections (Finkelman et al., 1997). IgE depleted rats have
increased T.spiralis larval numbers (Dessein etal., 1981) and rapid expulsion can be
transferred with purified IgE (Ahmad et al., 1991), suggesting a protective role for IL-4
or IL-13, since as previously discussed, these cytokines are responsible for IgE isotype
switching. The apparently unnecessary but protective effects o f IL-4 in T. muris, N.
brasiliensis, and T. spiralis have lead to the summary that while IL-4 is required for
protective immunity to H. polygyrus infections, it appears to provide a redundant
mechanism that becomes critical for some parasites when CD4 dependent mechanisms
are blocked (Finkelman et al., 1997).
In addition to IgE production, nematode infections are characteristically
associated with eosinophilia that is mediated by IL-5 (Coffinan et al., 1989; Sher et al.,
1990a, b) and mucosal mastocytosis that is mediated primarily but not exclusively by the
combined effects o f IL-3 and IL-4 (Takeda et al., 1997). Though eosinophils are known
to kill some parasites in vitro, IL-5 neutralization experiments which obliterate in vivo
eosinophilia have failed to indicate a necessary role for eosinophils in the immune
response to T. muris (reviewed in Finkelman et al., 1997), N. brasiliensis (Coffman et
al., 1989), and H. polygyrus (Urban et al., 1991b). However, there is evidence that IL-5
dependent mechanisms may be significant outside the confines o f the intestinal tract.
Anti-eosinophil serum has been shown to increase T. spiralis muscle larval recoveries
(Grove et al., 1977), and transgenic mice expressing elevated IL-5 levels exhibit
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increased killing o f M. brasiliensis in lung tissues (reviewed in Finkelman et al., 1997).
Additionally, ablation o f the eosinophil response with anti-IL-5 enhanced the survival o f
Angiostrongylus cantonensis (Sasaki eta l., 1993) and Strongyloides venezuelensis
(Korenaga et al., 1994) in mouse brain and lung, respectively.
In order to determine how IL-4 controls H. polygyrus and T. muris infections,
studies have focused on the physiological effects of this cytokine that could limit
infection (reviewed in Finkelman et al., 1997). Early evidence that IL-4 might have
physiological effects came from studies o f T. spiralis infections in immune rats in which
mast cells (Woodbury et al., 1984) and IgE (Ahmad et al., 1991), both regulated by
IL-4, have been shown to be strongly associated with the rapid expulsion phenomenon.
A localized anaphylactic reaction in which chemical mediators of anaphylaxis, including
serotonin, leukotrienes, and prostaglandins released through IgE or IgG mediated mast
cell degranulation cause increased smooth muscle contraction and increased fluid
secretion may be one mechanism which inhibits larval penetration of the mucosa.
Unfortunately, the role o f IL-4 in this phenomenon has not been elucidated because EL-4
neutralizing antibodies and IL-4 knockout rats are not available. Like T. spiralis, specific
antibodies can promote T. muris expulsion though mast cells do not appear to be
necessary. The role o f IL-4 (or IL-13) in T. muris expulsion has not been well
characterized.
In H. polygyrus infections o f mice, mAb to the IL-4 R has been shown to block a
mast cell and leukotriene dependent, parasite induced, increase in small intestinal fluid
influx and smooth muscle contractility during challenge infections. These changes can
also be induced in non parasitized mice treated with IL-4C. Though these findings
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suggest a mechanism by which EL-4 could be directly responsible for immunity in H.
polygyrus, there are a number o f discrepancies. Changes in smooth muscle contractility
with IL-4C treatment lag behind, by 3-5 days, the treatment induced decrease in
fecundity. In addition, in the natural immune response to H. polygyrus, endogenous EL-4
appears to eliminate early parasite stages, while mechanisms mediated by exogenous IL4 are directed against adult worms. Studies of IL-4's role in other immune mechanisms
including antibody-mediated defenses and alterations in cellular adhesion molecules such
as VCAM-1 are an area o f continued investigation.
Primary N. brasiliensis infections have also been shown to induce changes in
intestinal smooth muscle contraction and fluid dynamics, though these changes are B
cell, T cell, Ieukotriene, and mast cell independent. The role of EL-13 in protective
immunity to nematodes is an area of great interest at this time because STAT KO mice
6

fail to expel N. brasiliensis (Finkelman et al., 1997) and STAT is only known to be
6

involved in EL-4 and IL-13 receptor transduction (Yssell et al., 1991). Other IL-4
independent mechanisms that induce expulsion oiN . brasiliensis are an ongoing focus of
study and include mucous trapping, antibody dependent mechanisms, and lipid
peroxidation (Finkelman et al., 1997).
Like Thl responses, Th2 responses have also been linked to a number of human
diseases (reviewed in Romagnani, 1994). Allergen specific T-cells from atopic
individuals preferentially express TH2 profiles, while those from nonatopic donors
express Thl/ThO profiles. Th2 but not Thl cytokines have been found via in situ
hybridization at the site o f late phase reactions from atopic patients, bronchial biopsies
and BAL fluids from asthma patients, allergen challenged nasal mucosa of allergic
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rhinitis patients, and in the BAL fluids of allergic asthmatics. Over production o f Th2
cytokines and an associated decrease in Thl cytokines has also been documented in one
person with Omenn's syndrome, a rare immunodeficiency characterized by
hypereosinophilia and increased serum IgE.
In the eleven years since the cytokine profiles of mouse helper T cell clones were
first characterized, continued study of the in vivo cytokine responses to a variety of
stimulating antigens has confirmed that Thl and Th2 responses are true in vivo
phenomena which determine the resistance or susceptibility to pathogens. Noting that
some Th2 mediated functions are required for immunity to certain parasites while being
redundant for other parasites (eg IL-4 for H. polygyrus vs N. brasiliensis immunity), it
has been suggested that Th2 mediated immune mechanisms are generalized responses
initiated by attributes that are common to Th2 inducing pathogens (Finkelman et al.,
1997). Proteolytic enzymes are one potential common thread among Th2 inducing
extracellular pathogens which tend to traverse integumentary surfaces, but the
immunologic role o f these enzymes has been poorly studied. In the case of Thl inducing
attributes, lipopolysaccharide (LPS) is known to induce IL-12 production (Ozmen et al.,
1994) and is common to a number o f Thl inducing organisms. Therefore, it is likely that
for both Thl and Th2 responses, certain attributes are common to the organisms that
evoke the respective response. It has further been suggested that the Thl pathway which
protects against intracellular pathogens can be summarized as simply an EL-12/EFNy/iNOS mediated pathway, sharply contrasting the diverse mechanisms identified for the
control of nematode pathogens. Given the rapid rate of genetic mutations in single celled
organisms, it would seem that redundancies in Thl responses are even more critical to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

the survival o f the host than Th2 redundancies. Furthermore, redundancies in the Thl
response have been identified. For example, in addition to nitrogen-dependent
mechanisms, macrophages possess potent oxidative metabolic pathways which are
known to kill pathogens (Jones, 1993). At the cytokine level EL-18, which like IL-12 is
also induced by bacterial pathogens, potently induces IFN-y production, in an IFN-y
independent manner (Kohno et al., 1997). Antibodies induced during Thl responses may
also have phagocyte independent effects, such as virus neutralization and complement
mediated cytotoxicity. Thus, it appears that Thl and Th2 responses are more like sides
of the same coin. Each response being induced by pathogen attributes that relegate the
pathogen to one o f two immunologically relevant groups, with diverse effector mech
anisms in each response being redundant for some pathogens but required for others.
Strongylus vulgaris a Potential Model for the TH Paradigm in Horses
2

Because of the clear association between TH2 responses and nematode parasite
infections, a nematode parasite of horses was studied to determine if cytokine profiles
suggestive of the TH2 phenomenon are evident in the equine species. Strongylus
vulgaris is considered the most pathogenic nematode parasite of horses due to the
severe arterial lesions it causes in the cranial mesenteric artery during larval
migration. The life-cycle has been extensively reviewed (Enigk, 1950, 1951; Duncan
and Pirie, 1972; Ogbourne and Duncan, 1985). Infective third-stage larvae (L )
3

ingested from contaminated pasture penetrate the mucosa primarily o f the cecum and
ventral colon where they migrate for 4-7 days reaching the submucosa. There, larvae
molt to the fourth-stage (L4) and then proceed along arterioles and arteries that supply
the intestine toward the root o f the cranial mesenteric artery. Upon reaching the
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regions of ileo-ceco-colic and cranial mesenteric arteries, larvae cease migration and
molt to become immature adults (Ls), causing severe arteritis before returning, again
via the vasculature, to complete their life cycle in the large intestine. Arterial lesions
include the formation o f tortuous subintimal tracts, thrombi, and in severe cases,
verminous aneurysms, which can compromise perfusion of intestinal vascular beds.
This syndrome, known as verminous arteritis or thromboembolic disease, is
characterized by ischemic infarctions of the bowel which result in toxemia, abdominal
pain, and death in severe cases (White, 1985). Though the life cycle is prolonged,
taking 4-6 months to complete, signs associated with large innoculae of virulent L

3

including pyrexia, anorexia, depression and abdominal pain appear within the first
week following L ingestion and are near maximal by 14 days post infection (Klei et
3

al., 1982).
Though the importance of S. vulgaris as an equine pathogen has decreased
(Herd, 1990) due to regular use of ivermectin, which is efficacious against adult and
migrating larval forms o f the parasite (Slocombe et al., 1982; Klei et al., 1984), S.
vulgaris provides several advantages as a model in the study of the equine immune
response to nematode parasites. Horses can acquire an incomplete resistance to further
infection from natural exposure to S. vulgaris L (Amborski et al., 1974; Duncan,
3

1975; Klei et al., 1986), indicating that immune modulation in order to limit S.
vulgaris infestations is likely to be an attainable goal and that elucidation of the
mechanisms that limit natural infection could serve as a model to define some aspects
of the equine response to nematode parasites that may have more universal
applications. Singular infections can be produced by surgical implantation of adults
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into parasite free ponies (McClure et al., 1994) and late L and early L have been
3

4

successfully cultured in vitro (Chapman et a l., 1994). This provides both a ready
source of feces for collection o f infective S. vulgaris L and a source of late L and L
3

3

4

for characterization of the host immune response to these forms. While mature L

5

forms can be procured fairly easily from necropsy specimens, the availability of late
L and early L forms provides an invaluable tool for the characterization and
3

4

manipulation of the host immune reponse to these forms. As early larval forms
represent the first line o f immune evasion that ultimately leads to a patent and
pathogenic S. vulgaris infection, successful vaccine strategies will likely be directed
against epitopes of these early larval forms. In support of this, previous studies have
demonstrated that oral vaccination with radiation-attenuated S. vulgaris L induces
3

resistance to challenge infection for up to 9 months (Klei et al. , 1989) and prevents
classical lesions of verminous arteritis (Klei e ta l., 1982). However, radiationattenuated S. vulgaris vaccination does have its practical limitations. The protection is
species-specific and is influenced by management practices in that vaccinated animals
reared without anthelmintic therapy up until the time of challenge are not protected
from challenge infections o f S. vulgaris, whereas vaccinates reared with anthelminitc
therapy are protected (Klei et a l., 1989), suggesting that ongoing parasitism interferes
with the protective immune response induced by vaccination.
Eosinophils, though not apparendy essential in the protective immune response
to helminth parasites (Coffman et a l., 1989; Sher et al., 1990a; Urban et a l., 1991b),
are considered a hallmark o f helminth infections (Finkelman et a l., 1991) and
eosinophilia is an IL-5 dependent phenomenon (Coffman et a l., 1989). Following
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infection with S. vulgaris, both circulatory and tissue eosinophilia develop. A primary
circulatory eosinophilia occurs 3-5 weeks after infection in parasite free and
previously infected animals (Amborski et a l., 1974; Duncan and Pirie, 1975; Hofing
and Bennett, 1982) and corresponds temporally to establishment of larval infestation
in the mesenteric arteries. The timing of peripheral eosinophilia in ponies parenterally
vaccinated with larval or adult somatic extracts follows this pattern. However, both
irradiated larval recipients (Monahan et al. , 1994) and strongyle naive ponies
receiving immune serum (Klei, 1992) experience an anamnestic eosinophilia, which
begins to rise on week

2

following challenge and reaches a higher maximal value than

that of parenterally vaccinated ponies on week 4 . Primary eosinophilias have been
shown to disappear between

6

and

8

weeks following infection, which was the case

for parenterally and orally vaccinated ponies whose eosinophilia appeared to be
falling by week 5 post challenge. Depending upon the immune status of the animal, a
second peak in eosinophil numbers occurs sometime after the th-10th week. This
8

second eosinophilia, which tends to remain until the

2

0

th week, may be delayed in

lightly infected animals (Bailey, 1984) and its occurrence in horses with pre-existing
infections following experimental challenge is unclear (Amborski et al., 1974; Bailey,
1987). Trickle infections by contrast have been shown to result in sustained increases
in eosinophil counts (Drudge et a l., 1966; Amborski et al., 1974). Tissue
eosinophilia, along with a neutrophilic component, tends to predominate within the
submucosa shortly after infection

( 2

days to

1

week) but subsides until approximately

2-4 months following infection, presumably associated with larval return to the
intestine (Duncan and Pirie, 1972, 1975). By week 3 following infection,
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inflammatory cells o f the arterial intima are primarily plasma cells, lymphocytes, and
neutrophils with few eosinophils, though eosinophilic infiltration o f the adventitia
predominates. In other helminth systems, eosinophilia has been demonstrated in
associations with tissue migration, following parasite death in response to
anthelmentic therapy, and in response to tissue sequestration o f helminth antigens
(Walls and Beeson, 1972; Schriber and Zucker-Franklin, 1975).
In addition to the anamnestic eosinophilia associated with challenge infections
in ponies rendered immune by radiation-attenuated oral vaccination, in vitro
determinations of eosinophil functions suggest that eosinophils may play a role in the
protective immune response to S. vulgaris infection. Eosinophils have been suggested
to act as effector cells in anti-parasite immunity, based on their adherence and
cytotoxicity toward a variety o f nematode parasites, including Trichinella spiralis,
Dictyocaulus viviparus, and Angiostrongylus cantonensis (Kazura and Grove, 1978;
Wassom and Gleich, 1979; Kazura and Aikawa, 1980; Knapp and Oakley, 1981;
Yoshimura et al., 1984). Eosinophils from ponies with S. vulgaris induced
eosinophilia express more Fc and complement cell surface receptors than do
eosinophils from strongyle naive ponies (Dennis et al., 1988), and activated
eosinophils have been shown to release cytotoxic compounds including major basic
protein and reactive oxygen metabolites (Venge, 1990) that could lead to worm
destruction. Serum from strongyle immune ponies has been shown to mediate
adherence of eosinophils from strongyle sensitized but not strongyle naive ponies to
L resulting in L death (Klei et al., 1992), and suggesting that eosinophils become
3

3
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activated during S. vulgaris infections, allowing them to function as mediators of
cellular cytotoxicity.
Parasites that exhibit multistage lifecycles complicate investigations of the
host's antigen-specific immune response because o f the diversity of antigens that each
stage presents. Indeed this multistage changing of the parasite antigenic blanket, as
well as the presentation o f immunodominant antigens that divert the immune response
from other epitopes that may be critical to the parasite's survival, are considered
virulence factors employed by parasites. Early studies of the lymphoproliferative
response to S. vulgaris L and Ls extracts indicated that these extracts were mitogenic
4

and that differences in the proliferative responses of infected and noninfected animals
could not be detected (Bailey et al., 1984). Fractionation of these extracts by gel
filtration yielded three fractions which specifically stimulated lymphocytes from S.
vulgaris infected but not helminth free foals (Bailey, 1987; Bailey et al., 1989). One
fraction specifically stimulated PBMC from S. vulgaris infected ponies 1-3 weeks
post infection, but this responsiveness decreased by 7 weeks post infection and was
abscent by the end of the prepatent period, suggesting that the response was directed
at early forms of the parasite. Similar studies of naturally infected equines indicated
that the lymphproliferative responses were inversely correlated to larval burdens,
being more responsive in animals with less severe infections, whereas experimental
infections did not reveal differences in the proliferative responses of ponies receiving
innoculae of 200 or 700 L, (Bailey, 1984). Specific proliferative responses to soluble
adult 5. vulgaris antigens (SAWA) have been characterized in ponies with oral
radiation-attenuated L vaccine induced resistance to challenge (Klei, 1992). These
3
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initial attempts failed to detect significant differences in the proliferative responses o f
resistant and non-resistant ponies, both before and after challenge infection. Specific
proliferative responses to SAWA have been demonstrated in infected ponies and in
ponies receiving trickle infections o f 50 L, per week for 25 weeks, both with and
without the benefit o f anthelmintic therapy (Dennis et al., 1992; Klei, 1992).
Proliferative responses of PBMC from ponies receiving trickle infections were
examined prior to challenge and on weeks 7, 25 and 27 into challenge. PBMC from
all ponies, regardless of anthelmintic therapy, failed to proliferate on week 7 of
challenge but developed a significant proliferative response to SAWA by week 25 of
challenge, which was decreasing by week 27. Lymphocytes derived from the
mesenteric and mediastinal lymph nodes of these ponies at week 27 indicated that
mesenteric lymph nodes from ivermectin treated ponies were more reactive to SAWA
than nontreated ponies, although this difference was not statistically significant.
Mediastinal lymph node derived lymphocytes from ivermectin treated, untreated, and
uninfected control ponies were equally unresponsive, suggesting a compartmentalization o f the antigen-specific immune response.
In addition to the specific lymphoproliferative reponses of S. vulgaris
sensitized ponies, liberation of an eosinophil chemotactic factor or factors from
SAWA stimulated PBMC of S. vulgaris sensitized ponies confirms the generation of
cytokines in antigen-specific responses to S. vulgaris infections (Dennis et al., 1993).
Supemates from SAWA stimulated PBMC o f S. vulgaris sensitized but not S. vulgaris
naive ponies exhibited an eosinophil chemotactic activity. This chemotactic activity
was specifically stimulated by S. vulgaris in that S. vulgaris sensitized PBMC
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stimulated with S. edentatus antigen preparations did not induce eosinphil chemotactic
activity. Though the chemotactic factor(s) was only partially characterized as a
protein exceeding 8000 kDA that was heat labile and contained essential carbohydrate
moieties, its production following in vitro antigen stimulation o f PBMC that were
sensitized to S. vulgaris in vivo suggests the presence of an eosinophil chemotactic
factor that could contribute to the blood and tissue eosinophilia that is characteristic of
S. vulgaris infection.
In part due to the complexity of the S. vulgaris system, in which antibodies
evoked by the different larval stages suggest an array of epitopes that often cross react
both with other larval stages o f not only S. vulgaris but other parasite species as well,
the role of antibodies in the protective immune response to S. vulgaris has been
poorly characterized. Circulating P-globuIins increase following S. vulgaris infection,
primarily due to an increase in IgG(T) production (Patton et a l., 1978) and S.
vulgaris-specific antibodies have been demonstrated in response to infection (Bailey et
al., 1989). The nature of the immunodominant proteins associated with infection
appears to vary with the type o f exposure to S. vulgaris (reviewed in Klei, 1992).
Western blot analysis of adult antigen preparations identified 110, 100,

8

8

, and 79

kDa proteins as immunodominant in one foal with naturally acquired resistance
induced by trickle infectious of S. vulgaris, while a 21 kDa protein was recognized
with serum from orally vaccinated foals that were protected from challenge infections
by ivermectin treatment. 22 and 23 kDa bands were recognized by sera from all
ponies vaccinated or previously infected and subsequently challenged with virulent Lj.
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To date, the reactivity of larval antigen preparations with immune horse serum has
not been examined by western blot analysis.
Several findings heighten interest in antibodies specific for early S. vulgaris
larval stages. When compared to parenteral vaccination with adult or larval somatic
antigen homogenates, which did not confer resistance to challenge infection, oral
radiation-attenuated L vaccinated ponies which were protected from challenge had
3

higher prechallenge antibody titers specific for L surface antigens, as identified by
3

indirect fluorescent antibody testing, which remained higher than those o f parenterally
vaccinated groups for two weeks following challenge (Monahan et al., 1994). These
L -specific antibodies appear to be both species and stage specific in that antibodies
3

from vaccinates did not cross react with L of the closely related S. edentatus parasite,
3

but did react with both S. vulgaris and S. edentatus L (Klei et al., 1993). Antibodies
4

directed at L stages were also higher in irradiated larval vaccinates prior to challenge
4

but converged with those o f parenterally vaccinated ponies by

2

weeks following

challenge. In vitro assays also demonstrate that an anti-L^ antibody in immune sera
promotes adherence of eosinophils from strongyle sensitized but not strongyle naive
ponies to S. vulgaris L , but not L of closely related S. edentatus, resulting in L
3

3

3

death (Klei et a l., 1992) and suggesting that anti-L^ antibodies may function in
antibody dependent cellular cytotoxicity mechanisms. These findings, in conjunction
with in vivo findings that irradiated L vaccinates lack arterial lesions associated with
3

migration of late larval and adult forms (Klei et al., 1982), while animals acquiring
natural resistance sustain small numbers of later stage larval parasites in the face of an
immune response that rejects newly acquired infections (Duncan, 1973; Amborski,
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Bell et al., 1974; Klei, 1986), suggest that antibody to early larval stages may play a
role in the protective immune response generated by both natural immunity and
irradiated larval vaccines. However, humoral factors adoptively transferred from
immune ponies were not sufficient to protect nonimmune ponies when administered in
conjunction with or prior to oral challenge with S. vulgaris L (Klei, 1992). In fact,
3

the presence of high antibody titers in these adoptively transferred ponies, as well as
titers induced by parenteral immunization with larval or adult somatic extracts in
conjunction with Ribi adjuvant (Monahan et al., 1994), which also did not protect
from challenge infections, actually resulted in an exacerbation of lesions normally
associated with larval migration. This exacerbation of lesions seen with high
circulating titers does not necessarily rule out a role for antibodies in the protective
response to S. vulgaris but may suggest that additional factors, such as timing of the
induction o f certain epitope-specific antibodies, activation o f cellular immune
mechanisms, or differences in the local secretion pattern o f antibodies within the
lumen of the intestines may be significant in the protective immune response to S.
vulgaris.
Helminth infections are characteristically associated with eosinophilia and
elevated IgE production (Finkelman et al., 1991), traits that also characterize the
Type II or TH2 response initially described in cloned mouse cells (Mosmann et a l.,
1986; Mosmann and Coffman, 1989b). Type II responses, identified by the
production of IL-4 and IL-5, which are integral to the generation of IgE (Snapper and
Paul, 1987) and eosinophilia (Coffman et al., 1989) respectively, have been shown to
play a significant role in the protective immune response to metazoan helminths
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(reviewed in Mosmann and Coffman, 1989a; Cox and Lieu, 1992; Urban et al.,
1992). Though the role of IgE in equine S. vulgaris infection has not been examined
because equine-specific reagents have not been made commonly available, S. vulgaris
infections are characterized by the generation of a peripheral and tissue eosinophilic
response. As previously described, following oral vaccination with radiationattenuated S. vulgaris, the eosinophil response is induced in an amanestic fashion and
eosinophil chemotactic activity has been found in the supernatants of S. vulgaris
stimulated PBMC from immune but not nonimmune ponies (Dennis e ta l., 1993).
These findings suggest that differential cytokine production, perhaps similar to that
seen in classical Type II responses to helminth parasites may play a role in the
immune response to S. vulgaris.
Cytokine Quantitation
To date, no single surface marker has allowed Thl and Th2 clones to be
distinguished so that identification in cloned cells (Mosmann et al., 1986), purified CD4+
T-cells (Swain et al., 1991), and more recently nonhomogeneous cellular populations
(Yamamura et al., 1991; Robinson et al., 1992) has hinged on the ability to detect
differing relative amounts o f the characteristic Thl or Th2 cytokines. Early studies
examined supernatants from in vitro stimulated CD4+ T cells for cytokine activity using
bioassays (Mosmann et al., 1986). However, assay cell lines typically respond to more
than one cytokine and there are often positive and negative interactions between the
activities of different cytokines. Additionally, supernatants from stimulated cells contain
a variety of cytokines, many with effects on more than one cell type, making such assays
unreliable and, when panels o f neutralizing antibodies were used in attempts to eliminate

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

51
cytokine cross-reactivity, cumbersome. Thus, rigorously monospecific bioassays for
cytokines are difficult to establish.
Enzyme linked immunosorbent assays (ELISAs) are especially useful for
cytokine quantification in liquid samples, such as supemates, because they are
quantitative, not subject to cytokine cross-reactivity, and easily adaptable to large sample
throughput. However, two drawbacks to quantification of cytokine proteins by ELISA
are that cytokine-specific antibodies must be generated, and samples for ELISA analysis
are most commonly derived from cell culture, which introduces its own set o f biases.
Cherwinski et al. (1987) demonstrated that analysis of cytokine mRNA from
ConA stimulated Thl and Th2 clones using northern hybridization correlated with the
activity o f the cytokine protein as determined in bioassays of supernatants. Furthermore,
northern hybridizations were more efficient at detecting differences in cytokine
production between Thl and Th2 clones then previously utilized bioassays. These and
other findings confirmed that cytokines are transcriptionally regulated (Brorson et al.,
1991; Ye et al., 1997). Additionally, due to the advent of the polymerase chain reaction
(PCR), generating molecular reagents for the quantification of cytokine mRNA is much
less laborious then generating anti-cytokine antibodies. For these reasons, cytokine
mRNA quantification has become the most commonly utilized method to identify
cytokine profiles that characterize the Thl or Th2 phenotype.
A variety o f methods have been utilized to quantify cytokine mRNA These can
roughly be divided into northern hybridizations and PCR based methods. A quick scan o f
the literature suggests that northern hybridization methods, though still utilized, have
fallen out of favor. My experience with a variety of northern based methods, including
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dot blotting methods using both radio- and fluorescently labeled DNA and RNA probes,
as well as the RNase protection assay which is a solution based hybridization method,
suggests the following reasons for this trend. First, PCR methods are far more sensitive
(in the range o f 3-5 molecules) than the most sensitive northerns, which are solution
hybridization northerns using

3 2

P-Iabelled RNA probes. Second, radioisotopes must be

used to achieve the sensitivity required for cytokine quantification using northern
analysis but need not be utilized in PCR based quantitative methods. Third, though labor
intensive in their own right, PCR based methods require fewer manipulations with RNA
which is highly susceptible to environmental RNase contamination. Finally, PCR
methods require substantially less RNA with PCR based methods commonly requiring
pg o f total RNA for a complementary DNA (cDNA) reaction that allows quantification
of a large number o f cytokines versus 20 to 100 pg of RNA for the quantification of a
single cytokine in northern based methods.
The polymerase chain reaction (Saiki et al., 1985) provides a highly sensitive
method for the detection o f nucleic acids. In the case of cytokine mRNA quantification,
RNA is first reversed transcribed (RT) to cDNA and cDNA serves as the template for
PCR amplification. Barriers to accurate quantification that occur in this step can be due
to inaccurate spectrophotometric readings during RNA quantification, including
inaccuracies due to sample impurities, and tube to tube variations in RT reaction
efficiency. Accordingly, RNA extraction and cDNA synthesis are the first site at which
investigators differ in their methods. The quantity and type o f RN A total vs poly A as
well as the nature o f cDNA priming can be varied. Many investigators utilize 1 pg of
total RNA and Oligo d(T), as opposed to sequence specific priming for their RT
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reactions because it allows for the amplification o f several cytokines from a single cDNA
reaction. Some investigators spike their extractions and/or RT reactions with known
quantities o f RNA o f a specific sequence that contains priming sites common to the
PCR target(s) o f interest (Wang et a i, 1989). Spiking prior to extraction is useful for
intersample comparisons in which total RNA entering the cDNA reaction is not
quantified. RNA spikes are labor intensive but provide the best control in reverse
transcription followed by PCR (RT-PCR) based quantitative PCR (QPCR) systems
because the spike serves as an internal control for both the efficiency of the RT reaction
and the PCR reaction. However, the internal standard RNA may compete with the target
mRNA in the PCR when both are present in disproportionate concentrations in the initial
simultaneous RT reaction, necessitating, multiple simultaneous RT reactions with
varying amounts o f internal standard RNA (Babu et al., 1993).
Following reverse transcription, target cytokines are amplified from RT reactions
using PCR. The PCR has three phases: a negligible lag phase in which amplification is
initially non-exponential, an exponential amplification phase, and a linear or stationary
phase in which the amplification product gradually stops accumulating exponentially
(Saiki, 1989). Amplification (N) is characterized by the equation N=N (l+efficiency)“,
0

where N is the initial amount of target and n is the cycle number. Thus, minor variations
0

in starting template or reaction conditions that alter efficiency are magnified during the
exponential phase. The onset of the plateau phase appears at different stages depending
upon the initial target concentration and characteristics of the primers (Linz et a i, 1990;
Robinson and Simon, 1991). Though its mechanism is not fully understood (Morrison
and Gannon, 1994), the practical consequence o f plateau is that samples of differing
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initial template concentration can appear equivalent or even inversely related. This does
not appear to be as much o f a problem for competitive reactions in which co
amplification o f different concentrations of different targets into the plateau phase has
been shown to result in retention o f the initial targetrcompetitor proportions (Morrison
and Gannon, 1994) (within certain limits discussed later).
The simplest approach to quantification of RT-PCR products is measurement o f
the amount o f amplified product in the exponential phase by reference to a dilution series
of an external standard (Ferre, 1992; Clementi et al., 1993; Foley et a l 1993; Cross,
1995). This technique has two major drawbacks. First, preliminary experiments must be
utilized to determine conditions that allow the PCR to remain in its exponential phase,
and second, this technique is also the most susceptible to amplification induced errors.
Modifications in which internal standards are amplified in the same tube have been
utilized to overcome the latter drawback (Coutlee et al., 1995). Limiting dilution
techniques have also been applied to QPCR, but these techniques are extremely labor
and reagent consuming (Sykes eta l., 1992; Luque etal., 1994).
The most accepted PCR based method for cytokine quantification is quantitative
competitive RT-PCR (QC-RT-PCR) and is based upon the competitive co-amplification,
in a single reaction tube, o f the target sequence, together with known concentrations o f
an added internal standard, resulting in a series of tubes containing a fixed amount of
target and varying amounts o f internal standard (Wang et al., 1989; Zimmermann and
Mannhalter, 1996). The internal standard is designed to share primer recognition sites
with the target sequence but differs from the target either by size or an altered restriction
digest site that allows it to be distinguished from the wild type target. Following
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amplification, the number o f target copies in the sample is calculated by determining the
equivalence point for competitor and target on a regression plot created by plotting
log( )[signal intensity competitor/signal intensity target] vs quantity o f internal standard
1 0

template (Piatak et al., 1993). The term quantitative PCR has come to be almost
synonymous with QC-RT-PCR, while all other methods are often considered semiquantitative.
Once standardized, QC-RT-PCR is quite powerful but has several drawbacks.
The internal standard must amplify with the same efficiency as the wild type. The internal
standard as well as the target must be able to be analyzed separately, and signal
corrections are required as competitors commonly differ in size from wild type (Piatak et
al., 1993). QC-RT-PCR is laborious and reagent intensive, requiring a large series of
reactions with different competitor concentrations for the quantification o f a single
sample. Because o f this, replicate samples are rarely done. Amplification efficiency of
competitors can vary significantly from that of wild type target due to size differences or
the formation o f competitor/wild type heteroduplexes (Becker-Andre and Hahlbrock,
1989; Kanangat et al., 1992; McCulloch et al., 1995; Henley et a i, 1996; Souaze et al.,
1996). Most significantly, QC-RT-PCR is limited to a narrow linear dynamic range
where the targetrcompetitor ratios remains between 0.66 to 1.5 (Arnold et al., 1992;
Raeymaekers, 1993; Souaze et al., 1996).
A number o f methods have been utilized to generate competitors for QC-RTPCR (Zimmermann and Mannhalter, 1996) and are not germane to this discussion.
However, in addition to competitors which serve as controls for the errors inherent in
the PCR amplification phase o f a QC-RT-PCR assay, a "housekeeping gene" is generally
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quantified. Housekeeping genes have been shown to be useful as normalization factors
for intersample differences in RNA input and RT efficiency during cytokine
quantification (Babu e ta l., 1993). However, corrections utilizing housekeeping genes
are error prone due to the presence of processed pseudogenes in the genome, which are
related to some o f the commonly used transcripts o f housekeeping genes (Raff et al.,
1997). In theory a housekeeping gene should be constitutively expressed equally among
different tissues o f an organism, at all stages of development, for both control and
experimentally treated cell types. Unfortunately, there is no single RNA species that
meets these criteria, and the best compromise is to identify a gene that comes closest to
this ideal for the cell types being studied. P-actin was one o f the earliest mRNA species
utilized as an internal control (Chelly etal., 1988; Kashani-Sabet eta l., 1988). It
encodes a constitutively expressed, ubiquitous cytoskeletal protein, that is highly
conserved in eukaryotes and expressed at moderately abundant levels (0.1% o f mRNA
or 0.003 % of total RNA). P-actin's primary drawback is that it is expressed in much
higher levels than cytokine mRNA. In a 10 pg sample of total RNA (approximately 5 x
10s cells) there is approximately 300 pg of P-actin mRNA which 100-1000 times the
expression o f rare (0.3-3 pg/10 ug total RNA or 0.001% o f mRNA) mRNA species such
as cytokines (Smith, 1995). This translates to approximately 950 molecules o f P-actin
mRNA per cell ([MW RNA= #nucleotides x 339]+60). Levels of P-actin have been
shown to vary in cultured adipocytes, mammary epithelial cell lines, fibroblast cell lines,
and cultured human colon carcinoma cells (Dodge et al., 1990; Bonini and Hofhamm,
1991; Spanakis, 1993). P-actin mRNA levels have been shown to be higher in normal
mouse spleen, brain, ovary and thymus than in liver, lung, and testes (Kimball, 1996).
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When compared using a QC-RT-PCR method, P-actin levels in mitogen stimulated
human monocytic, promyelocytic, and lymphoma cell lines, were not significantly
different from unstimulated cells (Kanangat et al., 1992). Other studies o f T cell lines
(Melby et al., 1993) and normal human PBMC (McCaims et al., 1984) have respectively
demonstrated a 1.3 and three fold increase in P-actin mRNA following mitogen
stimulation.
Other mRNA species that have been utilized as internal controls include
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Dukas eta l., 1993),
hypoxanthine phosphoribosyltransferase (HPRT) (Murphy et al., 1993), and peptidylprolyl cis-trans isomerase (Cyclophilin) (Nast etal., 1994). GAPDH is a key enzyme in
glycolysis whose mRNA, like P-actin, is expressed at moderately abundant levels ( .1%
0

of mRNA) (Smith, 1995). GAPDH is constitutively expressed in many tissues, including
rat and human muscle and heart (Piechaczyk et al., 1984). However, GAPDH levels
show great variability. Levels have been shown to vary with the embryonic stage o f the
cell and dexamethasone treatment (Oikarinen, etal., 1991), viral or oncogene
transformation (Bhatia et al., 1994), as well as during different stages of the cell cycle in
skin fibroblasts (Mansur et al., 1993). GAPDH levels have also been shown to vary in
smooth muscle cells treated with vasoconstrictors and mitogens (Gadiparthi et al.,
1990), as well as in breast cell lines, and adipocytes cultured with insulin (Alexander et
al., 1990). GAPDH expression in mouse brain, muscle, heart, and kidney, exceeds that
of liver, spleen, lung, embryo, and hypothalamus (Smith, 1995).
HPRT is an enzyme which catalyzes the metabolic salvage of the purine bases
hypoxanthine and guanine. mRNA is constitutively expressed in all tissues at low levels
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(Ogasawara et al., 1996). Expression in the order of 1-3 mRNA molecules per cell was
found in normal human lymphocytes, amnion, fibroblasts, EBV-transformed lymphoid
cell lines, neuroblastoma, glioblastoma, and melanoma cultures (Steen et al., 1990).
Brain tissues, especially the basal ganglia, have been shown to express HPRT at a higher
level than other tissues (Jiralerspong et al., 1996), and resting lymphocytes have been
shown to have expression that exceeds fibroblasts by at least two fold (Steen et al.,
1991). Though HPRT expression remains steady in long term lymphocyte cultures,
HPRT is not a well suited housekeeping gene for immunologic studies because mitogen
stimulation (PHA) has been shown to increase HPRT expression by 10-20 fold in human
lymphocytes, with levels returning to within 20% of baseline 24 hours after mitogen
removal (Steen et al., 1990, 1991).
Cyclophilin encodes a cytoplasmic protein important in protein folding that is
highly conserved. Cyclophilin's expression has been shown to be less abundant than Pactin in all mouse tissues, though it is still fairly abundant, comprising close to . %
0

1

cytoplasmic RNA (Smith, 1995). Cyclophilin expression in rat brain, spleen, thymus,
adrenal glands, ovaries, and testes exceeds that of liver, lung, and anterior pituitary
(Danielson et al., 1988). In monkeys, expression has been shown to be lower in skeletal
muscle than other tissues (Danielson etal., 1988), and expression in some tumor lines
exceeds that o f their normal cellular counterparts (Haendler et al., 1990). Despite the
variable distribution of cyclophilin within body tissues, cyclophilin is a promising
lymphocyte housekeeping gene because levels have not been altered in T-lymphocytes by
treatment with mitogens or tumor promoters (Haendler et al., 1990).
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Following PCR, PCR targets as well as competitors in QC-RT-PCR must be
detected and quantitatively assessed. PCR products can be divided into those that bear
no endogenous labels, o r products which have been labeled during PCR through the use
of radioactive, fluorescent, or biotin-labeled nucleotides or primers. In the most basic
method, unlabeled PCR products are separated via agarose gel electrophoresis and
stained using ethidium bromide (Piatak et al., 1993; Zimmermann et al., 1994). Bands
are then assigned a signal strength using computerized image analysis. Gel electro
phoresis allows not only the separation of competitors and targets that vary by size, but
also reveals nonspecific bands resulting from PCR. To ensure accurate quantification in
the case of competitive PCR, correction factors are applied to accourrfgr^ater
fluorescence emitted by larger fragments. In noncompetitive methods, densitometry o f
ethidium bromide (EtBr) stained gels is associated with gel to gel variations in staining
intensities that can distort interpretations of absolute signal strength. Other methods
including capillary gel electrophoresis (Fasco et al., 1995) and high pressure liquid
chromatography (de Kant et al., 1994) have been utilized to separate PCR products by
size.
Methods in which labels are incorporated during the PCR process have greater
sensitivity than methods that utilize EtBr staining. Endogenously labeled PCR products
have been analyzed by a variety of methods depending upon the nature of the label.
Because PCR products labeled in this manner have the drawback of labeled nonspecific
PCR products that erroneously contribute to signal strength, they are generally separated
by gel electrophoresis, then quantified either from excised bands using direct assessment
of cpm (Scadden et al., 1992; Furtado et al., 1993), or from dried gels via
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autoradiography and densitometry (Dostal et al., 1994), or radioimaging (Arnold et al.,
1992). PCR products bearing biotin have been similarly separated via electrophoresis,
blotted onto filter paper, and quantified using streptavidin conjugated chemiluminescent
labels, autoradiography and image analysis (Su et al., 1994). Automated sequencers have
also been employed to quantify fluorescently labeled PCR products in polyacrylamide
gels (Cottrez et al., 1994; Michael et al., 1995).
To circumvent problems with labeled non-specific PCR products that are
generated from labeling during PCR amplification, hybridization with sequence-specific
probes followed by probe quantification has been adopted in some methods. These
methods either involve membrane transfer of PCR product following electrophoresis
(Telenti et al., 1992) or solid phase capture of PCR product onto microplates.
Biotinylated PCR product has been captured onto streptavidin coated plates (Jalava et
al., 1993; Lehtovaara et al., 1993, Martin etal., 1996), aminated PCR products onto
carboxylated plates (Kohsaka et al., 1993), as well as capture via plates bearing
covalently bound oligonucleotides (Bemdt et al., 1995). Once captured, PCR product is
hybridized with radiolabeled or enzymatically labeled oligonucleotides and quantified by
measuring incorporated radioactivity, fluorescence, or enzyme activated color change.
Two recent chemiluminescence based adaptations have been directed at
automating the detection process in QPCR procedures. Both of these methods have the
disadvantage o f requiring expensive reagents and machinery that is both expensive and
not commonly available. In the first, a biotinylated primer is incorporated into the PCR
reaction. An aliquot of the reaction is then hybridized in solution with a tris (2,2bipyridine) ruthenium II chelate (TBR)-labeled oligonucleotide probe that is
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complementary to the biotinylated strand. The biotinylated PCR product bearing its TBR
probe is then captured onto streptavidin coated iron beads and added to reagent assay
buffer. In an automated process carried out within a machine known as the QPCR
System 5000 (Perkin-Elmer, Foster City, CA), the entire reaction is analyzed and
assigned a luminosity value proportional to the amount of TBR-bearing, hybridized,
oligonucleotide probe that is detected. The QPCR System 5000 aspirates the iron beads
with their attached PCR products onto a working electrode and traps them magnetically.
The electrode is washed several times to eliminate unbound TBR-labeled probe and a
voltage is applied to the electrode, inducing a series of redox reactions whereby
stimulated TBR molecules emit light at 620 nm, which is then detected by a
photomultiplier tube. This system has been adapted for use in competitive PCR by the
use of two TBR-labeled oligonucleotide probes, one specific for the target, the other for
the internal competitor (Wilkinsone/ al., 1995; Blok et al., 1997). In a modification of
this system, TBR-labeled oligonucleotide can also be utilized as a complementary primer
to the biotin-labeled primer without a hybridization step, but this method has the
disadvantage o f label incorporation into nonspecific products of the PCR reaction. Use
of the QPCR System 500 has several advantages. The instrument's linear dynamic range
has been determined to be between 3 and 4 orders of magnitude (Jessen-Eller et al.,
1994) and allows high sample throughput. The QPCR System 5000 has greater
sensitivity than P-labeled methods (Zhao et al., 1996) which have been calculated to be
3 2

7.4 x 10"“ mole of PCR product above background (Crivello, 1997), and the ability to
determine starting copy number over
( 1 0

1 0 11

1 0

orders of magnitude in competitive methods

copies) with 90% accuracy (Crivello, 1997).
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The second method referred to as Taq-Man (Perkin-Elmer), is a real time QPCR
system (Heid et al., 1996) which exploits the 5' exonuclease activity of Taq (Holland et
a l, 1991). The reaction is carried out with three primers, two for amplification, and a
third that hybridizes internally in the amplified region. A fluorescent dye on the 3' end of
the internal primer (such as TAMRA, -carboxy-tetramethyl rhodamine) quenches
6

fluorescence from a reporter fluorescent tag on the 5' end (such as FAM, 6

carboxyfluorescein) of the internal primer (Livak et al., 1995). During PCR, the 5'
exonuclease activity o f Taq degrades the 3' quenching activity on the internal primer,
resulting in fluorescent emission which is determined during the PCR process. This
approach is less sensitive (limit o f detection 10,000 copies) then the QPCR System 5000
(Crivello, 1997) but allows much higher throughput because post PCR manipulations are
not required. The system can also be easily adapted for simultaneous detection of
competitors through the use o f different fluorescent dyes.
The plethora, permutations, and drawbacks of the aforementioned methods
should raise one resounding truth about quantitative PCR - that accurate quantification is
difficult to achieve and that each method has its drawbacks. QC-RT-PCR, despite its
many drawbacks, has the primary advantage of being commonly accepted. Because of
the nature o f our laboratories' work in which large numbers of samples from a
genetically heterogeneous population of horses serve as the source of RNA, a rapid,
labor conserving method in which replicate samples could be run became the primary
force that governed our assay development. Our system synthesizes the use o f a dilution
series of an external standard with solution hybridization techniques that minimize errors
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due to nonspecific PCR products. The housekeeping gene P-actin is used to correct for
differences in initial RNA concentrations or variations in RT efficiency.
The underlying hypothesis o f this study was that horses exhibit cytokine
profiles consistent with the TH2 phenotype in response to S. vulgaris infection. The
primary aim of this study was to determine if differences existed in the cytokine
profiles of lymphocytes derived from immune and susceptible ponies, both in
response to vaccination and following challenge. Lymphocytes for examination were
collected both from the local site o f parasite invasion along the large colon, as well as
from peripheral blood, and immunity was induced by oral vaccination with radiationattenuated S. vulgaris L . Characterization of the TH1 and TH2 cytokine profiles in
3

the horse necessitated the development of molecular tools which included the cloning
and sequencing of equine P-actin, to be used as a housekeeping gene for quantitative
assays, and IL-10, considered a member of the TH2 cytokine family, and most
significantly, the development o f a PCR based assay for the quantification of equine
cytokines.
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CHAPTER 1
M O LECU LA R CLONING AND SEQUENCING OF EQUINE
IL- , IL-10, AND BETA-ACTIN
6

Introduction
Equine interleukin

- 6

(IL- ), IL-10, and (3-actin were cloned and sequenced to
6

facilitate their use as immunologic reagents in assays to quantify equine cytokines.
IL

- 6

and IL-10 are produced by Th2 cells in the murine system but this polarization is

not always clear in human CD4+ subsets (Romagnani, 1992). IL

- 6

(Robinson et

al,. 1993) and IL-10 (McKay et al., 1995) have been examined as inflammatory
mediators in the horse. However, neither the significance of the Thl/Th2 paradigm in
equine disease, nor the role of IL

- 6

or IL-10 in T hl and Th2 responses have been

examined in the horse.
M aterials and M ethods
Preparation o f cells
Equine peripheral blood mononuclear cells (PBMC) were isolated from venous
blood by differential centrifugation over Ficoll-Pague (Pharmacia LKB
Biotechnology, Piscataway, NJ). After washing in calcium and magnesium free
phosphate-buffered saline (CMF-PBS), PBMC were suspended in media consisting of
RPMI 1640 (Sigma Chemical Co., St. Louis, MO) supplemented with 2-mercaptoethanol (100 mM), glutamine (2 mM), 100 U/ml penicillin, 100 /xg/ml streptomycin,
and 5% heat inactivated fetal bovine serum (Hyclone Laboratories, Logan, UT).
PBMC were incubated at a concentration of 2 x 106/ml for 72 hours
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with phytohemagglutinin-M (2ptg/ml, Sigma) at 39°C in a humidified environment
with 5% C02.
Total RNA isolation and complementary DNA (cDNA) synthesis
Small scale preparations o f total RNA were isolated from 2-3 x 10 PHA
6

stimulated PBMC using RNA Stat 60 reagent (Tel-Test, Friendswood, TX) and
chloroform extraction as per the manufacturer's directions. 0.30 fig of RNA in a
volume of 17.5 fil diethyl pyrocarbonate-treated water were heated to 65°C for 10
minutes to denature the RNA and then chilled in ice and pulse spun in a
microcentrifuge at 4°C. 22.5 fil of reagent master mix were then added resulting in a
final reaction containing IX first strand buffer (Gibco BRL, Gaithersburg, MD), 0.5
mM dNTP (Perkin-Elmer, Norwalk, CT), 1.0 fiM Oligo-dT (Promega, Madison,
WI), 10 mM DTT (Gibco), 0.075 fig/fil BSA (NEB, Beverly, MA), 60 Units RNAsin
(Promega), and 400 units Moloney Murine Leukemia Virus Reverse Transcriptase
(BRL). The reaction was incubated 1 hour at 40°C, then frozen at -20°C until use.
Equine TL- . IL-10. and B-actin message amplification
6

Equine IL- , IL-10, and P-actin were amplified using the polymerase chain
6

reaction (PCR). All PCRs were performed in 50 fi\ volumes containing 5 y\ cDNA,
IX PCR buffer (Perkin-Elmer), 2.5 units Taq polymerase (Perkin-Elmer), 200 /zM
dNTP (Perkin-Elmer), and 10 pmoles of each 5' and 3' primer. Primers were derived
from phylogenetically conserved regions of the respective genes using published
nucleotide sequences (Table 1.1). The amplification steps involved denaturation at
94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for
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Table 1.1. Primer sequences used for PCR amplification and sequencing of equine IL- , IL-10, and P-actin cDNA.
6

cDNA

Coding Strand Primer

Noncoding Strand Primer

Internal Sequencing Primers

IL

5'ATGAACTCCTTCTTCACAAG3'

5' TCCTA ACGCTC ATACTTT3'

543AS: 5'CCACTCATTCTGTGAATGCAGACT3'

IL-10

5' ATGCACAGCTCAGCACT3'

5'TTCACAGAGAAGCTCAGTAAAT3'

S 103: S' AAGAGAAAGGGTGTCTAC AAGCCA3'

P-actin

5'ATGGATGATGATATCGCCGCG3'

5'CTAGAAGCAnTGCGGT

255S: 5 'TCTGGCACCACACCTTCTAC3'

- 6

GGACGATGGAGGGGCC3'

5I0S: 5'CCATCCTGCGTCTGGAC3'

739AS: 5'TCGTrGCCGATGGTGATGAC3'

964AS: 5'TGATCrTCATCGTGCTGGG3’

67
minute. Reactions were amplified to 40 cycles in a GeneAmp PCR System 9600
Thermal Cycler (Perkin-Elmer).
Cloning and sequencing
The equine IL- , IL-10, and P-actin PCR products were purified by
6

electrophoresis and excision from a 1.2% agarose (Sigma) gel using diatomaceous
earth (Prep-a-Gene; Bio Rad, Hercules, CA). Fragments of approximately 670, 740,
and 1150 base pairs (bp) respectively were cloned into pCRII vector (Invitrogen,
Carlsbad, CA) using the TA cloning method according to the manufacturer's
instructions, then transformed into competent E. coli DH5aMCR using heat shock
(Lederberg and Cohen, 1974). Transformants were selected by ampicillin resistance
and loss of p-lactamase gene function, then screened by restriction digest mapping.
The cloned PCR-vector products were purified from overnight cultures using
alkaline lysis followed by CsCl gradient separation in the presence o f ethidium
bromide (Sambrook et al. , 1989) or using a commercial miniprep kit (Qiagen,
Valencia, CA). Sequencing was accomplished using dideoxynucleotide chain
termination from double stranded plasmid DNA. Plasmids containing IL-10 and Pactin were sequenced manually using alkali denaturing according to the Sequenase
Version 2.0 kit (United States Biochemical, Cleveland, OH) followed by
polyacrylamide gel electrophoresis. IL

- 6

was sequenced using dye primer cycle

sequencing (ABI PRISM Dye Primer Cycle Sequencing Core Ready Reaction Kit
with AmpliTaq DNA polymerase, FS; Perkin-Elmer). Sequences were resolved using
capillary gel electrophoresis on an ABI Prism 310 Genetic Analyzer (PerkinElmer/ Applied Biosystems Division). Sequencing primers were -48 (GeneLab, Baton
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Rouge, LA) and T7 (Promega, Madison, WI) plasmid primers, and primer pairs used
for PCR. Intemalprimers were generated to span the middle of the IL- , IL-10, and
6

P-actin fragments as needed from the derived sequences (Table 1.1). The sequence
information was entered into the Mac Vector database program for subsequent
alignment with published cDNAs for other species IL- , IL-10, and P-actin.
6

Results
Amplification of mononuclear cell mRNA
PCR amplification o f cDNA from PHA stimulated PBMC produced distinct
745, 739, and 1128 base pair fragments for IL- , IL-10, and P-actin respectively
6

(Figure 1.1). Because these fragments were the same size as predicted from sequence
analysis of other species, the products were purified and cloned for sequencing.
Sequencing of equine IL- . IL-10. and B-actin
6

The nucleotide sequences of the IL- , IL-10, and P-actin cDNA inserts are
6

shown in Figures 1.2, 1.3 and 1.4, respectively. These sequences have been
submitted to GenBank EMBL and bear the following accession numbers: IL- :
6

U64794, IL-10: U38200, and P-actin: AF035774. All clones of the three cDNA
sequences contained a single open reading frame which included a stop codon. The
745 bp IL

- 6

cDNA included the coding sequence which spans bases 1 to 627, and 118

bases in the 3’ nontranslated region. Based upon comparisons to IL

- 6

sequences of

other species, bases 1-84 encode the hydrophobic signal peptide. The 739 bp IL-10
cDNA included a coding sequence from bases 1-537. Bases 1-54 encode the putative
signal peptide. The IL-10 cDNA also includes 202 bases in the 3' nontranslated
region. The 1128 bp P-actin cDNA encodes only the translated regions of the protein.
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Figure 1.1 PCR amplification of equine IL- , IL-10, and P-actin. Lanes I
and contain the size marker phage X174 DNA HaelII digested (the size
of the fragments in base pairs is given); lanes 2, 4, and contain the PCR
products from PHA stimulated equine PBMC cDNA for IL- , IL-10. and
P-actin, respectively. Lanes 3, 5, and 7 are the respective PCR negative
controls which contained water instead of cDNA template.
6

8

6

6
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atgaactcct tcttcacaag caccgtcact ccagttgcct tctccctggg gctgctcctg
61 gtgalggcta ctgctttccc caccccacta cccctgggag aagatgaaac cacctcaaat
ggaccactac tcaccactgc agacaaaacc aaacagcaca ttaagtacat cctcggcaaa
181 atctctgccc tgaaaaatga gatgtgtaac aattttagca agtgtgaaaa cagcaaggag
241 gtactggcag aaaacaacct gaatcttcca aagatggcag aaaaagacgg atgcttccaa
301 tctgggttca atcaggagac ctgcctgatg aaaatcacca ctggtctttc ggagtttcag
361 atatacctgg agtacctcca gaacgagttc aagggtgaaa aggaaaacat caagactatg
421 cagatcagta ccaaagtcct ggtccagatc ctgatgcaaa agatgaagaa tccagaagta
481 accacccctg acccaactgc aaaaagcagc ctgctggcta agctgcattc acagaatgag
541 tggctgaaga acacaacaac tcacctcatc cttcgaagcc ttgaggattt cctgcagttc
601 agcctgagag ctgttcggat aatgtaacct tggcatctaa gattgttgta gttcatgggc
661 attccttcct ctggtcagaa acctgtccac tgggcacata acttatgttg ttctctatga
721 agaactaaaa gtatgagcgt tagga
1

1 2 1

Figure 1.2: Nucleotide sequence o f amplified equine EL cDNA. The nucleotide
sequence of the cDNA insert was determined by automated cycle sequencing of
double stranded plasmid. The coding sequence spans bases 1-627. Bases 1-84 encode
the hydrophobic signal peptide, and bases 628-745 are in the 3 ’ nontranslated region.
Primer sequences are represented in bold. The stop codon is underlined. The
GenBank accession number for this sequence is U64794.
- 6

atgcacagct cagcactgct atgttacctg gtcttcctgg ccggggtggg agccagccga
61 gaccggggca cccagtctga gaacagctgc acccacttcc caaccagcct gccccacatg
ctccatgagc tccgagccgc cttcagcagg gtgaagactt tctttcaaat gaaggaccag
181 ctggacaaca tgttgttgaa cgggtccctg ctggaggact ttaagggtta cctgggttgc
241 caagccttgt cggagatgat ccagttttac ctggaggagg tgatgcccca ggctgagaac
301 cacggcccag acatcaagga gcacgtgaac tccctggggg aaaagctgaa gaccctccga
361 gtgaggctgc ggcgctgtca tcgatttctg ccctgtgaaa ataagagcaa ggcagtggag
421 caggtgaaga gtgccttcag taagctccaa gagaaaggtg tctacaaagc catgagtgag
481 tttgacatct tcatcaacta catagaagcc tatatgacaa cgaagatgaa aaactgaagc
541 atcctaggga acgaagcatc caggacggtg actctactag actctaggac ataaattgga
601 gatctcccaa atcccatcca gggttctggg agagctgaat cagctccttg gaaaaccctg
661 tggtacctct ctcctgaata tttattaact ctgatacctc aactcctatt tctatttatt
721 tactgagctt ctctgtgaa
1

1 2 1

Figure 1.3. Nucleotide sequence o f amplified equine IL-10 cDNA as determined
from double stranded plasmid using manual chain termination sequencing. The
coding sequence spans bases 1-537. Bases 1-54 encode the hydrophobic signal
peptide, and bases 538-739 are in the 3’ untranslated region. The stop codon is
underlined. The GenBank accession number for this sequence is U38200.
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1 atggatgatg atatcgccgc gctcgtggtc gacaacggct ccggcatgtg caaggccggc
61 ttcgcgggcg acgacgctcc ccgcgccgtc ttcccctcca tcgtggggcg cccccggcac
121 cagggcgtga tggtgggcat gggccagaag gactcatacg tgggcgacga ggcccagagc
181 aagaggggca tcctgaccct caagtacccc atcgagcacg gcatcgtcac caactgggac
241 gacatggaga agatctggca ccacaccttc tacaacgagc tgcgcgtggc ccccgaggag
301 caccccgtgc tgctgaccga ggcccccctg aaccccaagg ccaaccgcga gaagatgacc
361 cagatcatgt ttgagacctt caacaccccg gccatgtacg tggccatcca ggccgtgctg
421 tccctgtacg cctctggccg caccactggc atcgtgatgg actccggtga cggggtcacc
481 cacactgtgc ccatctacga ggggtacgcc ctcccccacg ccatcctgcg tctggacctg
541 gctggccggg acctgacgga ctacctcatg aagatcctca cggagcgtgg ctacagcttc
601 accaccacgg ccgagaggga aatcgtgcgt gacatcaagg agaagctctg ctatgtcgcc
661 ctggacttcg agcaggagat ggccaccgcg gcctccagct cttccctgga gaagagctac
721 gagctgcccg acggccaggt catcaccatc ggcaacgagc ggttccgctg ccccgaggcc
781 ctcttccagc cctccttcct gggcatggaa tcctgtggca tccacgaaac taccttcaac
841 tccatcatga agtgtgacgt cgacatccgt aaggacctgt acgccaacac agtgctgtcg
901 ggtgggacca ccatgtaccc aggcatcgcc gacaggatgc agaaggagat cacagccctg
961 gctcccagca cgatgaagat caagatcatt gcgccccctg agcgcaagta ctccgtatgg
1021 atcggcggct ccattctggc ctcattgtcc accttccagc agatgtggat cagcaagcag
1081 gagtacgacg agtccggccc ctccatcgtc caccgcaaat gcttctag

MDDDIAALW
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VMDSGDGVTH
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IKEKLCYVAL
FQPSFLGMES
RMQKEITALA
YDESGPSIVH

FAGDDAPRAV
EHGIVTNWDD
IMFETFNTPA
PHAILRLDLA
DFEQEMATAA
CGIHETTFNS
PSTMKIKIIA
RKCF

FPSIVGRPRH
MEKIWHHTFY
MYVAIQAVLS
GRDLTDYLMK
SSSSLEKSYE
IMKCDVDIRK
PPERKYSVWI

QGVMVGMGQK
NELRVAPEEH
LYASGRTTGI
ILTERGYSFT
LPDGQVITIG
DLYANTVLSG
GGSILASLST

Figure 1.4. Nucleotide coding sequence of amplified equine P-actin cDNA (top
panel) and deduced amino acid sequence (bottom panel). The nucleotide sequence of
the cDNA insert was determined by chain termination sequencing o f double stranded
plasmid. Primer sequences are represented in bold. The stop codon is underlined.
The GenBank accession number for this sequence is AF035774
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P-actin is a cellular cytoskeletal protein which is not secreted and therefore lacks a
signal peptide. Nucleic acid homology of these equine sequences with the respective
sequences in other mammalian species were analyzed using the BLAST program
(Basic Local Alignment Search Tool, National Center for Biotechnology Information,
National Library o f Medicine, National Institutes of Health). These homologies were
extensive and are summarized in Table 1.2.
Amino acid analysis
The open reading frames for IL- , IL-10, and P-actin encode 208, 178, and
6

375 amino acids, including 28 and 18 amino acid signal peptides for IL

and IL-10,

- 6

respectively. Like the nucleic acid sequences, the predicted amino acid sequences for
equine IL- , IL-10, and P-actin have a high degree of similarity at the amino acid
6

level with the respective sequences of other species as determined using the BLAST
program. These similarities are summarized in Table 1.2. The predicted amino acid
sequences for IL- , and IL-10, aligned to the respective human sequences, are shown
6

in Figures 1.5, and 1.6. The amino acid sequence of equine P-actin is shown in
Figure 1.4 and is identical to the human sequence.
The open reading frame for equine IL

- 6

encodes 208 amino acids with a

predicted relative mass o f 23,383. Comparison to other IL

- 6

sequences suggests that

the first 28 amino acids serve as the signal peptide which is cleaved off during
secretion, making proline the amino terminal amino residue of mature IL- . The
6

mature protein would consist of 180 amino acids and have a predicted relative mass
of 20,471. The predicted molecular weights do not take into consideration any posttranslational modifications of the polypeptide. Sequence alignments also indicate that
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Table 1.2. Comparison o f equine IL and equine IL-10 nucleotide coding and
predicted amino acid sequences with other mammalian species.
- 6

Equine IL

Equine IL-10

- 6

Species

Nucleotide
identity (%)

Amino acid
similarity (%)

Nucleotide
identity (%)

Amino acid
similarity (%)

Human

81.7

77.6

89.3

91.0

Pig

84.4

82.1

8

92.8

Dog

82.3

83.7

83.5

8

Cat

83.7

81.4

86.5

90.4

Sheep

80.7

74.9

87.3

92.5

Cow

80.3

70.7

86.9

90.4

Red
Deer

-

-

96.4

89.7

Mouse

69.9

64.0

79.7

85.4

EHV-2
vIL-10

-

-

85.1

83.6

6

. 0

6

. 1

Comparisons were made using the BLAST program of National Center for
Biotechnology and Information, National Library of Medicine, National Institutes
of Health (http:Wwww.ncbi.nIm.nih.gov/BLAST/)
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_______ Alpha helix A______
*

* * * * * *

***

*

*

Equine: MNSFFTSTVTPVAFSLGLLLVMATAFPT PLPLGED ETTS NGP - - - LLTTADKT- KQHI KYILGK
MNSF TS
PVAFSLGLLLV+ AFP P + P GED
P
L T+ + + + KQHI+YTL
Human: MNSFSTSAFGPVAFSLGLLLVLPAAFPA PVPPGEDSKDVAAPHRQPLTS S E RIDKQ -I RYILDG
1

20

Alpha Helix B______
*

* *

*

* * * * * * *

*

*

*

*

*

* * *

Equine: 1SALKNEMCNNFSKCENSKEVLAENNLNLPKMAEKDGCFQSGFNQETCLMKITTGLSEFQ I
ISAL+ E CN + CE+SK E LAENNLNLPKMAEKDGCFQSGFN+ ETCL+ KI TGL E F+ +
Human: ISALRKET CNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNE ETCLVKI ITGLLEFEV
40

50

_

60

80

Alpha Helix C_________________

*

*

*

Equine: YLEYLQNEFKGEKENI KTMQI STKVLV Q ILMQKMKNPE V -TT PDPTAKSSLLAKLH SQN
YLEYLQN F +
+E
+ + Q +ST K V L + Q L +K KN +
T PDPT +SL L KL +Q N
Human: YLEYLQNRFES SEEQARAVQMSTKVL I QFL Q KKAKNLDAI TTPD PTTNASLLTKLQAQN
100

120

140

153

Alpha Helix D___________
*

* *

*

Equine: EW LKNTTTHLILRSLED FLQFSLRA VR IM
+ W L + + TTHLILRS + + F L Q SL R A +R M
Human: QWLQDMTTHLILRSFKE FLQSSLRA LRQM
160

180

Figure 1.5. Deduced amino acid sequence o f equine IL aligned with peptide
sequence of human EL-6. The putative signal sequences are in italics. Locations o f
structural a-helices (A-D) determined for human IL are shown (after Bazan,
1990). Cysteine residues are marked (A) at positions of putative conserved disulphide
bridges. Arginine 179 (♦ ) and other invariant residues (*) are also shown. Amino
acids are numbered according to the human sequence (Gen Bank accession
M145840. Gaps (-) were inserted to maximize alignment.
- 6

- 6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

75

_______Alpha helix A ________
Equine: M//55ALLCKLVFLAGKC/1SRDRGTQSENSCTHFPTSLPHMLHELRAAFSRVKTFFQMKDQ
MHSSALLC L V L G V AS +GTQSENSCTHFP + L P -M L + L R AFSRVKTFFQMKDQ
Human: MHSSALLC CL VLLTG VRASPGQGTQSENSCTHFPGNLPNMLRDLRD AFSRVKTFFQMKDQ
1

40

Alpha helix C __________

_ helix B_
*

20

____ Alpha helix D___

*

Equine: LDNMLLNGSLLEDFKGYLGCQALSEMIQFYLEEVMPQAENHGPDIKE HVNSLGEKLKTL
L D N +L L
SLLEDFKGYLGCQALSEMIQFYLEEVMPQAEN
PDIK HVNSLGE LKTL
Human: LDN LLLKE SLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPD1KAHVNSLGENLKTL
60

________

80

Alpha helix_E__

100

Alpha helix F________
*

«

Equine: RVRLRR CHRFLPCENKSKAVEQVKSAFSKLQEKGVYKAMSEFDIFINYIEAYMTTKMKN
R+RLRRCHRFLPCENKSKAVEQVK+AF+KLQEKG+YKAMSEFDIHNYIEAYMT- K+ + N
H u m an :: R LRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGI YKAMSEFDIFINYIEAYMTMKIRN
120

140

160

Figure 1.6. Deduced amino acid sequence of equine DL-10 aligned with peptide
sequence of human IL-10 (GenBank accession M57627). Putative signal sequences
are in italics. Locations o f predicted structural a-helices (A-D) are shown (after
Walter, 1995). Putative receptor binding residues are marked (*). Cysteine residues
are marked (A) at positions o f putative conserved disulphide bridges.
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equine IL

- 6

possesses the 40 amino acids, including 4 conserved cysteine residues,

which are invariant in humans, the domestic animal species, mice, and several sea
mammals (King et al., 1996).
The open reading frame for equine IL-10 encodes 178 amino acids with a
predicted relative mass o f 20,449. The N-terminal amino acid o f mouse IL-10 is
Gin22, while the N-terminus o f human IL-10 is Ser19. Equine IL-10 has a Ser and a
19

Gin25. Phylogenetic analysis o f equine IL-2 indicates that equine and human
sequences are more closely related evolutionarily than equine and murine sequences
(Vandergrifft and Horohov, 1993), making Ser the more likely N-terminal amino
19

acid in the horse. With Ser as the N-terminal amino acid, the mature equine IL-10
19

would consist of 160 amino acids and have a predicted molecular mass o f 18,615,
without post-trans.lational glycosylation.
The open reading frame for equine P-actin encodes a 375 amino acid protein.
Beta-actin is a cytoskeletal protein and therefore lacks a signal peptide. After removal
of the initiator methionine, the 374 amino acid equine P-actin protein has a predicted
relative mass of 41,603.
Discussion
40 amino acid residues o f IL

- 6

have been shown to be invariant among a wide

variety of species and these residues are also conserved in the equine sequence (King
et al., 1996). This is in line with observations that cell supernatant from many
different mammals can demonstrate biological activity in mouse bioassays. However,
mouse IL

- 6

is unable to activate human cells (Ehlers et al., 1994). The biological

activity of IL

- 6

is mediated through two different receptor components. IL
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binds to a low affinity IL- R alpha (gp80) which is stabilized when bound by the
6

signal transducing IL- R beta unit (gpl30) (Tage et al., 1989). The carboxy-terminus
6

has been shown to be important for receptor binding of the functional protein
(Kruttgen et al., 1990; Brakenhoff et al., 1990). The gp80 binding site (termed site I)
is thought to involve an area where the carboxy-terminus of IL

and a section of the

- 6

chain at the beginning of a-helix A are in close proximity (Brahenhoff et al., 1989,
1990). However, TPhe in the loop between the second and third a-helix has been
7 8

shown to be critical for gp80 binding (Ehlers et al., 1996) and is conserved in the
equine sequence. Amino acid deletions at positions 171-179 in the carboxy terminus
of the human sequence have demonstrated that residues 177-179 contribute to the
formation of this receptor binding site and Arg

1 7 9

is required for biological activity of

the molecule in the mouse bioassay (Fontaine et al., 1993). Residues 177-179, Ser,
Leu, Arg, which are invariant among domestic and sea mammals are also conserved
in the horse. The mouse has a Thr177, but this substitution has not been reported to be
a cause of species specificity. In fact, the specificity of mouse IL

- 6

activity has been

linked to three of the four domains (van Dam et al., 1993) including residues 50-55
which activate gpl30 (Ehlers et al., 1995).
The gpl30 binding region of IL- , involves regions early in the loop between
6

the first and second a-helix, specifically Cys^-Glu

5 5

(Ehlers et al., 1994), and regions

at the end of the third and fourth a-helix, specifically GlnI -Hisl6S (de Hon et al.,
5 3

1995). Equine IL

- 6

shares 100% and 85% similarity to the human sequence in these

regions. Determination of the significance of specific residues in this region is an area
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of ongoing study. However, Lys

5 4

is known to be critical to gpl30 activation (Ehlers

et al., 1996) and is conserved in the horse.
IL

- 6

produced by macrophages (Bauer et al., 1988, Gross et al., 1989), and

fibroblasts (Santhanam et a l., 1989), as well as recombinant products of eukaryotic
expression systems (Tanner et al., 1990; Schiel et al., 1990) has been shown to be
variably glycosylated at both N - and O-linked positions. However, recombinant IL

- 6

expressed in E. coli is biologically active indicating that glycosylation is not required
for biological activity (Skelly et al., 1994). Proper protein folding is required for
maximal activity and IL

- 6

mutants lacking the first and second cysteine residues retain

activity similar to nonmutated IL

- 6

while mutants lacking the third and fourth cysteine

residues have a significant reduction in biological activity (Snouwaert et al., 1991;
Skelly et al. , 1994).
IL-10 exists as a homodimer with each monomer composed of six a-helices,
two of which intertwine to form the dimer (Walter and Nagabhushan, 1995). The
resulting structure forms a four helix bundle motif. The molecule is predominantly ahelical (67%) and the putative helix regions derived from X-ray crystallographic
structure of human IL-10 are shown in (Figure 1.6). Human IL-10 lacks detectable
glycosylation but murine IL-10 is variably N-glycosylated near its N-terminous
(reviewed in Moore et al., 1993). However, glycosylation is not required for activity.
IL-10 is expressed (reviewed in Moore et al., 1993) and binds its receptor (Tan et
al., 1993) as a noncovalent dimer. Equine IL-10 shares four conserved cysteine
residues with human IL-10 and mouse IL-10. The first cysteine residue in the mature
peptide pairs with the third and the second with the fourth. The reduced protein
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displays no biological activity suggesting that one or both of these bonds is critical for
structure and function (Windsor et al., 1993).
Equine IL-10 demonstrates DNA and amino acid homology to an IL-10-like
sequence of equine herpes virus-2 and also to a similar IL-10 like motif in the
sequence of Epstein Barr virus termed BRCF or viral IL-10 (vIL-10). vIL-10 has
been shown to have a specific activity 3-10 times lower than human IL-10 (Moore et
al., 1991). Postulated functions of this molecule include the inhibition of virus
induced T or NK cell activation, promoting the growth and differentiation of B cells
(EBV transforms human B cells), and promoting Fc receptor-mediated uptake of the
virus into susceptible cells (reviewed in Moore et al., 1993).
Though the X-ray crystallographic structure of human IL-10 has been resolved
(Walter and Nagabhushan, 1995; Zdanov et al., 1996), mutagenesis studies to
identify residues critical to receptor binding have not been reported. The 85 invariant
amino acid residues in human, BRCF, equine herpes virus-2, murine, and porcine IL10 described by Walter and Nagabhushan (1995) are also conserved in the horse.
Based on the structural similarities between IL-10, IFN-y, and growth hormone, and
the residues critical to receptor binding in these latter two molecules, Ser14l is
predicted to be a critical receptor binding residue for IL-10. Leu^, LeuJ3, and Ilel4S
are also predicted to interact with the receptor. Three of these four residues are
invariant in the equine with Leu being replaced by a biochemically similar Met
4 6

residue. This residue is not, however, invariant and Met substitution is reported in the
equine herpes virus type II sequence. Serl4, is also not an invariant residue among the
published sequences.
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Equine cDNA's with considerable nucleic acid and amino acid homology to
the IL

- 6

and IL-10 sequences o f other species have been amplified using PCR and

primers based on the consensus sequences of these genes in other species. The cloned
equine IL

- 6

the IL

- 6

bears 80-84% nucleic acid identity and 71-84% amino acid similarity to

sequences o f humans and domestic animal species. Equine IL-10 exhibits

8

6

-

89% nucleic acid identity with these species and 96% with red deer. The predicted
IL-10 amino acid sequence similarity is in the range of 87-92% when compared to the
previously noted species. Though functional assays are required to definitively
determine if the proteins encoded by these sequences are biologically active, the high
degree of sequence similarity suggests that these sequences are indeed equine IL

- 6

and

IL-10. The cloned P-actin gene shares 100% amino acid identity with human P-actin
and therefore is identifiable as equine P-actin without functional assays of the protein.
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CHAPTER 2
A NOVEL METHOD FOR QUANTIFICATION OF EQUINE CYTOKINE
MESSENGER RNA USING TARGET SPECIFIC STANDARD CURVES

Introduction
RT-PCR provides a powerful tool for the detection of mRNA which has been
widely applied to quantify a variety of transcripts including cytokines. Quantitative
competitive RT-PCR (QCRT-PCR) is accepted as a reliable method for quantifying
differences in mRNA. However, QCRT-PCR has many drawbacks. The assay is
labor and reagent intensive requiring competitor construction and the generation of a
large series of reactions with differing competitor:target ratios in order to assay a
single sample. Amplification efficiency of competitors can vary significantly from
that of wild type target due to size differences or the formation of competitor/wild
type heteroduplexes (Becker-Andre and Hahlbrock, 1989; Kanangat et al., 1992;
McCullough et al., 1995; Henley era/., 1996; Souaze et al. , 1996). Post PCR
detection generally requires signal corrections as competitors commonly differ in size
from wild type (Piatak et al., 1993). Most significantly, the accuracy of QCRT-PCR
is limited to a narrow range where the targetxompetitor ratio remains between

0

. 6

6

to 1.5 (Raeymaekers, 1993; Souaze et al., 1996). Because QCRT-PCR assays are
labor intensive, replicate determinations of the same sample are rarely done which can
lead to overestimation of the accuracy of this technique. In fact, well established tests
of this type by experienced scientists yield errors between

1

0

% and

2

0

% for analysis

of replicate portions of the same sample on different occasions indicating that it is
preferable to calculate the mean of replicate determinations of the same sample for
81
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reliable discrimination o f two fold differences in copy numbers between two samples
(Apostolakos et al., 1993; Piatuk et al., 1993; Besnard and Andre, 1994; de Kant et
al., 1994; Zimmerman et a l., 1994; Xia et al., 1995).
Standard curves are routinely used in a variety of scientific disciplines
including immunology to evaluate enzymatically dependent phenomenon characterized
by an exponential rise to maximum. Standard curves derived from dilutions of cloned
cDNA sequences have been described (Melby et. al., 1993; Martin et. al.-, 1995) and
RNA standard curves have recently been employed to quantify mRNA in a
competitive RT-PCR assay with excellent intra- and inter-assay precision (Tsai and
Wiltbank, 1996). We demonstrate, using equine cytokines, that the quantity of mRNA
can be determined via RT-PCR using standard curves generated from dilutions of
double stranded circular plasmids encoding the transcript of interest and that by
decreasing the cycle number and cDNA volume used for P-actin amplification, as
compared to cytokine amplifications, P-actin is an accurate normalization factor for
the differences that are inherent in the RT step of the assay. Advantages o f this
method include: (i) the assay has a linear dynamic range on the order of 3 logs; (ii)
the target utilized to generate the standard curve is identical to the cDNA target
thereby minimizing differences in amplification efficiency commonly reported with
the use of competitor molecules; (iii) post PCR detection and analysis does not utilize
radioisotopes or require adjustment for size of the reference molecule; (iv) the assay
is technically straightforward and easily adaptable to any gene that has been cloned
without subcloning or competitor construction; (v) the assay requires fewer reactions
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than QCRT-PCR assays (vi) the method accommodates high sample throughput and,
(vii) replicate samples are easily generated to allow statistical analysis of data.
Materials and M ethods
Preparation o f cells
Equine peripheral blood mononuclear cells (PBMC) were isolated from venous
blood by differential centrifugation over Ficoll-Pague (Pharmacia LKB
Biotechnology, Piscataway, NJ). After washing in calcium and magnesium free
phosphate-buffered saline (CMF-PBS), PBMC were suspended in media consisting of
RPMI 1640 (Sigma Chemical Co., St. Louis, MO) supplemented with 2mercaptoethanol (lO M), glutamine (2mM), 100 U/ml penicillin, 100 pig/ml
-8

streptomycin, and 5% heat inactivated fetal bovine serum (Hyclone Laboratories,
Logan, UT). PBMC were incubated at a concentration of 2 x 106/ml for 72 hours
with phytohemagglutinin-M (PHA, 2pglml, Sigma) at 39°C in a humidified
environment with 5 % C 0 2. Aliquots of PBMC (2 x 10 cells) were frozen at -70°C in
6

RNAStat60 (Tel-Test, Friendswood, TX) until use.
RNA isolation and cDNA synthesis
Samples o f PHA stimulated PBMC which had been frozen in RNAStat60
(Tel-test) were defrosted and processed to RNA using chloroform extraction as per the
reagent manufacturer’s directions. RNA, which was quantified spectrophotometrically, consistently yielded absorbance ratios (260 nm:280 nm) on the order of
1.9. 0.60 fig of RNA in 35 pi diethyl pyrocarbonate (DEPC)-treated water were
heated to 65°C for 10 minutes to denature the RNA then chilled on ice and pulsed in a
microcentrifuge at 4°C. 45 pi o f reagent master mix was then added resulting in a
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final reaction containing IX first strand buffer (Gibco BRL, Gaitherburg, MD),
0.5mM dNTP (Perkin-Elmer, Norwalk, CT), 120 Units RNAsin (Promega, Madison,
WI), 0.075 fig/fil BSA (NEB, Beverly, MA), 1.0 pM Oligo-dT (Promega), 10 mM
DTT (Gibco) and 800 Units Moloney Murine Leukemia Virus (MMLV)-Reverse
Transcriptase (Gibco). The final reaction volume was 80pl. The reaction was
incubated at 25°C for 10 minutes to facilitate primer annealing, then 40°C for 1 hour,
and then frozen at -20°C until used for PCR. DEPC-treated water was substituted for
MMLV-RT in control reactions in order to detect genomic DNA contamination.
In some experiments cDNA reactions were synthesized from serial two fold
dilutions of RNA ranging from 2 fig to 0.0625 fig per reaction. The RNA from these
reactions originated from the same extraction of PHA stimulated cells. This set of
cDNA reactions is referred to as the RNA dilution series. In other experiments, three
cDNA reactions were synthesized from identical amounts of RNA originating from a
single extraction procedure in order to isolate variability associated with the RT
reaction from that associated with RNA extraction and spectrophotometric
quantification. These reactions are referred to as identical cDNA reactions. In assays
that examine the inter- and intra-assay variation associated with RNA that originates
from separate RNA extractions, a split sample design was utilized. Six aliquots of
cells from a PHA stimulated culture of equine PBMCs were frozen in RNAStat60 at
-80°C. RNA was extracted from three of the six samples and processed to cDNA on
two separate days.
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Preparation of plasmid templates and oligonucleotides
Each cDNA encoding equine IL-2, IL-4, IL-5, IL-10, and P-actin was cloned
into a plasmid vector and sequenced in our laboratory. The respective GenBank
accession numbers are: IL-2:L06009, IL-4:L06010, IL-5: U91947, IL-iO: U38200,
p-actin: AF035774. Sequences for equine IL-2 (Vandergrifft and Horohov, 1993) and
IL-4 (Vandergrifft et al., 1994) have been published. Equine Interferon-y (IFN-y)
was a gift from Dr. D. Antczak (James A. Baker Institute for Animal Health, College
of Veterinary Medicine, Cornell University, Ithaca, New York). Plasmids encoding
these cDNA sequences were purified from 50 ml cultures using CsCl
ultracentrifugation in the presence of ethidium bromide (Sambrook et al, 1989) and
quantified spectrophotometrically.
In order to generate standard curves, double stranded plasmids containing the
equine cytokines and P-actin were serially diluted in one-half log increments to
achieve eight dilutions. Cytokine plasmid dilutions ranged from 1 x 10

' 19

to 1 x IQ'225

moles (approximately 40 to 1.2 x 10 cytokine molecules for double stranded plasmid)
5

of plasmid per PCR reaction. P-actin plasmid dilutions ranged from 1 x 10

' 16

1 0 ' 1 9 -5

to I x

moles (approximately 1.6 x 10 to 4.8 x 10 P-actin molecules for double
4

7

stranded plasmid) per PCR reaction.
Equine-specific PCR primers and oligonucleotide probes for hybridization
were selected using ‘Oligo’ primer analysis software (National Biosciences,
Plymouth, MA) and were commercially prepared (Genelab, Baton Rouge, LA; Baron
Biotech, Milford, CT). Sequences of the PCR primers, hybridization probes, as well
as the length of the PCR products are listed in Table 2.1. PCR primers were designed
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Table 2.1 PCR primers, hybridization probes, and expected fragment size for PCR amplification and detection
of equine EL-2, EL-4, IL-5, IL-10 and P-actin.
Amplicon

Positive Strand primer
(5'Biotin-3')

Minus strand primer
(5,-3')

Hybridization probe
(5'TBR-3')

Fragment
size (bp)

IL-2

gcacctacttcaagctctaagag

cacatgtgaatcttgtttcagacc

ttcaattctgtggccttcttgg

303

IL-4

ctcacagatggaaagggcaagaat

cacagtacagcaggtcccgttt

cagcaaaggcatccgctacag

213

EL-5

cgaactctgctgataggcgatg

agacaaagttttggaatagtttggcc

ttggacagtttgattcttcaatgtg

216

IL-10

gactttaagggttacctgggttg

tgcttcagtttttcatcttcgttg

gcctggggcatcacctcct

324

IFN-y

acccagatgtaggggatggtg

cttccgcttcctcaggttagctt

gcttgctggtgctgctgttaa

345

P-actin

atggatgatgatatcgccgcg

aggatgcccctcttgctctg

acgatggaggggaagacggc

194

The positive strand primers were labeled with biotin at their 5' terminus. Hybridization probes were labeled with
TBR at their 5' terminus. Labeled oligonucleotides were purified by HPLC to eliminate unlabeled oligonucleotides.
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to encompass approximately 250 base pairs of the cDNA sequence (range 194 bp to
345 bp). Positive strand primers were biotinylated on their 5' terminus. Oligomers
used for hybridization were complementary to the biotinylated strand and were
labelled with tris (2,2'-bipyridine) ruthenium II chelate (TBR) on their 5 ’ terminus.
Labelled primers and hybridization probes were purified by HPLC to eliminate nonlabelled oligonucleotides.
Polymerase chain reaction
Reactions were optimized for the amplification of both cDNA and plasmid in
preliminary experiments using commercially prepared buffers ( PCR Optimizer Kit,
Invitrogen, Carlsbad, CA; 10X PCR Buffer, Perkin-Elmer) in order to achieve a
single band of maximal intensity on a 3% NuSeive 3:1 GTG agarose gel (FMC
BioProducts) with ethidium bromide staining. The target sequences were amplified in
50jd reactions whose final components were IX PCR Buffer (Table 2.2), 200/xM
dNTP (Perkin-Elmer), 2.5 units Taq DNA polymerase (Perkin-Elmer), and 0.2 fxM
of each sense and .anti-sense primer. Unless otherwise noted, 5 /xl of the cDNA
reaction were used to amplify cytokines and 2ptl to amplify P-actin. Cycling
parameters were 94°C for 30 sec, 55°C for 30 sec, and 72°C for 1 minute except for
IL-4 which annealed at 60°C for 30 seconds. Samples were cycled using a GenAmp
9600 (Perkin-Elmer). PCR reactions were performed in triplicate and plasmids
constituting the standard curve were included on the same plate with the unknown
cDNA reactions using the same PCR reagent master solution.
The optimal number of PCR cycles which would maintain the targeted sample
population in the exponential amplification phase of the PCR reaction were
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Table 2.2 PCR buffer composition.
Amplicon

Buffer Composition (5X)
Tris-HCl (mM) (NH )S0 (mM)
4

4

MgCl (mM)
2

pH @22°C

Gelatin (%)

Source

EL-2

300

75

12.5

IL-4

300

75

12.5

IL-5

250

IL-10

300

75

7.5

8.5

-

INV(G)

IFN-y

300

75

12.5

9.0

-

INV(A)

P-actin

250

-

-

1 0 . 0

9.5

7.5

7.5

-

INV(O)

-

INV(K)

0 . 0 1

0 . 0 1

P-E

P-E

INV(A,G,K, or 0 ) signifies buffer designation in PCR Optimizer Kit (Invitrogen,Carlsbad, CA). 10X PCR
buffer with MgCl used to amplify equine IL-5 and equine p-actin, was obtained from Perkin-Elmer (P-E).
2

00
00

89
determined for each cytokine as well as for P-actin using cDNA from PHA stimulated
equine PBMC. A PCR master mix that included cDNA was divided into equal
aliquots. Tubes were amplified under conditions previously described and one tube
was removed at 15, 20, 25, 30, 35, and in the case of the cytokines at 40 and 45
cycles. Tubes were kept on ice until analyzed.
For plasmid standard curves, plasmids were serially diluted in half log
increments to achieve final concentrations of 2 x IO to 0.2 x 10
' 20

cytokines and

2

x 10 to
17

2

xlO

*2 0

5

"2 3

5

moles//d for

moles//d for P-actin. 5/d of each plasmid dilution

were amplified in each PCR reaction. A standard curve therefore was created by the
amplification of eight dilutions of plasmid encoding the cDNA of interest. Plasmid
standard curves were always generated in parallel with amplifications from cDNA
using the same PCR reagent master mix.
Quantification of PCR product
PCR targets were quantified using the QPCR System 5000 (Perkin-Elmer).
5/d of PCR product were hybridized in solution in a 50/d reaction containing 10
pmoles of target-specific TBR labeled oligonucleotide probe and IX PCR Buffer
without MgCU (Perkin-Elmer). The reaction was heated to 95°C for 90 seconds
followed by a 5 minute hold at 55°C. Biotinylated PCR product was then captured by
adding 15/d of streptavidin coated iron beads (Dynabeads, Perkin-Elmer) to the
hybridization reaction and incubating at 55°C for 30 minutes. The entire 65 /d
reaction was transferred to a 175 mm polypropylene tube containing 335 /d QPCR
Assay Buffer (Perkin Elmer) and quantified on the QPCR System 5000. The QPCR
System 5000 aspirates the iron beads with their attached PCR product bearing TBR
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labeled probe onto a working electrode. TBR on the target specific probe emits light
at 620 nm as a result o f a series of redox reactions that are induced when voltage is
applied to the electrode. The emissions are detected and quantified by a
photomultiplier tube and reported as luminosity units. A plot of luminosity values vs
initial template number was derived from plasmid amplifications. Initial template
numbers in the cDNA reactions were then interpolated using luminosity values. These
values were designated as copy units.
Statistical analysis
Interpolated copy units and luminosity values were compared using one way
analysis of variance. Where data were not normally distributed, the analysis was
performed on ranks. In the case of amplifications originating from identical cDNA
reactions, that is cDNA reactions which were synthesized using equivalent amounts o f
RNA from the same extraction, interpolated copy units were compared using repeated
measures analysis o f variance. Post hoc pairwise comparisons were made using the
Student-Neuman-Keuls method. Inter-assay sample variation was compared using a
paired t-test and the correlation between the predicted cytokine and the predicted Pactin copy numbers derived from the same cDNA sample was determined using
Pearsons Product Moment analysis. Unless otherwise noted, differences are
considered significant when P< 0.05.
Results
Determination o f PCR cycle number
To determine the optimal cycle number which would maintain the
amplification of the cytokines and P-actin in their exponential amplification phase, the
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transcripts of interest were amplified in duplicate reactions to varying cycle numbers
from cDNA reactions and assayed for luminescence with sequence-specific probe. By
plotting luminosity vs cycle number, the exponential amplification phase of the
reactions could be identified. Cycle numbers 20 and 30 defined the limits o f the
exponential amplification phase during amplification of equine P-actin (Figure . ).
2

1

Accordingly, 25 cycles was chosen for subsequent P-actin amplifications. By contrast,
35 cycles were found to provide better sensitivity for cytokine amplification while
maintaining the reactions in their exponential amplification phase.
Generation o f PCR standard curves
Using 25 cycles in the case of p-actin and 35 cycles for the cytokines, one-half
log dilutions o f plasmid ranging from
1

0

19

to

1

x

1

0

1

x 10

' 16

to

1

x 10 s moles for P-actin and
19

1

x

moles for the cytokines were amplified to generate a standard

'2 2 5

curve. A plot o f luminosity vs template number allowed rapid identification o f the
exponential amplification and plateau phases of each reaction (Figures 2.2, 2.3, and
2.4). Because the noncoding strand of the plasmid derived sequence serves as a
template for the PCR reaction, each molecule of plasmid was considered equivalent to
%

2 cDNA molecules when labeling the standard curve axis. A linear relationship was
maintained for all cytokines from 1 x I O

' 2 2 5

to 1 x 10

' 2 0 3

moles of plasmid DNA

indicating a three log dynamic range for input DNA. Similarly, post PCR
quantification o f P-actin also demonstrated linearity of three logs for input DNA
ranging from 1 x 10

19 3

to 1 x IO

' 17'3

moles. For brevity, amplifications from these

series of plasmid dilutions will be referred to as a standard curve.
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Figure 2.1. Optimizing cycle number to maintain P-actin amplification in the
exponential amplification phase of the PCR. Identical 50 ml PCR reactions
containing cDNA from PHA stimulated equine PBMC were amplified to different
cycle numbers as indicated. 5 ml of each PCR reaction were hybridized with
sequence specific probe, captured onto streptavidin-coated iron beads (Dynabeads,
Perkin-Elmer), and assayed using the QPCR System 5000. Reactions amplified
between 20 and 30 cycles defined the exponential amplification phase of the
reaction.
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Figure 2.2. PCR Standard Curves: Beta-actin and Interleukin-2. Luminosity
(measured by the Perkin-Elmer QPCR System 5000) vs. differing initial quantities
of plasmid encoding beta-actin or interleukin-2 after PCR cycles 25 and 35
respectively. Data points represent mean and standard deviation of three replicate
PCR reactions. Regression adjustment represents a two parameter exponential rise
to maximum fit of the data defined by the equation y= a(l-e'^x).
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Figure 2.3. PCR Standard Curves: Interleukin-4 and Interleukin-5. Luminosity
(measured by the Perkin-Elmer QPCR System 5000) vs. differing initial quantities
of plasmid encoding interleukin-4 or interleukin-5 after 35 PCR cycles. Data points
represent mean and standard deviation of three replicate PCR reactions. Regression
adjustment represents a two parameter exponential rise to maximum fit of the data
bx
defined by the equation y = a (l-e ).
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Figure 2.4. PCR Standard Curves: Interleukin-10 and Interferon-gamma.
Luminosity (measured by the Perkin-Elmer QPCR System 5000) vs. differing
initial quantities o f plasmid encoding interleukin-10 or interferon-gamma after 35
PCR cycles. Data points represent mean and standard deviation of three replicate
PCR reactions. Regression adjustment represents a two parameter exponential rise
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to maximum fit o f the data defined by the equation y= a(l-e ).
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Mathematical characterization o f PCR standard curves
To determine the mathematical equation that accurately modeled the standard
curves over a wide range o f input DNA, IL-4, IL-10, and P-actin were amplified
from six cDNA reactions whose RNA content constituted serial two fold dilutions of
RNA (2.0, 1.0, 0.5, 0.25, 0.125 and 0.0625 /xg). Standard curves encoding the
targeted cytokine or P-actin were amplified in the same run.
Several mathematical regression models were applied to the standard curve
data which was graphed on combinations of log and linear scales (SigmaPlot™,
Jandel Scientific, San Francisco, CA). Luminosity values from the RNA dilution
series were then interpolated to copy units using each regression model to determine
if two fold differences in message content were predicted (Figures 2.5, 2.6).
Mathematical models of the standard curve included a linear polynomial (y=b+ax)
adjustment to data graphed as log luminosity vs log copy units. A logistic
mathematical adjustment (y=[(a-d)/(l+(x/c)b)]-fd) was applied to data graphed as
luminosity vs log copy units where a = signal maximum, b=slope parameter,
c=value at inflection point, and d=signal minimum. These analyses of PCR standard
curve data have been previously published (Melby et al., 1993; Reyes-Engel et al.,
1996). The logistic mathematical equation was also applied to data on a log
luminosity vs log copy units scale.
Though the aforementioned adjustments sometimes provided superior
correlation coefficients (r) and did predict dilutions of message that approximated two
fold at the lower RNA concentrations, a two parameter exponential rise to maximum
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Figure 2.5. Mathematical characterization of the PCR standard curves. IL-4 and
IL-10 were amplified from a series o f cDNA reactions whose input RNA constituted
serial two fold dilutions ranging from 2 pg to 0.0625 pg. Luminosity values were
interpolated to copy units using four mathematical analyses of the standard curve and
plotted according to the predicted fold change. Mathematical analyses included: (•)
two parameter exponential rise to maximum (y=a[l-e'*3X]), ( o ) linear polynomial
(y=b+ax) applied to log luminosity vs log copy units, (▼) logistic mathematical
(y=[(a-d)/(l+(x/c)b)]+d) applied to luminosity vs log copy units and, ( v ) the
logistic mathematical equation applied to log luminosity vs log copy units. The line
( ----- ) represents the ideal prediction of two fold changes between samples. Data
represents the fold change between the mean of triplicate PCR reactions.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

98

120

p-actin

<D

.Q

E 1°°
>*

Q.
O
O

32 -

ID

O
C)
.c

O

16 -

2

o

Li_

0.25

0.50

1.00

2.00

RNA per cDNA reaction (pg)

Figure 2.6 Mathematical characterization of the PCR standrd curve. P-actin was
amplified from a series of cDNA reactions whose input RNA constituted serial
two fold dilutions ranging from 2 pg to 0.0625 (ig. Luminosity values from the
cDNA reactions were interpolated to copy units using four mathematical analyses
of the standard cufve and plotted according to the predicted fold change.
Mathematical analyses included: (•) two parameter exponential rise to maximum
(y= a[l-e ]), (o) linear polynomial (y=b+ax) applied to log luminosity vs log
copy units, (▼) logistic mathematical (y=[(a-d)/(l+(x/c)b)]+d) applied to luminosity
vs log copy units and, (v ) the logistic mathematical equation applied to log
luminosity vs log copy units. The line ( ----- ) represents the ideal prediction of
two fold changes between samples. Data represents the mean of triplicate PCR
reactions. (*) indicates replicate beyond the final iteration of the standard curve.
Luminosity values for amplifications from 2 mg of RNA were beyond the final
iteration of the two parameter exponential rise to maximum analysis.
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regression analysis given by the equation y=a(l-e‘ta) was superior at predicting the
expected two fold dilutions (Figure 2.7).
One way analysis o f variance of interpolated copy units from this RNA
dilution series indicated that the predicted two fold dilutions were significantly
different for each o f the PCR targets examined (P<0.01). Pairwise comparison of the
RNA dilution groups indicated that differences among all groups were statistically
significant with the exception o f the 0.0125 fig vs 0.0625 fig comparison for IL-4
whose t-test approached significance (P=0.067). Data representing IL-4 at 2 fig and
P-actin at 1.0 fig and 2.0 fig were not included in the statistical analysis as one or
more values of the triplicate were within the plateau phase of the curve and therefore
beyond the final iteration o f the mathematical model.
Reproducibility of the RT-PCR process
To determine the precision o f the combined RT-PCR process, IL-2, IL-4,
IL-10, IFN-y, and P-actin were amplified using PCR from three identical cDNA
reactions. The identical cDNA reactions were synthesized using RNA from a common
extraction procedure and a common cDNA reagent master mix. Luminosity values
from the cytokine amplifications were interpolated to copy units (Figure 2.8) using
the two parameter exponential rise to maximum adjustment of the respective standard
curves. Copy units for IL-4 and IFN-y could not be interpolated because their
luminosity values were beyond the final iteration of the standard curve within the
plateau phase of the reaction. Luminosity values for IL-4 and IFN-y amplification are
shown in Figure 2.9.
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Figure 2.7 Interpolated copy units from cDNA reactions whose RNA content differed
by two fold. Following PCR, luminosity values were interpolated to copy units using
a two parameter exponential rise to maximum fit of the standard curve given by the
equation y=a(l-e"*>x). The distribution of P-actin values among the cDNA reactions
was positively correlated to the distribution of IL-4 and IL-10 values. All 2 pg P-actin
replicates were beyond the final iteration of the regression. (*) indicates replicate
of the triplicate was beyond the final iteration of the regression.
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Figure 2.8. To determine the precision of the RT-PCR assay, IL-2 and IL-10
(top panel) as well as p-actin (bottom panel) were amplified from 3 identical
cDNA reactions. Copy units were interpolated from luminosity values using
the appropriate standard curves. Data represents the average and standard
error of the mean from triplicate PCR amplifications of each cDNA reaction.
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Figure 2.9. To determine the precision of the RT-PCR assay, IL-4 and IFN-y
were amplified from 3 identical cDNA reactions. Luminosity values for these
amplifications could not be interpolated to copy units because they were
beyond the final iteration o f the standard curve. Data represent the average
and standard error of the mean from triplicate PCR amplifications of each
cDNA reaction.
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The error, determined by the coefficient of variance associated with replicate
amplifications from an individual cDNA reaction ranged from 5-10% for p-actin, and
8-33% for the cytokines (with most values being < 10%). The error in the average
predicted copy units from replicate cDNA reactions ranged from 7-13%. When
subjected to repeated measures analysis of variance, the interpolated IL-2, IL-10 and
P-actin copy units from the 3 identical cDNA reactions were not significantly
different (P > 0 .1 ). Similarly, luminosity values following IL-4 and IFN-y
amplification from the identical cDNA reactions were not significantly different
(P>0.08).
Inter and Intra-Assav Variability
To determine the inter- and intra-assay variation associated with RNA that
originates from separate RNA extractions, IL-2, IL-4, IL-10 and IFN-y were
amplified in triplicate PCR reactions from six cDNA reactions whose RNA originated
from separate extractions o f the same culture. As noted in the methods section, onehalf of the RT reactions (1-3 vs 4-6) were performed on two separate days. PCR
amplification was repeated on a second day. Standard curves were amplified from a
common PCR reagent master solution on each day and message from the

6

cDNA

reactions was determined by interpolation against the standard curve (Figure 2.10).
To assess inter-assay variability, interpolated copy units from the first day’s
amplification were compared to those of the second day for each of the six cDNA
reactions using paired t-tests. The interpolated copy units on day 1 and day 2 were not
significantly different for IL-2, IL-4, and IL-10. Consistent with prior analyses,
IFN-y luminosity values from the 72 hr PHA stimulated cDNA samples tended to be
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Figure 2.10. Comparison o f cytokine message amplified on two separate days
( ■ ■ I day 1, andEHS day 2) from cDNA reactions whose RNA originated
from separate extractions o f the same culture. Message detected from an individual
cDNA reaction did not differ significantly when the two days were compared but
there were significant differences in message content among the six reactions.
(*) denotes IFN-y values which had reached the plateau phase of the reaction.
Bars represent the mean with standard error of triplicate amplifications.
6
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beyond the final iteration o f the standard curve. However, one o f the six cDNA
reactions had luminosity values that were much lower for each o f the transcripts
examined than the other 5 cDNA reactions. The IFN-y luminosity values for this
cDNA (#3) did fall within the exponential amplification phase o f the standard curve
and the interpolated copy units were not significantly different on days

1

and .
2

To assess the intra-assay variability, the interpolated cytokine copy units from
the sue cDNA reactions were compared. As anticipated, there were significant
differences (P < 0 .0 1 ) among the

6

cDNA reactions in the predicted copy units. IL-4

values differed on day I and IL-10 on both day 1 and day 2. IL-4 values on day 2
were not significantly different due to a single reaction (#4) whose coefficient of
variation for the three replicates was very high (135%). Removal of this cDNA
reaction from the statistical analysis restored normality to the sample population and
indicated significant differences (P =0.002) between the predicted IL-4 content of the
remaining 5 cDNA reactions. Interpolated copy units for IL-2 among the

6

cDNA

reactions were not significantly different. The inability to resolve differences in IL-2
input among the

6

cDNA reactions reflected the fact that, as expected for a 72 hour

PHA stimulation, IL-2 message was extremely low and approached the lower limit of
detection of the assay for all of the

6

cDNA samples.

P-actin as a Normalization Factor
The usefulness of P-actin as a house keeping gene for quantitative PCR has
been questioned primarily because its expression exceeds that o f cytokines by

1 0 0

-

1000 fold such that cycle numbers optimized for detection of cytokines cause P-actin
amplifications to enter the plateau phase of the reaction. Accordingly, in order to
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maintain P-actin amplification in the exponential amplification phase of the reaction
cDNA samples were amplified to only 25 cycles in this protocol whereas cytokines
were amplified to 35 cycles. T o define the limitations of this approach, P-actin was
amplified from the RNA dilutions and

6

extraction cDNA sets. cDNA samples were

amplified in conjunction with a standard curve from a common master mix. P-actin
copy units from each PCR reaction were interpolated using the standard curve and a
normalization factor which corrected each sample to 500,000 copies. (500000/average
copy number of three P-actin replicates) was derived. The P-actin luminosity values
from the cDNA reaction that contained 2/xg of RNA were beyond the final iteration o f
the standard curve, within the plateau phase. Due to the magnitude of the P-actin
copy numbers, data were log transformed for statistical analysis.
Pearson’s product moment analysis of the predicted cytokine and P-actin copy
values indicated that the cytokine values for each cDNA were positively and
significantly correlated to P-actin values from the same cDNA reaction (Figure 2.7
and 2.11). Thus, there was a statistically significant correlation between predicted
cytokine copy units and predicted P-actin copy units over a wide range of input RNA
even in the practical situation where PCR reactions resulting from multiple RNA
extractions were compared.
To define the conditions for using p-actin as a normalization factor,
interpolated cytokine copy units from the previous experiments were multiplied by
their respective P-actin normalization factor and compared. In the case of the cDNA
series whose input RNA constitute serial two fold dilutions (Figure 2.12), the
normalized IL-4 values from each cDNA reaction were not significantly different.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

108

1e+6 -

P-actin

£

c

1e+5

z>
QO
o 1e+4

1e+3 -

3

4

cDNA Reaction
Figure 2.11. Correlation between cytokine and P-actin levels from the same cDNA
reaction. IL-2, IL-4, IL-10 and P-actin were amplified in triplicate PCR reactions
from six cDNA reactions whose RNA was derived from separate extractions of a
single PBMC culture. Cytokine values for each cDNA were positively and
significantly correlated to P-actin values from the same cDNA reaction.
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Figure 2.12 Cytokine copy numbers normalized for P-actin content o f the cDNA
reaction. Interpolated IL-4 and IL-10 values derived from PCR amplification of cDNA
reactions that contained two fold dilutions of RNA were normalized to 500,000 copies
of P-actin and compared. O f the two cytokines only the 1 pg amplification of IL-10
was significantly different from the other cDNA reactions. However, 1 pg P-actin
replicates were within the plateau phase of the reaction (*).
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However, the normalized IL-10 value for the cDNA reaction that contained 1 pig o f
RNA was significantly different from the normalized values for the other dilutions.
Because two fold dilutions of IL-10 were predicted at all dilutions prior to
normalization, this finding suggested that amplification of P-actin from 1 pig of RNA
was beginning to exceed the useful limits of the assay.
When normalized cytokine copy units for the

6

cDNA reactions that originated

from separate RNA extractions of PHA stimulated cells were compared (Figure
2.13), there were significant differences among the cDNA reactions for IL-2 and IL10. Normalized copy units were not significantly different for IL-4 but this reflected a
large coefficient o f variance associated with cDNA #3, a phenomenon previously
observed with PCR amplifications on very low template concentrations. Normalized
IL-4 values for the remaining cDNA reactions were significantly different when
analyzed without data from cDNA #3. Though there was some overlap in the
statistical groupings of the six cDNA using pairwise comparisons of the normalized
cytokine numbers, there was a tendency for three groupings. Group one consisting o f
cDNA ff6 and M . Group two consisting of cDNA #1, ft2, and ft5. and group three
having only cDNA ff3. Closer scrutinization of the luminosity values revealed an
explanation for these findings. Cytokine luminosity values for cDNA #3 were at or
below the lowest dilution of the plasmid standard curve, while the luminosity values
for P-actin from cDNA #4 and ff6 were between the two highest dilutions of the Pactin standard curve at the portion of the curve entering the plateau region. Analysis
of the data with and without values from these reactions (#3, #4, if6) determined that
values in these ranges could not be used in comparisons of the data (Table 2.3).
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reaction.The cytokine content o f six cDNA reactions derived from separate RNA
extractions of the same culture were normalized to 500,000 copies of P-actin using
P-actin values amplified from the same cDNA reaction. Bars represent the mean
and standard deviation o f triplicate reactions run on ( ■ ■ ) dayl and repeated on
C
) day .
2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2.3 Effect of P-actin normalization on the coefficient of variation (CV)
cDNA #1-6

cDNA #1,2,4-6

cDNA# 1,2,5

cDNA#4,6

X

STD

CV

X

STD

CV

X

STD

CV

X

STD

CV

IL-2 PCR 1
raw
normalized

396.8
237.2

109.2
380.0

0.28
1.60

428
67.8

92.2
34.3

0.22
0.51

341.0
92.0

38.0
19.0

0.11
0.20

438.0
28.5

17.0
0.5

0.04
0.02

IL-2 PCR II
raw
normalized

576.1
256.7

158.2
371.9

0.27
1.45

611.2
91.2

150.6
40.9

0.25
0.45

549.0
134.5

214
12.5

0.38
0.09

689.0
45.0

22.0
2.0

0.03
0.04

IL-4 PCR 1
raw
normalized

7399.8
1811.8

3708.0
1233.2

0.50
0.68

8693
1334.2

2542.7
675.3

0.29
0.51

7762.0
1787.7

2066.1
478.7

0.27
0.27

10089.5
654.0

2551.5
159.0

0.25
0.24

IL-4 PCR II
raw
normalized

9768.2
2274.0

5353.9
1331.3

0.55
0.59

11961
1721.5

3433.5
830.1

0.29
0.48

9532.5
2510.0

1808.5
320.0

0.19
0.13

14389.5
933.0

2917.5
180.0

0.20
0.19

IL-10 PCR I
raw
normalized

1259.0
287.5

687.7
197.0

0.53
0.69

1480.2
207.2

491,3
88.7

0.33
0.43

1301.7
270.0

530.1
55.7

0.41
0.21

1748.0
113.0

250.0
15.0

0.14
0.13

IL-10 PCR II
raw
normalized

1144.8
222.8

842.3
111.3

0.56
0.50

1354.4
179.8

481.2
61.2

0.36
0.34

1087.3
223.7

453.8
37.8

0.42
0.17

1755.0
114.0

51.0
2.0

0.03
0.02

The average of triplicate normalized cytokine amplifications from cDNA reactions (#1-6) whose RNA originated from separate
extractions of the same culture were grouped as noted and analyzed for their effect on the assay error. Removing data derived from
the extremes of the standard curves (reactions 3, 4, and 5) decreased the error to 13-27%.
6

N>
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Values at or below the bottom of the cytokine curves and at the top of the P-actin
curve overestimated the copy values leading to erroneously high correction factors.
When all six reactions were analyzed, normalization did not improve the sampling
error as determined by the coefficient of variation (CV) among the average values for
the sue reactions and actually tended to increase it to unacceptable levels (50> 100%). Removing values from cDNA #3 decreased the errors in both normalized
and non-normalized samples from the same population but the errors were still up to
two fold greater in the normalized than the non-normalized data. However, when the
cDNA #4 and

#

6

were removed from the analysis, the coefficients of variance (CV)

prior to normalization ranged from 20-40% and were decreased to 13-27% after
normalization. This confirms that when values lying outside the linear portion of the
standard curve are excluded, P-actin is a valuable normalization factor and differences
of + /-

2

standard deviations about the mean will adequately discriminate significant

differences between samples.
Discussion
Amplifications from cloned cDNA of identical sequence to the wild type target
have been previously utilized to generate standard curves for the quantification of
PCR products (Martin et. al.\ 1995, Melby et. al., 1993). As with our experiments,
the standard curve and unknown cDNA samples were amplified using the same PCR
reagent master mix and were analyzed in replicates to minimize any tube to tube
variation in the PCR reaction. This approach eliminates the need for synthetic
templates of different sizes from wild type. This has several advantages. First,
because the target and control sample are of identical sequence but amplified in
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different tubes, the concerns regarding different amplification efficiencies based on
size differences ( Becker-Andre and Hahlbrock, 1989; Kanangat et al., 1992; Souaze
et a l., 1996) or the formation o f competitor/wild type heteroduplexes are minimized
(McCullough et al., 1995; Henley et al., 1996). This method is less labor intensive
because there is no internal standard to construct nor is there a large series of samples
with differing competitor:target ratios. Varying the competitor:target ratio is required
for accurate quantification using competitive methods (Arnold et a l., 1992; Souaze et
al., 1996;; Raeymaekers, 1993). Most significantly, this method is easily performed
with very high sample throughput from cells to quantified product in replicates
sufficient for statistical analysis of the data in a single day.
The generation of standard curves and their graphical representation of signal
intensity (luminosity) vs copy number on a linear scale allowed identification of the
exponential amplification and plateau phases of the PCR reaction. It is well accepted
that in noncompetitive methods, samples must remain in the exponential amplification
phase of the reaction for meaningful comparison because all reactions, regardless of
starting template concentration, will reach a maximum defined as plateau (Ferre,
1992; Morrison and Gannon, 1994). Despite occasional reports to the contrary
(Dostal et. al., 1994; Ruster et. al., 1995) competitive reactions can be run to plateau
without adversely affecting target:competitor ratios (Bouaboula et. al., 1992; Siebert
and Larrick, 1992; Couttrez et. al., 1994; Morrison and Gannon, 1994) Decreases in
PCR product following plateau have been described and the reason for this
phenomenon is not known (Personal communication, John Pfeifer, Perkin-Elmer).
The mathematical model applied to these standard curves, a two parameter
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exponential rise to maximum given by the equation y = a (l-e bx), has the advantage of
preventing interpolations beyond the final iteration of the standard curve which lie
within the plateau phase o f the reaction. The most commonly utilized mathematical
model for PCR based quantifications is a linear fit where data is graphed following
detection o f PCR product as log,0 signal strength vs Iog10 copy number (Wang et. a l.,
1989; Murphy et. al., 1990; Noonan et. al., 1990; Melby et al., 1993). However, a
logistic mathematical analysis of signal strength vs logi0 template concentration has
been shown to provide a superior fit to the curve over a wide range of template
concentration (Reyes-Engel et al., 1996). When these models are applied to
noncompetitive methods, because there is no mathematically imposed maximum, the
beginning of the plateau is subjectively determined by the investigator. Experience
with different graphical representations of our standard curve data indicated that linear
adjustments made it difficult to appreciate the onset of plateau.
Unlike other experiments which simply utilize a mathematical adjustment that
provides the best fit o f the standard curve data, in this instance cDNA reactions
created from serial two fold dilutions of RNA, which should therefore contain two
fold dilutions of cytokine template, were utilized to determine the mathematical model
which most accurately modeled the performance of the PCR amplification. Though
the other mathematical adjustments to the standard curves often provided superior
correlation coefficients, the two parameter exponential rise to maximum adjustment
was chosen because it most closely predicted the anticipated two fold dilutions of
message with minimal variation such that the two fold dilutions were significantly
different when subjected to analysis of variance. This also indicates that the assay is
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capable of resolving at least two fold differences in message, though the limits of
resolution were not determined. Based on the graphical representation of the standard
curves and amplifications from diluted RNA, the assay has a linear dynamic range on
the order of 3 logs.
To our knowledge this is the first report of the use of double stranded (ds)
circular plasmid to generate standard curves used for quantification o f PCR product.
Other reports have used linearized cDNA plasmid (Martin et al. , 1995) or liberated
the cDNA fragment using restriction digests (Melby et al., 1993) but use of ds
plasmids eliminates the need to purify the fragments from inhibitors o f the PCR
reaction following digests. Though there are reports of differences in the efficiency of
amplification between double stranded and single stranded templates, the curves
described here accurately predicted a two fold difference in transcript numbers from
cDNA reactions whose input RNA varied by two fold for each of the transcripts
examined. This indicates that, at least over the range of these template dilutions which
in the case of IL-10 covered most o f the linear portion of the standard curve, the
amplification efficiency of the target sequences from double stranded circular plasmid
and linear single stranded cDNA was equivalent.
A number of housekeeping genes including glyceraldehyde-3-phosphate
dehydrogenase (GADPH) (Dukas et al. , 1993), hypoxanthine phosphoribosyltransferase (HPRT) (Murphy et al., 1993) and peptidyl-prolyl-cistrans isomerase
(Cyclophilin) (Nast et al. , 1994) have been utilized in PCR analysis of cytokine
mRNA content. P-actin was chosen as the internal control for this assay because the
equine sequence has been determined allowing the generation of sequence-specific
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oligonucleotide probes and primers. Additionally, attempts to amplify HPRT using
published sequences (Grunig et al., 1992) were variably successful in our hands.
While 1.3 (Melby et al. , 1993) to three fold (McCairns, 1994) increases in P-actin
message have been reported in response to mitogen stimulation using cloned T cells
and normal human PBMC respectively, increases in HPRT production on the order o f
10-20 fold have been demonstrated in mitogen stimulated human lymphocytes (Steen
et al., 1990; Steen et al., 1991) making HPRT a less favorable internal control for
immunologic studies. The primary drawback o f P-actin is that it is a moderately
abundant transcript whose expression is several orders of magnitude greater than
cytokines, a problem not significantly different for GADPH and Cyclophylin which
are, respectively, moderately abundant and slightly less than moderately abundant
species (Smith, 1995).
To address the difference in expression between P-actin and cytokine species,
the volume of cDNA and the cycle number used for P-actin amplification were
lowered when compared to parameters used for cytokine amplification. The premise
that normalization should not be compromised and actually improved by this
difference in template concentration cycle number reflects the fact that normalization
values are based on relative differences between the samples which can only be
resolved in non-competitive methods if all samples are within the exponential
amplification phase of the reaction. This is well illustrated by the results of cDNA # 4
and

#

6

in the six extraction set of cDNA reactions whose P-actin values approached

the plateau phase and whose normalized cytokine values were significantly lower than
those of the other replicates. 25 cycles have been previously reported for p-actin
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amplifications using non-competitive methods but these reports utilized comparatively
more RNA per PCR reaction, on the order of 0.5 fig per PCR reaction (Melby et a l.,
1993). In preliminary experiments, RNA quantities of this magnitude consistently
pushed the PCR reaction into the plateau phase which eliminates the ability o f P-actin
amplifications to resolve the differences inherent in the RT step. The finding in this
series of experiments that p-actin values in the region of the standard curve
immediately preceding the plateau phase are associated with normalization errors has
restricted use of samples whose P-actin values amplify to this level. Negative samples
are still accurate but amplifications from samples with positive cytokine values are
repeated on dilution. To our knowledge this is the first time that different cycle
numbers and cDNA volumes have been used to amplify the housekeeping gene and
cytokine targets.
By using RNA from a single RNA extraction in the synthesis of three identical
cDNA reactions the precision o f the PCR process (given by the error associated with
repeated amplifications from the same cDNA reaction) as well as tube to tube
differences in the efficiency of the RT reaction, were examined. The precision of this
PCR process (10-30%) is quite good when compared to other investigators whose
pre-normalization errors ranged from 20% to as high as 50% (Kanangat et al., 1992;
Melby et al., 1993; Jessen-Eller et al., 1994). The fact that the average predicted
copy numbers from these identical cDNA reactions were not significantly different
and varied by only 5-10% indicates that there was no difference in the tube to tube
efficiency of the RT reaction. When amplifications were made from multiple cDNA
reactions whose RNA was derived from separate extractions of the same culture, at
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least two o f the reactions had significantly less message (prior to normalization) than
the remaining four reactions and this distribution of message was equivalent for each
of the cytokines examined. Taken together these findings suggest that the differences
in RT efficiency which are commonly reported (Cone et al., 1992; Jessen-Eller et al.,
1994) most likely reflect either errors in RNA quantification or, the presence o f RT
reaction inhibitors which are copurified with the RNA during extraction.
While the findings from the cDNA reactions created from RNA dilutions and
from the identical cDNA reactions synthesized using RNA from a single extraction
demonstrated that the use of plasmid standard curves is repeatable and accurately
detects two fold changes in input RNA, single RNA isolations do not reflect
laboratory practice. Using six separate cDNA reactions whose RNA originated from
separate extractions of the same PBMC culture, there was no difference in the
predicted copy values for each of the cytokines when amplifications from the same
cDNA reactions on two different days were compared. This confirms that plasmid
derived standard curves can be used to overcome day to day variability in the PCR
reaction. There were however, as previously mentioned, differences in the predicted
cytokine values among the six reactions prior to normalization. The relative ranking
of the six cDNA reactions based on quantity o f transcript was significant and
positively correlated with the ranking derived from P-actin amplification for each of
the transcripts examined. This confirmed that P-actin amplified under these conditions
could be used to determine which reactions had significant differences in the RT step,
suggesting that P-actin might be useful as a normalization factor.
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When P-actin was examined as a normalization factor several limitations to the
assay were identified. W hile it was previously assumed that the final iteration of the
standard curve would prevent errors due to interpolations within the plateau phase,
instances did occur in which the final iteration of the standard curve was between the
2

highest dilutions of the standard curve, within the plateau. P-actin luminosity values

from cDNA reactions which were in this region were falsely overestimated, resulting
in low normalization factors which therefore underestimated the normalized cytokine
values. Similarly, cytokine values at or below the bottom of the curve overestimated
the copy number causing normalization errors even when P-actin values were derived
from the exponential amplification portion of the P-actin standard curve. Samples
falling in these regions must therefore be re-amplified using an appropriate cDNA
volume adjustment. It is also important to note that the luminosity values derived
from negative controls are not equivalent to

0

copy units using this regression model

so that comparisons with negative values must be adjusted based on the value
interpolated from the negative control. When these contingencies are applied to
normalized values both from the RNA dilution set and the set o f six separate
extractions from a single culture, the corrected copy numbers are not significantly
different despite significant differences prior to normalization. These contingencies
are not unique but simply reiterate the need for strict adherence to the limits of the
exponential amplification phase of the PCR reaction. Normalized values from the
nonexponential regions o f the curves increased the assay error (defined by the
variance when the average cytokine copy units from each cDNA reaction are
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compared) from 13-27% to 45-160% for the reactions from separate extractions and
from 13% to 21% in the RNA dilution samples.
The objective in the development o f this assay was to create a quantitative
method for the analysis o f cytokine mRNA in equine lymphocytes but not necessarily
to achieve the highest sensitivity accessible by PCR. However, this method is readily
adaptable to increased or decreased sensitivity by altering cycle number and/or the
quantity of RNA utilized based on pilot studies o f the population in consideration.
This method is precise, repeatable, easily resolves two fold differences in message
(and perhaps smaller differences), and has a dynamic range on the order of 3 logs
without the use o f competitors. By strictly adhering to the limits of the exponential
amplification phase of the PCR reaction, a range of + /- 2 standard deviations about
the mean will predict significant differences between samples.
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CHAPTER 3
VACCINATION AGAINST STRONGYLUS VULGARIS IN HORSES:
C O M PA R ISO N O F THE CYTOKINE, HUM ORAL AND
LYM PHOPROLIFERATTVE RESPONSES OF VACCINATES AND
NONVACCINATES

Strongylus vulgaris is considered the most pathogenic nematode parasite of
equidae due to the severe arterial lesions it causes in the cranial mesenteric artery
during larval migration. Infective third-stage larvae (Lj) ingested from contaminated
pasture penetrate the mucosa o f the large intestine, molt to fourth-stage larvae (L4) in
the submucosa, and then proceed along arterioles and arteries that supply the intestine
to the root o f the cranial mesenteric artery (Ogboume and Duncan, 1985). There
larvae molt to become immature adults (Ls) causing severe arteritis before returning,
again via the vasculature, to complete their life cycle in the large intestine. Arterial
lesions include the formation o f tortuous subintimal tracts, thrombi, and in severe
cases verminous aneurysms which can compromise perfusion of intestinal vascular
beds. This syndrome known as verminous arteritis or thromboembolic disease is
characterized by ischemic infarctions of the bowel which result in toxemia, abdominal
pain, and death in severe cases (White, 1985).
Previous studies have demonstrated that oral vaccination with radiationattenuated S. vulgaris L induces resistance to challenge infection and prevents
3

classical lesions of verminous arteritis (Klei et al., 1982). When compared to
parenteral vaccination with adult or larval somatic antigen homogenates which did not
confer resistance to challenge infection, the protection observed in oral radiationattenuated L vaccinated ponies correlated to both prechallenge anti-5, vulgaris
3
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antibody titers specific for surface antigens of late L stages and to induction of a post
3

challenge anamnestic-like eosinophilia (Monahan et al., 1994). Infections by S.
vulgaris have been shown to activate eosinophils and neutrophils in vitro (Dennis et
a l., 1988) and eosinophils from S. vulgaris primed but not unprimed ponies kill S.
vulgaris L in vitro in an antibody-dependent manner (Klei et al., 1992), indicating
3

that an antibody-dependent phenomenon involving eosinophils may contribute to the
resistance seen in immune ponies.
Helminth infections are characteristically associated with eosinophilia and
elevated IgE production (Finkelman et al., 1991), traits that also characterize the
Type II or TH2 response initially described in cloned mouse cells (Mosmann et al.,
1986; Mosmann and Coffman, 1989b). Type II responses, identified by the
production of IL-4 and IL-5 which are integral to the generation of IgE (Snapper and
Paul, 1987) and eosinophilia (Coffman et al., 1989) respectively, have been shown to
play a significant role in the protective immune response to metazoan helminths
(reviewed in Mosmann and Coffman, 1989a; Cox and Liew, 1992; Urban, J. F. et
al., 1992). A cytokine or combination of cytokines which exhibits chemotactic
activity for eosinophils has been found in the supernatant of S. vulgaris stimulated
PBMC from immune but not nonimmune ponies (Dennis et al., 1993). This finding
coupled with the anamnestic eosinophilia which is characteristic of immunity to S.
vulgaris suggest that differential cytokine production, perhaps similar to that seen in
classical Type II responses to helminth parasites may play a role in immunity to S.
vulgaris.
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Methods
Experimental design
Ten yearling ponies were raised and maintained under parasite-free conditions
(Monahan et al., 1997), housed in pairs on wood shavings, and fed a pelleted ration
and water ad libitum. The experimental design consisted of three groups. Four ponies
in group 1 (vaccinates) were orally vaccinated with 500 S. vulgaris Lj irradiated with
90 kRads “ Co as described (Klei et al., 1982). Vaccination larvae were administered
in tap water by syringe behind the tongue, then the syringe was rinsed and the rinsate
administered orally as well. Immunization was repeated in this group 3 weeks after
the first immunization. Group 2 (nonvaccinates) consisted of 4 ponies and group 3
(controls) consisted of two ponies. Six weeks following the second immunization
vaccinates and nonvaccinates were challenged per os with 1000 S. vulgaris L .
3

Following challenge ponies were monitored at least twice daily for fever, signs of
abdominal pain, depression, and anorexia. Observers were blinded to the nature of
the ponies’ treatment and pyrexia was considered to be any rectal temperature above
39°C. Four days prior to challenge (D-4), on the day of challenge (DO), and on days
4 (D4) and 9 (D9) post challenge, exploratory celiotomies were performed to collect
lymph nodes from the region of the cecum in close proximity to the ceco-colic fold,
termed colonic lymph nodes (CLN). Blood was collected for hematologic evaluation
and collection of peripheral blood mononuclear cells (PBMC) at these time points as
well as fourteen days following challenge (D14). On D14 necropsy examinations
were performed as described previously (Klei et al., 1982) for evaluation of lesions,
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collection of CLN, and recovery o f larvae from cranial mesenteric artery (CMA)
dissections.
Hematology
Blood was analyzed in a routine fashion. Total white blood cell counts were
analyzed using a Baker 9000 analyzer (Serono-Baker, Allentown, PA). Differential
white cell counts were determined by counts of

1 0 0

cells examined at

1 0 0

x under oil

immersion.
Strongylus vulgaris larvae and soluble antigen
Larvae for use in the irradiated immunizations were recovered as

from

Baermann sedimentations o f fecal cultures from monospecifically infected S. vulgaris
donor ponies (McClure et al., 1994). Larvae were washed and stored in tap water at
4°C until use. Soluble adult S. vulgaris antigen (SAWA) preparations used in ELISA
and lymphoproliferation assays were prepared as previously described (Klei et al.,
1982) from adult S. vulgaris recovered from the intestines o f horses.
Enzyme-linked immunosorbent assay (ELISA)
Circulating antibody isotypes specific for adult S. vulgaris soluble antigens
were monitored by ELISA using serum collected on D-4 and D14. Soluble adult S.
vulgaris antigen was diluted in buffer (0.015 M NajCC^, 0.035 M N aH C03, 0.003 M
NaN3) to 5 /zg/ml. Antigen preparation was added to wells o f 96-well flat bottom
polystyrene microtiter plates in 50 pi volumes (Dynatech Laboratories, Chantilly,
Virginia) and incubated overnight. Unless otherwise noted, incubations were
performed at 37°C in a humidified incubator. Plates were washed three times with a
solution o f 0.05% Tween 20 in PBS (PBST) and nonspecific binding sites were
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blocked using 1% fish gelatin (Sigma, St. Louis, MO) in PBS (PBSG), 100 fi\ per
well, for 1 hour at room temperature. A 1:200 dilution of serum was made in PBSG
and added to triplicate wells in 50 fil aliquots. Serum from known high responders
and negative responders served as standard positive and negative controls on each
plate. Plates were incubated for 90 minutes then washed three times with PBST.
Culture supemates from hybridoma lines specific for equine IgA, IgM, IgGa, IgGb,
or IgG(T) (Lunn et al., 1996) were diluted 1:100 in PBSG, added to appropriate
wells in 50 fil volumes, and incubated for 90 minutes. Following incubation, wells
were washed three times with PBST. Affinity-purified, horseradish peroxidaseconjugated goat anti-mouse IgG and IgM, heavy and light chain specific (Jackson
Immunoresearch Labs, West Grove, PA) was diluted 1:1000 in PBSG, added to wells
in 50 fil aliquots, and incubated for 90 minutes. Plates were washed three times with
PBST. The substrate was 3,3',5,5'-tetramethylbenzidine (TMB, Kirkeguard and
Perry, Gaithersburg, MD) at 75 fi\ per well. Reactions were allowed to proceed for
10 minutes for optimum color development. Optical density (OD) was recorded using
a Dynatech MR 700 automated microtiter plate reader (Dynatech Industries) with
absorbance set a t 630 nm.
Preparation of cells
Equine PBMC were isolated from venous blood by density gradient
centrifugation over Ficoll Paque (Pharmacia LKB Biotechnology, Piscataway, NJ).
After washing in calcium and magnesium free phosphate buffered saline (CMF-PBS),
PBMC were suspended in media consisting o f RPMI 1640 (Sigma Chemicals, St.
Louis, MO) supplemented with 2-mercaptoethanol (10 M), glutamine (2mM), 100
"8
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U/ml penicillin, 100 pcg/ml streptomycin and 5 % heat inactivated fetal bovine serum
(HyClone Laboratories, Logan,UT). Cells were isolated from colonic lymph nodes by
disruption through sterile mesh screens. Colonic lymph node derived cells (CLNC)
were washed twice in media, resuspended and counted. Aliquots of PBMC and
CLNC (2 x 10 cells) were frozen at -70°C in RNA Stat 60 (Tel-Test, Friendswood,
6

TX) for use in cytokine quantification assays.
Lymphoprol iferation
On D-4, D4, D9, and D14, PBMC and CLNC were seeded onto multiple
wells of a 96 well round bottomed tissue culture plate (Costar, Assonet, MA) at a
density of 2 xlO cells and incubated in 200 fil o f media containing soluble adult S.
5

vulgaris antigen at a final concentration o f 4 jzg/ml. Proliferation was measured by
( H)-thymidine incorporation. After incubation for 5 days at 39°C with 5 % C 0 2,
3

50[il (0.5 fiCi) o f H-thymidine was added to each well and incubation was continued
3

for 4 hours. The pulsed cells were harvested onto glass fiber filter pads with a
Tomtech 96-well Harvester for liquid scintillation counting using a LKB Betaplate
counter (Pharmacia).
Cytokine quantification
Samples of PBMC and CLNC which had been collected at D-4, D4, D9, and
D14 and frozen in RNA Stat 60 reagent were defrosted and processed to RNA using
chloroform extraction as per the reagent manufacturer's directions. RNA was
quantified spectrophotometrically and the ratio of optical densities at 260nm and 280
nm (O.D.

2 6 0

nm:O .D .2g0nm) was consistently in the range of 1.9. 0.60 fig o f RNA in a

volume of 35 fil DEPC-treated water were heated to 65°C for 10 minutes to denature
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the RNA, then chilled on ice for two minutes and pulse-spun at 14,000 x g in a
microcentrifuge at 4°C. 45 fil o f reagent master mix were then added resulting in a
final reaction containing lx first strand buffer (Gibco BRL, Gaithersburg, MD), 0.5
mM dNTP (Perkin-Elmer, Foster City, CA), 1.0 pM Oligo-dT (Promega, Madison,
WI), 10 mM DTT (Gibco), 0.075 pg/pl BSA (NEB, Beverly, MA), 120 Units
RNAsin (Promega), and 800 units Moloney Murine Leukemia Virus Reverse
Transcriptase (BRL). The reaction was incubated 1 hour at 40°C then frozen at -20°C
until use.
Equine IL-2, IL-4, IL-5, IL-10, and IFN-y were quantified with the aid of the
polymerase chain reaction (PCR) by interpolation against a standard curve as
descrived in chapter 2. Standard curves were generated for each cytokine by
simultaneously amplifying, from a common PCR master mix, known quantities of
plasmids which contained the equine cytokine sequence o f interest. Briefly, cytokines
were amplified in 50 fil PCR reactions from 5 /d of each cDNA reaction using 2.5
units of taq polymerase (Perkin-Elmer), 0.5 mM dNTP (Perkin-Elmer), and speciesspecific primers at a final concentration of 0.2 pM. Primers were commercially
prepared (Genelab, Baton Rouge, LA; Baron Biotech, Milford, CT) from speciesspecific sequences which were determined using Oligo primer analysis software
(National Biosciences, Plymouth, MN). Upstream primers were biotinylated on their
5' terminus. Cycling parameters including buffer (PCR Optimizer, Invitrogen,
Carlsbad, CA) and annealing temperatures were optimized for each cytokine. All
cytokines were amplified to 35 cycles which was previously determined to maintain
the reactions in their exponential amplification phase. P-actin, which was utilized as a
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housekeeping gene, was amplified from 2 pi of cDNA using 25 cycles in order to
remain within its exponential amplification phase.
PCR products were quantified using the QPCR System 5000 (Perkin-Elm er)
as has been described (Zhao et al., 1996; Blok et al., 1997). 5 pi o f each PCR
reaction were hybridized in a 50 pi reaction containing lx PCR buffer II (PerkinElmer) and 10 of pmoles tris(2,2'-bipyridine) ruthenium II chelate labeled
oligonucleotide probe whose sequence was specific to the cytokine targeted by PCR.
Oligonucleotide probes were commercially prepared (Baron Biotech, Milford, CT)
and purified by HPLC to eliminate non-labeled oligonucleotides. The reaction was
heated to 95°C for 90 seconds followed by a 5 minute hold at 55°C. 15 fil of
streptavidin-coated iron beads (Dynabeads, Perkin-Elmer) were added to each
reaction followed by incubation at 55°C for 30 minutes. The entire 65 p 1 reaction was
transferred to a 175 mm polypropylene tube containing 335 p 1 QPCR Assay Buffer
(Perkin-Elmer) and quantified on the QPCR System 5000 whose output is in
luminosity units.
Statistical Analysis
The number of days that anorexia, pyrexia, depression, and abdominal pain
were exhibited by ponies in each treatment group in response to oral challenge with S.
vulgaris larvae were subjected to one way analysis of variance. Lymphoproliferation
data was subjected to one way repeated-measures analysis of variance. ELISA OD
data was subjected to two way analysis of variance. Due to the wide distribution of
cytokine responses displayed by this outbred population of ponies, cytokine data were
log transformed for statistical analysis. For each day examined (D-4, D4, D9, and
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D14), differences in cytokine production among the three treatment groups were
compared using one way analysis of variance while comparisons of daily cytokine
production within a treatment group were made using repeated-measures analysis o f
variance. Daily cytokine production in PBMC was compared to that o f CLNC for
each treatment group using the Student's t-test. Differences were reported as
significant when P< 0.05.
Results
Clinical signs..
Ponies in the vaccinal group exhibited significantly fewer episodes o f pyrexia,
depression, and abdominal pain than nonvaccinates (Table 3.1). Pyrexia, depression,
and abdominal pain exhibited by vaccinates was not significantly different from that
exhibited by control ponies. There was no difference in the number of days that
anorexia was exhibited by ponies in the three treatment groups.
Larval recoveries
Irradiated recipients had a 100% reduction of migrating larvae compared with
nonvaccinates (Table 3.2). Larval numbers in nonvaccinates ranged from 3 to 28 per
pony.
Eosinophil counts
Differentials performed on peripheral blood smears from ponies on D-4, DO,
D4, D9, and D14 following challenge demonstrated that ponies vaccinated with
radiation attenuated larvae developed an eosinophilia by day 4 following challenge
(Figure 3.1). In contrast, eosinophil counts from nonvaccinated ponies failed to show
significant elevations within the two weeks following challenge.
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Table 3.1. Summary o f the clinical signs exhibited by vaccinated, nonvaccinated, and
control ponies in response to challenge with 1000 S. vulgaris L .
3

Group

Anorexia

Vaccinates
Nonvaccinates
Controls

Pyrexia

8

Depression

1

9

0

5*

2

Colic

0

0

3*

3*

0

0

Data represent the mean number of days that ponies exhibited the respective clinical
sign. Pyrexia was considered any rectal temperatures exceeding 39°C . (*) indicates
values are significantly higher than vaccinates and controls.

Table 3.2. Larval recoveries from vaccinated and nonvaccinated ponies following
challenge with 1000 S. vulgaris L ..
3

Immunization Group

Vaccinates
Nonvaccinates

Average Larval Recovery

0

Percent Protection

100 %

16

Larvae were recovered from scrapings of the lumen of the CMA and its branches and
counted using a dissecting microscope. Larval numbers in nonvaccinates ranged from
3 to 28 per pony.
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Figure 3.1. Eosinophil response to S. vulgaris challenge in vaccinate, nonvaccinate
and control ponies. Mean eosinophil counts for each group were calculated by
multiplying the WBC count/p.1 blood, as determined by automated counting, by
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ELISA
Levels o f IgM, IgA, IgGa, IgGb, and IgG(T) specific for SAWA were
determined using sera collected from vaccinate and nonvaccinate ponies on D-4 and
D14 (Figure 3.2). When compared to prechallenge levels from nonvaccinates, levels
of SAWA-specific IgGa, IgGb, and IgG(T) were significantly greater in the sera o f
vaccinates. Following challenge IgG(T) levels of vaccinates remained significantly
greater than those o f nonvaccinates but did not change significantly from prechallenge
levels. Challenge with S. vulgaris L resulted in statistically significant increases in
3

IgA in both vaccinates and nonvaccinates with nonvaccinate IgA levels significantly
exceeding those o f vaccinates following challenge. Nonvaccinates also exhibited a
statistically significant increase in IgGa in response to challenge. There were no
differences in IgM production within or among the treatment groups prior to or
following challenge.
Lymphoproliferation
The proliferative response of PBMC and CLNC from vaccinate, nonvaccinate
and control ponies to SAWA was determined using cells collected on D-4, D4, D9,
and DI4 (Figure 3.3). Vaccinates and nonvaccinates demonstrated a significant
elevation in the proliferative response of both PBMC and CLNC to SAWA on D14.
Though differences in the lymphoproliferative responses of vaccinates and
nonvaccinates were not statistically significant, the proliferative responses of PBMC
and CLNC from vaccinates to SAWA exceeded those of nonvaccinates prior to
challenge. Proliferation to SAWA in the CLNC of vaccinates continued to exceed that
demonstrated by nonvaccinates by as much as five fold on day 4 following challenge.
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Figure 3.2. Antibody isotype response of vaccinated and nonvaccinated ponies to S. vulgaris soluble
adult worm antigen 4 days prior to and 14 days following challenge. Serum samples were analyzed
by ELISA in quadruplicate.
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Figure 3.3. Lymphoproliferative response of pony PBMC and CLNC to S. vulgaris
antigen. PBMC (top panel) and CLNC (bottom panel), collected 4 days prior to
challenge and on days 4, 9, and 14 following challenge, were incubated for 5 days
with 4 Kg/ml soluble adult worm antigen. Proliferation was measured by thymidine
incorporation. ( B B v a c c i n a t e s n o n v a c c i n a t e s , n m controls)
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Cytokine quantification
Differences in the levels of IL-2, IL-4, IL-5, IL-10 and IFN-y on D-4, D4,
D9, and D14 post challenge were compared within each treatment group (Figure 3.4
and 3.5). PBMC from vaccinates demonstrated a significant decrease in IL-10 at D4
and D9 while IL-2, IL-4, IL-5, and IL-10 increased significantly at D14. However,
IL-2 and IL-10 did not exceed prechallenge levels (ie. fold increase < 1). PBMC from
nonvaccinates demonstrated significant decreases in IFN-y and IL-10 at D9 followed
by a significant rise in IL-10 on D14. Interferon-y production decreased significantly
in the CLNC of both vaccinates and nonvaccinates on D9 followed by a significant
increase in both groups on D14. On D9, nonvaccinates also experienced a significant
increase in IL-4 and a decrease in IL-10 in their CLNC. Significant increases in IL-4,
IL-5, and IL-10 were also observed in nonvaccinates on D14.
Comparisons of cytokine production among the three treatment groups on each
day (Figure 3.6) indicated that IL-4 production in vaccinates was significantly greater
than in nonvaccinates and controls on D4 in CLNC and on D9 in PBMC.
Comparisons of daily cytokine production in PBMC to that of CLNC for each
treatment group indicated that on D9 IL-4 production in CLNC of nonvaccinates
significantly exceeded that in PBMC.
Discussion
Differences in postchallenge clinical signs and larval recoveries demonstrated
that ponies immunized orally with irradiated L developed a protective response to
3

challenge when compared to nonimmunized ponies. In previous studies, necropsies
performed six weeks following challenge with S. vulgaris L demonstrated that ponies
3
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Figure 3.4. Cytokine production in PBMC from vaccinated, nonvaccinated, and control ponies after
oral S. vulgaris L3 challenge. Cytokine copy numbers were determined using a quantitative RT-PCR
assay and were normalized for P-actin content of each cDNA. Data is represented as the fold increase
in geometric mean over prechallenge values on the indicated days following oral challenge with
S. vulgaris L3. ( ■ ■ § Day 4, i n n Day 9 , H H Day 14). (*) represents a significant decrease, and
(A) a significant increase in cytokine production in relationship to the other days examined.
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Figure 3.5. Cytokine production in colonic lymph node derived lymphocytes (CLNC) from vaccinated,
nonvaccinated, and control ponies after oral S. vulgaris L3 challenge. Cytokine copy numbers were determined
using a quantitative RT-PCR assay and were normalized for P-actin content of each cDNA. Data is represented
as the fold increase in geometric mean over prechallenge values on the indicated days following oral challenge
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and C) a significant increase in cytokine production in relationship to the other days examined.
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vaccinated with irradiation-attenuated L did not develop lesions of verminous arteritis
3

but instead had significant periportal fibrosis, suggesting that the protective response
is generated within the intestinal submucosa and that larval antigens are cleared via
the portal system prior to L migration into the intestinal vasculature (Monahan et al
4

1994). Blocking parasite entrance to the intestinal arterioles in vaccinates should both
limit peripheral exposure to parasite antigens and prevent arterial lesions resulting in
the significant reductions in fever, depression and abdominal pain we observed in
vaccinates relative to nonvaccinates. Massive killing of larvae within the wall of the
intestine in vaccinates should, however, be expected to trigger the cascade of
inflammatory mediators responsible for pyrexia including tumor necrosis factor-a,
IL-1, and IL- . It has been postulated that clearance of killed larvae and inflammatory
6

mediators by the portal system, which is by virtue of its network of vessels of
expanding diameter, mechanically less susceptible to procoagulant effects and
thrombus trapping then intestinal vasculature, could also contribute to the decrease in
both pyrexia and abdominal pain observed in vaccinates as compared to nonvaccinates
(Monahan et al., 1994).
Following challenge with S. vulgaris, vaccinates developed an anamnestic
eosinophilia which began to rise on D4 and appeared to be peaking at D9. The
kinetics of this response preceded those previously reported (Monahan et al., 1994)
and may be the result o f a larval challenge which exceeded previously published
doses, or perhaps improved viability of either the vaccinal or challenge larvae leading
to more robust stimulation of the eosinophilic response mechanisms. IL-5 is required
for the eosinophilic response to helminth parasites (Coffman et al., 1989; Sher et al.
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1990b). Levels o f IL-5 in both the PBMC and CLNC of vaccinates exceed those of
nonvaccinates by at least four fold prior to challenge and on D4 and D9 following
challenge. Though not statistically significant, these findings appear to be
physiologically significant with greater IL-5 production prechallenge and on D4 post
challenge correlating to the more rapid increase in eosinophil numbers observed in
vaccinates relative to nonvaccinates.
Though the magnitude o f the IL-5 response in PBMC from nonvaccinates on
D14 actually exceeded that o f vaccinates, this change was not statistically significant.
However, analysis of the fold increase in IL-5 produced by PBMC of nonvaccinates
over prechallenge levels indicated that the IL-5 response on D14 was statistically
significant. Significant increases in IL-5 production were also observed in the CLNC
of nonvaccinates on D14. In previous experiments, eosinophil responses in
nonvaccinates lagged behind that observed in vaccinates by approximately one week
(Monahan et al., 1994). Accordingly, the slight increase in eosinophil counts
observed in nonvaccinates on D14 which correspond temporally with significantly
elevated IL-5 levels may signal the beginning of the eosinophilic response in this
group.
Though cytokine regulation o f murine IgG isotypes is well characterized,
allowing one to correlate antigen-driven isotype production to cytokine profiles
consistent with either Type I or Type II responses, both cytokine regulation of equine
immunoglobulin production and the relationship between the equine and murine IgG
isotypes have not been characterized. IgE production, a hallmark of helminth
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infection, was not quantified because equine-specific reagents have not been made
commonly available.
Prior studies have demonstrated that following immunization with radiationattenuated S. vulgaris L,, vaccinates develop a small increase in total immunoglobulin
directed against soluble adult S. vulgaris antigen and that following challenge with S.
vulgaris L , this SAWA-specific antibody production displays an anamnestic
3

response, converging with that o f nonvaccinates by 3 weeks post challenge (Monahan
et al. 1994). We examined the differences in immunoglobulin isotypes specific for
SAWA in vaccinates and nonvaccinates in response to challenge with S. vulgaris. Our
data indicate that the previously described increase in SAWA-specific immuno
globulin titers seen in response to vaccination are at least in part due to production of
isotypes IgGa, IgGb, and IgG(T) in response to vaccination. Following challenge,
SAWA-specific IgG(T) remained significantly greater in vaccinates compared to
nonvaccinates but was not significantly different from prechallenge levels. Increases
in IgG subclasses in response to S. vulgaris infection have been previously
demonstrated with IgG(T) showing the greatest increase (Patton et al., 1978).
However, to our knowledge, this is the first data to demonstrate the antigenspecificity of this elevation in IgG subclasses. Challenge resulted in significant
increases in SAWA-specific IgA production in both vaccinates and nonvaccinates.
SAWA-specific IgA titers observed in nonvaccinates following challenge were
significantly greater than those o f vaccinates indicating that vaccination was associated
with a blunting of the antigen-specific IgA response to adult parasite antigen.
SAWA-specific IgGa also increased significantly in the sera of nonvaccinates but not
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vaccinates following challenge. Though no changes in SAWA-specific IgM were
noted, only day D14 serum samples were assayed and given the acute nature of
antigen-specific IgM responses, it is likely that earlier samples might have detected a
difference in SAWA-specific IgM. Serum from D4 and D9 is available and
characterizing SAWA-specific isotype responses on these days is a focus of ongoing
study
Stimulation o f PBMC from ponies infected with S. vulgaris has produced a
specific proliferative response to SAWA that is absent in uninfected ponies (Dennis et
al., 1992). However, attempts to demonstrate differences in the proliferative response
to adult worm antigens between resistant and non-resistant ponies before and after
challenge infection were not successful (Klei, 1992). Though not statistically
significant, in this experiment the prechallenge proliferative responses of PBMC and
CLNC from vaccinates exceeded those of nonvaccinates suggesting that some
component of the larval vaccine was able to prime these individuals for a secondary
response to adult antigen. Following challenge, both vaccinates and nonvaccinates
respond similarly demonstrating statistically significant increases in the proliferative
responses of both PBMC and CLNC that were not significantly different between
vaccinates and nonvaccinates.
Statistical analyses o f cytokine data was complicated by the wide range of
responses seen in this outbred population as well as the limited number of controls.
Significant increases in IL-4 production were noted in the PBMC of vaccinates on
D14. Unlike IL-5 which tended to increase (though not significantly) in the PBMC of
each nonvaccinate pony, IL-4 showed minimal response in the PBMC of
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nonvaccinates over the course o f the experiment and in feet the small response on
D14 reflected that o f a single individual with a disproportionately high IL-4 response.
In contrast to the IL-4 response o f PBMC from nonvaccinates, IL-4 production was
significantly elevated on D9 and D14 in nonvaccinate CLNC. Vaccinates also
demonstrated a daily increase in CLNC IL-4 levels throughout the duration o f the
experiment but these changes were not statistically significant.
IL-4 was unique among the cytokines in that it's production by vaccinates on
D4 in CLNC and D9 in PBMC significantly exceeded that of nonvaccinates and
controls. This was not the case for IL-2, IL-5, IL-10 and IFN-y production. Though
not statistically significant, prechallenge IL-4 levels in the CLNC o f vaccinates tended
to exceed those of nonvaccinates. These differences between vaccinates and
nonvaccinates, namely greater IL-4 production in prechallenge CLNC and
significantly greater IL-4 production occurring first at the local site of parasite
invasion followed by an increase in peripheral IL-4 production by PBMC constitute
an anamnestic IL-4 response presumably associated with priming during
immunization o f vaccinates that is of course absent in nonvaccinates. Nonvaccinates,
however, did demonstrate a significant increase in IL-4 production which lagged
behind the response of vaccinates temporally, being first detected in CLNC on D9.
Though the role of IL-4 in IgE production by memory B-cells is unclear (Le Gros et
al., 1996; Levy et al., 1997), IL-4 is required for the generation and maintenance o f
secondary antigen-specific IgE responses in vivo (Finkelman et al., 1990). Therefore,
anamnestic IL-4 production might be associated with an antigen-specific anamnestic
IgE response in vaccinates following challenge. Elimination of the IgE response with
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anti-IL-4 has been shown to reverse protection in both Heligmosomoides polygyrus
immune mice (Urban, J. 1. et a l., 1991b) and primary Trichuris muris infections
(Else et al., 1994). A synthesis of these findings leads to the hypothesis that
anamnestic IL-4 production, possibly leading to an anamnestic antigen-specific IgE
response may be one component o f the immune response that differentiates S.
vulgaris immune from susceptible ponies.
Though further characterization o f the differences in IL-4 production in CLNC
and PBMC associated with vaccination and challenge are warranted, it is clear that
both vaccinates and nonvaccinates respond to challenge with S. vulgaris by producing
IL-4, and that at least in immune animals, this production of IL-4 is not restricted to
the CLNC. Though further studies are warranted to confirm that IL-4 production
varies in its magnitude and site of initial production in S. vulgaris immune ponies,
significant increases in IL-4 production in vaccinates relative to nonvaccinates at the
CLNC on D4 and PBMC on D9 suggest that the occurrence of a local immune
response characterized by the production of the Type II cytokine IL-4 which spreads
to a peripheral immune response in which IL-4 also plays a role may differentiate
susceptible and immune ponies. This difference in peripheral IL-4 production was
unique to the vaccinates and could reflect a peripheral recognition event present in
vaccinates but absent in nonvaccinates that contributes to the protective immune
response.
We observed statistically significant decreases in IFN-y on D9 in the CLNC
and PBMC o f nonvaccinates as well as in the CLNC of vaccinates. Depression of
IFN-y production was also observed in the PBMC of vaccinates though this was not
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statistically significant. Nonetheless, unlike the other cytokines assayed, IFN-y
production was consistently lower on D-4, D4, and D9 in the CLNC of vaccinates
and nonvaccinates as compared to controls. In light of the association between
decreased IFN-y production and the increased TH2 response, these findings are
certainly noteworthy.
In the TH1/TH2 paradigm inhibition o f IFN-y production is often attributed to
IL-10. Though IL-10 was originally described as a product of mouse TH2 clones, it is
now clear that IL-10 is also secreted by TH1 cells (especially in humans) and
activated macrophages (Somasse et al., 1996; Martinez et al., 1997). IL-10 is a
potent inhibitor of IFN-y production (Fiorentino et al., 1989; Urban, J. J. et a l.,
1991b). However, in our experiments a temporal relationship between increased IL10 levels and decreased IFN-y levels was not clear. All groups exhibited a decrease in
IL-10 production following challenge which was significant on D4 and D9 in the
PBMC of vaccinates and D9 in the PBMC and CLN of nonvaccinates. Significant
increases in IL-10 which were noted on D14 in the PBMC of vaccinates and the
PBMC and CLNC of nonvaccinates were relative to the depression on D9 and were
not significantly different from prechallenge levels. It is important to remember that
while IFN-y is capable of directly inhibiting the TH2 response, IL-10 inhibition o f
IFN-y production is indirect, acting on antigen presenting cells to reduce their ability
to stimulate cytokine secretion by TH1 cells. Other cytokines including IL-3 and IL-4
(Liew et al., 1989), IL-11 (Leng and Elias, 1997), IL-13 (Doherty et al., 1993), and
TGF-P (Hausmann et al., 1994) have been shown to interfere with macrophage
activation. Statistically significant elevations in IL-4 production were observed in the
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CLNC of vaccinates on D4 which could account temporally for the significant
decrease in IFN-y production seen on D9 in these individuals.
IFN-y and IL-2 tended to increase by D14 in PBMC and CLN of both
vaccinates and nonvaccinates. These increases were significant for IL-2 in the PBMC
of vaccinates, and IFN-y in the CLNC of vaccinates and nonvaccinates and may
reflect a Type I response associated with an inflammatory response to dead parasites
from the challenge dose.
It appears from this data that the immune response of both naive susceptible
and vaccinated immune ponies to S. vulgaris may involve the generation of a classical
Type II response rather than being dramatically polarized as seen in Type I and Type
II responses that define susceptibility and resistance, respectively, to murine helminth
parasites. Both S. vulgaris immune and susceptible ponies showed similar
lymphoproliferative and antibody responses to adult worm antigen following
challenge and both groups exhibited characteristics of a Type II response producing
IL-4 and IL-5 in response to challenge. However, the timing of the immune response
to challenge infections of S. vulgaris in vaccinates appears to precede that of
nonvaccinates. Natural exposure to S. vulgaris L is known to induce resistance to
3

further infection (Ogborune and Duncan, 1985) and our data support the notion that
oral vaccination with radiation-attenuated larvae may simply induce this resistance
quicker than natural exposure, thereby protecting animals from pathology. Prior to
challenge vaccinates exhibited greater antigen-specific proliferative responses and
produced more IL-4 and IL-5 in CLNC than did nonvaccinates, though these
differences were not statistically significant. Following challenge IL-4 production by
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nonvaccinates lagged behind vaccinates. Vaccinates produced significantly more IL-4
in response to challenge then nonvaccinates first in CLNC at D4 and then in PBMC at
D9 while IL-4 production in the CLNC of nonvaccinates increased significantly by
D9. Thus the ability to generate an anamnestic IL-4 response to S. vulgaris either at
the site of parasite invasion and/or perhaps in peripheral blood appears to be one
component of the protective immune response generated by vaccination with
radiation-attenuated S. vulgaris Lj.
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SUMMARY

The purpose o f this dissertation was to create reagents for the study of equine
Type I and Type II responses, to develop an assay for the quantification o f equine
cytokine mRNA, and to apply this assay in order to examine the cytokine responses of
control ponies and ponies vaccinated with radiation-attenuated Strongylus vulgaris
larvae during the generation o f their immune response to challenge with S. vulgaris L .
3

In order to develop reagents for the study of cytokine responses o f the horse, equine
IL- , IL-10 and p-actin were cloned from mitogen stimulated equine PBMC using
6

reverse transcription followed by polymerase chain reaction amplification (RT-PCR)
with primers based on consensus sequences of these cytokines in other species.
Equine IL

- 6

cDNA comprises 745 bases including 118 bases in the 3'

untranslated region. The cDNA shares 82% nucleotide identity with human IL- . The
6

open reading frame for equine EL

- 6

encodes 208 amino acids including a 28 amino acid

signal peptide. The mature protein would consist of 180 amino acids and have a
predicted relative mass of 20,471, without post-translational modification. The predicted
amino acid sequence o f equine IL

- 6

shares 78% similarity with human EL

- 6

and includes

the residues which have been shown by other investigators to be critical for biological
activity of the protein (Brakenhoff eta l., 1989, 1990; Kruttgen et al., 1990; Fontaine et
al., 1993; van Dam et al., 1993; Ehlers et al., 1994, 1995, 1996; de Hon et al., 1995;
King et al., 1996). The GenBank accession number for equine EL

- 6

is U64794.

Equine EL-10 cDNA comprises 739 bases including 202 bases in the 3'
untranslated region. The cDNA shares 89% nucleotide identity with human EL-10. The

149
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open reading frame for equine IL-10 encodes 178 amino acids including an 18 amino
acid signal peptide. The mature protein would consist of 160 amino acids and have a
predicted relative mass o f 18,615 without post-translational modification. The predicted
amino acid sequence o f equine IL-10 shares 91% similarity with human IL-10 and
includes the residues which are postulated to be significant in receptor binding based on
the X-ray crystallographic structure o f human recombinant IL-10 (Walter et al., 1995).
Equine IL-10 shares 85% nucleotide identity with an IL-10-like sequence in the genome
of Equine Herpes Virus-2. The GenBank accession number for equine IL-10 is U38200.
The cloned equine P-actin comprises a single open reading frame o f 1128 bases.
The cDNA shares 94% nucleotide identity and 100% amino acid identity with human Pactin. The mature protein has a predicted relative mass of 18,615 without posttranslational modification. The GenBank accession number for equine P-actin is
AF035774.
A RT-PCR based assay was utilized to quantify cytokine message in cDNA
samples by comparison to a standard curve. To generate the standard curve, known
concentrations o f plasmid encoding the cDNA of interest were amplified in conjunction
with the unknown cDNA samples in triplicate PCR reactions. PCR product was detected
using a luminescence based assay in which sequence-specific probes were hybridized to
the PCR products in solution and detected using a Perkin-Elmer QPCR System 5000.
The message content o f the unknown samples was determined by interpolation against
the standard curve using a two parameter exponential rise to maximum analysis of the
standard curve data. P-actin was used as a normalization factor by altering the cycling
parameters to maintain its amplification within the exponential amplification phase o f the
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reaction. The assay resolves 2 fold changes in cytokine message, has a linear dynamic
range on the order of 3 logs, and is precise with errors most commonly in the range of
10% for replicate amplifications from the same sample. The error between replicate
samples whose RNA was derived from separate extractions o f the same cell population
following P-actin normalization was 13-27%. This assay was utilized to determine the
effect of oral vaccination with radiation-attenuated S. vulgaris larvae on the cytokine
response to oral challenge with S. vulgaris.
1 0

ponies were reared in a parasite free environment and divided into three

groups. Four ponies were orally vaccinated with 500 S. vulgaris third-stage infective
larvae (vaccinates) which had been radiation-attenuated with 90 krads from a “ Co
source. Vaccinations were performed 9 and

6

weeks prior to oral challenge with 1000

non-attenuated L, on day 0. Four other ponies were not vaccinated (nonvaccinates) and
were also challenged with 1000 L on day 0. Control ponies were neither vaccinated nor
3

challenged. Four days prior to challenge, as well as on days 4 (D4) and 9 (D9) post
challenge, peripheral blood as well as lymph nodes from the region o f the cecum (CLN)
were collected. Peripheral blood and CLN were also collected at necropsy on day 14
(D14) post-challenge.
Oral immunization with radiation-attenuated S. vulgaris L, provided protection
from challenge. Ponies immunized with irradiated L developed anamnestic
3

eosinophilias, had fewer episodes o f pyrexia, depression, and abdominal pain, and were
1 0 0

% protected from larval migration when compared to nonvaccinated ponies.
Soluble adult S. vulgaris antigen-specific antibody isotypes from vaccinates and

nonvaccinates were compared on D-4 and D14. Vaccination caused significant increases
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in SAWA-specific IgGa, IgGb, and IgG(T). IgG(T) remained significantly greater in
vaccinates than nonvaccinates on D14 but was not significantly different from D-4
values. Challenge significantly increased IgA in vaccinates and nonvaccinates.
Vaccination blunted the SAWA-specific IgA response. IgGa also increased significantly
in the sera o f nonvaccinates but not vaccinates by D14.
The proliferative response o f PBMC and CLNC from vaccinate, nonvaccinate,
and control ponies to SAWA was determined on D-4, D4, D9, and D14. Prior to
challenge, the proliferative responses o f PBMC and CLNC from vaccinates exceeded
those of nonvaccinates but these differences were not significant. By D14 vaccinates
and nonvaccinates demonstrated a significant elevation in the proliferative response of
both PBMC and CLNC to SAWA.
Total RNA from PBMC and CLN derived cells (CLNC) was assayed for IL-2,
IL-4, IL-5, IL-10, and IFN-y message in the aforementioned RT-PCR assay. Prior to
challenge, vaccinates produced more IL-4 and IL-5 than nonvaccinates, though these
differences were not statistically significant. Following challenge, both vaccinates and
nonvaccinates demonstrated a Type II cytokine pattern with significant elevations in EL4 and IL-5 production. Vaccinates demonstrated significant increases in IL-2, IL-4, IL-5,
and IL-10 production in PBMC on D14 post-challenge though IL-10 production initially
decreased significantly on D4 and D9. Nonvaccinates demonstrated significant decreases
in IL-10 and IFN-y production on D9 and a significant increase in IL-10 production on
D14 in their PBMC. In CLNC, only nonvaccinates demonstrated significant increases in
IL-4 and IL-5 production in response to challenge. Vaccinates also demonstrated
increases in IL-4 and IL-5 production in CLNC in response to challenge but these

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

153
increases were not significant because o f the higher pre-challenge levels o f IL-4 and IL-5
in their CLNC. Vaccinates did exhibit a significant decrease in IFN-y production on D9
followed by a significant increase on D14. Nonvaccinate CLNC exhibited significant
decreases in IFN-y and IL-10 message on D9 followed by significant increases in IL-4,
IL-5, IL-10 and IFN-y by D14. When groups were compared, vaccinates produced
significantly more IL-4 in response to challenge then nonvaccinates or controls, first in
CLNC at D4 and then in PBMC on D9. There was not a significant difference in the
production o f IL-2, IL-5, IL-10, or IFN-y between groups.
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CONCLUSIONS

Equine IL

and IL-10 exhibit significant nucleic acid homology (>80%) and

- 6

amino acid similarity (>70%) with the respective sequences o f other domesticated
mammals. The sequences include putative receptor binding residues and are therefore
likely to be biologically active. Expression and determination of the biological activity o f
the recombinant proteins is a focus o f continuing research.
Cytokine messenger RNA can be quantified using RT-PCR in the exponential
amplification phase o f the reaction by interpolation against a plasmid standard curve
derived from known dilutions o f plasmids encoding the cytokines o f interest. Analysis of
the standard curve using a two parameter exponential rise to maximum analysis of the
data graphed on linear scales, given by the equation y=a(l- e'bx), provides superior
prediction of two fold dilutions in RNA content of cDNA reactions when compared to
other published analyses o f the standard curve. This also indicates that amplification
from double stranded plasmid can accurately model the amplification efficiency o f
cDNA. Using triplicate amplifications from the same cDNA, the assay resolves 2 fold
changes in cytokine message and is precise with errors most commonly in the range of
1 0

% for replicate amplifications from the same sample which is in line with the results

achieved with quantitative competitive RT-PCR methods. The dynamic range o f this
assay is on the order of 3 logs, exceeding the dynamic range achieved by competitive
methods.
Despite its

1

0 0 - 1

0

0

0

fold greater expression, equine P-actin, whose amino acid

sequence is identical to that o f human P-actin, is useful in normalizing inter-sample
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variability in the RNA extraction and reverse-transcription steps of the RT-PCR assay
provided its values fall within the exponential amplification portion of the standard
curve. Under these conditions the error between replicate samples whose RNA was
derived from separate extractions o f the same cell population following normalization
was 13-27% which is in line with the errors using quantitative competitive methods.
As previously demonstrated, oral immunization with radiation-attenuated S.
vulgaris L protects ponies from challenge infections, preventing larval migration and
3

significantly decreasing clinical signs associated with challenge including pyrexia,
depression, and abdominal pain. Vaccination is associated with the development o f an
anamnestic eosinophilia which is known to be a Type II dependent response though a
temporal relationship between elevated IL-5 production and eosinophilia was not
established.
Vaccination induced significant increases in SAWA-specific IgGa, IgGb, and
IgG(T). Challenge induced significant increases in IgA in vaccinates and nonvaccinates
and significant increases in IgGa in nonvaccinates. Though cytokine regulation o f murine
IgG isotypes is well characterized, allowing the correlation of antigen-driven isotype
production to cytokine profiles consistent with either Type I or Type II responses, both
cytokine regulation of equine immunoglobulin production and the relationship between
equine and murine IgG isotypes have not been characterized so that the relevance of
Type I and Type II cytokine responses to equine isotype production cannot be
established.
Though not statistically significant, the prechallenge proliferative responses of
PBMC and CLNC from vaccinates exceeded those of nonvaccinates suggesting that
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some component of the larval vaccine was able to prime these individuals for a
secondary response to adult antigen. Challenge sensitized both vaccinates and
nonvaccinates to adult antigen.
Both vaccinates and nonvaccinates exhibited characteristics o f a Type II cytokine
response producing significant IL-4 and EL-5 in response to challenge and indicating
that equine species generate Type H responses to gastrointestinal nematodes. However,
the timing of the immune response to challenge infections in vaccinates appears to
precede that o f nonvaccinates. Thus, the ability to generate an anamnestic IL-4 response
either at the site of parasite invasion and/or perhaps in peripheral blood appears to be
one component o f the protective immune response generated by vaccination with
radiation-attenuated S. vulgaris L, indicating that the protective immune response to S.
vulgaris probably involves the induction o f a Type II cytokine response.
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